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Department of cardiology 
Rein Teesalu 
Department of cardiology is one of the 18 clinical departments of the 
University of Tartu. It has 3 equally important and mutually related 
functions: 1) clinical work, 2) teaching and 3) research work. 
Clinical work is carried out in three divisions — cardiological 
(80 beds), myocardial infarction (36 beds, including 7 beds in CCU) 
and cardiosurgical (40 beds, including 6 beds in postoperative ward). 
The staff of the department is also involved in outpatients' service, 
working in the outpatients' clinic of the University of Tartu as consul­
tants in cardiology. 
Teaching is an important part of our activities as the only medical 
faculty in Estonia is at the University of Tartu. The number of me­
dical undergraduate students has shrunk in the near past and is now 
(in 1994) 1200. On the other hand, more attention is now payd to 
postgraduate students, though the system of postgraduate teaching 
is still in state of rearrangements.Postgraduate students are interns 
(2-year study period), residents (3-year study period) and doctorants 
(4 years to obtain Ph.D.). Teaching is carried out in three chairs: 
1) cardiology, 2) cardiosurgery and 3) internal medicine propedeu­
tics. In addition, a subunit for more profound teaching of nurses 
(headed by associate professor Mare Lind) was lately founded. 
Research work has become more effective in comparison with 
what it was a few years ago. We took part in the biggest multicent­
ral study in cardiology ISIS-4. At the present time our colleagues 
are taking part in several international projects: 1) "Randomized, 
Double-Blind, Placebo-Controlled Study of the Efficacy and Safe-
ty/Tolerability of Miroton® forte for Heart Failure". Clinical pro­
ject manager: Prof. Dr. Axel Brattström, Knoll Deutchtand GMBH. 
Investigator: Prof. Rein Teesalu, University of Tartu. 2) "Blin­
ded Comparison of d-Sotalol and Amiodarone in the Treatment of 
Life-Threatening Ventricular Arrhythmias". Study Director Kathleen 
Moulton. Bristol-Myers Squibb Pharmaceutical Research Institute. 
3) "Efficacy and Safety of Dofetilide in the Acute Conversion of Pa­
roxysmal Supraventricular Tachycardia to Sinus Rhythm- a Rando­
mised Comparison with Verapamil and Placebo". Study Director 
Peter Aurup. Pfizer Ltd. We were represented (jointly with the de­
partment of biochemistry) by an oral report on the Joint XHth World 
Congress of Cardiology and XVIth Congress of the European Society 
of Cardiology (T. Parik, К Allikmets, K. Zilmer, T. Vihalemm, T. Kul-
lisaar, R. Teesalu, M. Zilmer "Evidence for oxidative stress in essential 
hypertension: perspective for antioxidant therapy). Two of our col­
leagues — Margus Viigimaa and Rein Kolk — have obtained Ph.D. 
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in 1994: 1) Margus Viigimaa "Primary Haemostasis, Antiaggregative 
and Anticoagulant Treatment of Acute Myocardial Infarction". Tar­
tu, 1994. 2) Rein Kolk "Atrial versus Ventricular Pacing in Patients 
with Sick Sinus Syndrome". Tartu, 1994. 
Board of the department of cardiology. 
1) Rein Teesalu, M.D., Ph.D., prof, of cardiology, head of the de­
partment 
2) Lembit Roostar, M.D., Ph.D., prof, of cardiosurgeiy 
3) Kaljo Valgma, M.D., Ph.D., extraordinary prof, of cardiology 
4) Maido Uusküla, M.D., Ph.D., associate prof, of cardiology 
5) Margus Viigimaa, M.D., Ph.D., senior research worker 
6) Kai Saks, M.D., Ph.D., associate prof, of propedeutics of internal 
medicine 
7) Enno Kõiv, M.D., Ph.D., head of the division of cardiology 
8) Üllar Soopõld, M.D., Ph.D., head of the division of myocardial 
infarction 
9) Kadri Siim, M.D., senior doctor of the division of cardiology 
10) Mati Ress, M.D., head of the division of cardiosurgery 
11) Maiju Meus, chief nurse of the division of myocardial infarction 
12) Svetlana Rääbis, chief nurse of he division of cardiology 
13) Anita Priks, chief nurse of the division of cardiosurgery 
14) Ulvi Sooru, nurse of the division of cardiology 
Chair of cardiology 
Rein Teesalu 
Teaching staff: 
1) Prof. Rein Teesalu, head 
2) Extraordinary prof. Kaljo Valgma 
3) Associate prof. Mare Lind 
4) Associate prof. Eevi Maiste 
5) Associate prof. Maido Uusküla 
6) Assistent prof. Külliki Karu 
7) Laboratory assistent Sille Tamme (on maternity leave) 
Teaching: 
1) Full course on cardiology for 4th year medical students 
a) 24 lectures each 2 academic hours (prof. R. Teesalu) 
b) practical training (80 hours, whole staff) 
2) Seminars and practical training for 6th year students (75 hours, 
whole staff) 
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Optional courses for students: 
1. Diseases of myocardium. Prof. 1  Valgma 
2. Fundamentals of clinical echocardiography. 
Associate prof. E. Maiste 
3. Atherosclerosis. Diagnostics, prevention, treatment. Epidemio­
logy of ischemic heart disease. Assistent prof. M. Zemtsovski 
4. On diagnostic mistakes in heart patients. Associate prof. M. Lind 
5. Acute coronary insufficiency. Unstable angina, myocardial in­
farction. Associate prof. M. Uusküla 
Courses for physicians: 
1. Arrhythmias. Diagnosis. Treatment. Prof. R. Teesalu 
2. Acute coronary insufficiency. Unstable angina. Myocardial in­
farction. Associate prof. M. Uusküla 
3. Electrocardiography. Assistent prof. K. Karu 
4. Clinical physiology and functional diagnostics of circulation. As­
sociate prof. E. Maiste 
5. Actual problems of cardiology. Extraordiary prof. K. Valgma 
6. Selected problems of diagnostics and treatment of heart diseases. 
Associate prof. M. Lind 
7. Intensive course on electrocardiography. Assistent prof. K. Karu 
8. Electrocardiogrphy. Associate prof. I. Liiv 
9. Selected problems of cardiology. Associate prof. I. Liiv 
Research: 
I Doctorants and their topics of research: 
1) Kristina Allikmets (supervisor prof. R. Teesalu): "Renin Profiling 
in Arterial Hypertension: Association with Metabolic Cardio­
vascular Risk Factors". 
2) Thin Parik (supervisor prof. R. Teesalu): "Oxidative Stress and 
Metabolic Disturbances in Essential Hypertension". 
3) Tiina Ristimäe (supervisor prof. R. Teesalu): "Silent Myocardial 
Ischemia in Patients with Congestive Heart Failure". 
II Main research fields of the clinical physiology research group (Dr. 
Margus Viigimaa, PhD; Dr. Y. Saareoja, Dr. Maie Ojamaa, researcher 
Tiiu Jõudu): 
1) Blood coagulation, antiaggregative, anticoagulant and thromboly­
tic treatment in cacdiac patients. 
2) Nuclear medicine methods in cardiology. 
Current collaboration: 
1) Low molecular weight heparin in the treatment of coronary heart 
disease (Uppsala University, Dept. of Cardiology, Prof. L. Wal-
lentin). 
2) Activated protein С resistence in young patients suffering from 
myocardial infarction (Lund University, Prof. B. Dahlbäck). 
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Personnel of the outpatients' consultation room. Sitting (from the leht): 
Ljubov Keis, cardiologist; Enno Kõiv, head of the devision of cardiology; 
Koidu Tauk, nurse.Standing (from the left): Urve Angerjärv, nurse; Helgi 
Kärner, nurse. 
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3) Preclinical studies of recombinant hirudin and transcutaneous 
prostaglandin El (Hannover Medical School, Dept. of Clinical 
Pharmacology, Prof. J. Frölich). 
4) Nuclear medicine methods in cardiology (Oulu University, Dept. 
of Nuclear Medicine, Dr. A. Ahonen). 
Ill Research work of the clinical cardiology research gpoup (Maido 
Uusküla, Kristin Lamp, Silvia Noodla): 
During many years the group has studied the immune response in 
acute myocardial infarction. TWo original methods were elaborated by 
this group: the test for detection lymphocytes, specifically sensitized 
to myocardial antigen-active rosette formation inhibition test (Labo-
ratornoje Delo, 1985, No 1, pp. 38^40) and the test of spontaneous 
and specific adherence and spreading of phagocytes in presence of 
myocardial antigen (Immunologija, 1989, No 9, pp. 50-52). The pre­
sent topic of research is the role of immunological and clinical data 
in the diagnosis, clinical course and prognosis of myocarditis, dilated 
cardiomyopathy and bacterial endocarditis. Also, the study on cardiac 
morphometry and body composition is carried out to investigate their 
role as risk factors in borderline hypertension in young age. 
Grants of the Estonian Scientific Foundation. 
1. Estimation of the antithrombotic efficacy of low molecular weight 
heparin in patients with acute myocardial infarction. 
2. Influence of different antihypertensive drugs on arterial hyper­
tension as risk factor of coronary artery disease. 
Chair of Cardiothoracic Surgery 
Lembit Roostar 
The Department of Cardiothoracic Surgery is part of the Univer­
sity Heart and Lung Hospitals, situated at the Maarjamõisa Hospital 
Complex. This is a training center for university students in cardiac 
and thoracic surgery, disaster medicine and military surgery. The De­
partment is also responsible for postgraduate and continued education 
studies. The Department has designed programs for three year cour­
ses of cardiac and thoracic surgery. The Department is in charge of 
both lecture courses and practical supervised training (2500 hours per 
year). Students are required to work in hospital under the guidance 
of experienced doctors. 
The programs the Department offers are: 
* cardiac surgery aimed at fourth-year students, 30 hours of work: 
lectures —10 h, practical training — 18 h, seminars — 2 hours; 
* thoracic surgery for fourth-year students, 30 hours of work: lec­
tures —10 h, practical training —18 h, seminars — 2 hours; 
* disaster medicine and military surgery for sixth-year students, 
85 hours of work: lectures — 25 h, practical training — 54 h, 
seminars — 6 hours; 
* cardiothoracic surgery for residents of general surgery, 180 hours 
of work; 
* cardiac surgery for residents of heart surgery lasting three years 
(lectures — 54 hours, seminars — 86 hours, clinical and research 
work); 
* thoracic surgery for residents of chest surgery lasting three years 
(lectures — 60 hours, seminars — 80 hours, clinical and research 
work); 
* for students in doctorate studies lasting four years in cardiotho­
racic surgery, disaster medicine and military surgery. 
Clinical training is conducted in the following study and therapeutic 
centers: 
* Cardiosurgery Division (40 beds) including invasive procedure 
center and operating theaters: 
* Thoracic Surgery Division (25 beds): 
* Intensive Care Unit of the Anaesthesiology and Intensive Ca-
reHospital and the Traumatology and Orthopedics Hospital and 
General Surgery Division of the Surgery Hospital. 
The Cardiosurgery Division takes care of all the patients in Es­
tonia with congential and acquired heart defects and rhythmic dis-
durbances and for 50 per cent of the patients with coronary artery 
disease. The relevant statistics for the 1994 are: 141 open heart ope­
rations with the help of heart-lung machine, 71 closed operations and 
250 pacemaker implantations. 
The Division of Thoracic Surgery takes care of 30 per cent of the 
patients in Estonia. About 200 operations are performed in a year. 
The research work concerns: 
* epidemiology of heart surgical diseases, 
* Estonian heart disease building registers, 
* diagnosis and surgery of infective endocarditis, 
* diagnosis and surgery of multiple valve diseases, 
* reoperations of the heart, 
* emergency cardiac surgery on newborns and infants, 
* use of biological materials, 
* intraoperative cardiac function measurements, 
* operative techniques in coronary bypass grafting, 
* prevention and surgery in pleural empyema, 
* combined lung tumors treatment, 
* thoracic traumata, 
* polytraumata, 
* gunshot injuries in peacetime. 
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The basic lines of research for 5-10 years are: 
* congential heart defects, 
* acquired heart defects, 
* coronary disease, 
* heart rhythmic disturbances, 
* heart transplantation, 
* invasive endovascular surgery, 
* by-pass circulation, anaesthesia and intensive care in cardiac sur­
gery, 
* new materials and techniques in thoracoscopy, 
* reconstructive thoracic operations, 
* lung transplantation, 
* analysis of disasters from their medical point of view, 
* organisation of first-aid institution for disasters of multiple casua­
lties, 
* combined and multiple injuries, 
* gunshot injuries. 
At present the staff of the Chair of Cardiothoracic Surgery includes: 
Professor L. Roostar — head of the Chair, 
T. Arak — assistent, part-time 0,25 
T. Aro — assistent, part-time 0,25 
H. Kuiv — assistent, part-time 0,25 
V. Laisaar — assistent, part-time 0,5 
E. Leesik — assistent, part-time 0,5 
T. Loog — assistent, part-time 0,25 
В. Malikov — assistent, part-time 0,5 
M. Murruste — assistent, part-time 0,5 
M. Ress — assistent, part-time 0,25 
I. Roose — assistent, part-time 0,25. 
There are four students of the doctorate study. The subjects of their 
research are: 
M. Murruste: "Therapy strategy by combined injuries of the intraab­
dominal organs" 
T. Loog: "Long-term prognosis of surgical treatment of acquired heart 
defects" 
T. Arak: "Preventive measures to avoid wound complications" 
T. Laisaar: "Therapy strategy by pleural empyema" 
The members of the Department have published over the past five 
years 111 papers (monographts, papers, abstracts) and participated in 
international conferences abroad and at home. 
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Chair of internal medicine propedeutics 
Kai Saks 
Teaching staff: 
Kai Saks, M.D., Ph.D., Associate Professor, Head of the Chair 
Elmut Laane, M.D., Ph.D., Professor Emeritus 
Michail Zemtsovsky, M.D., Ph.D., assistant 
Riste Ridala, M.D., assistant 
Tiit Pokk, M.D., assistant 
Andres Mesila, M.D., doctorial student 
Research work: 
Myocardial reserve, heart failure. 
Physical rehabilitation of cardiac patients (mineral water baths, 
curative mud baths, sauna procedures, regulation of respiratory 
rhythm, etc.). 
Blood lipids and lipoproteins in coronary heart disease patients. 
Teaching courses: 
1. Propedeutics of internal medicine 
Subject supervisor: Associate Professor Kai Saks 
For: 
1) students of the department of medicine, 6. semester, 80 hours 
2) students of the department of stomatology, 5. semester, 32 hours 
At the end of this course the student should be able to elicit, orga­
nize, record and present a full medical history, to have the skills requi­
red to conduct a full physical examination, to interpret the meaning 
of information obtained by such examination, to present (orally and 
in writing) the results of the examination, and to establish the most 
common syndromes in internal medicine. 
2. Cardiology 
Subject supervisor: Associate Professor Kai Saks 
For: 
1) students of the department of stomatology, 6. semester, 48 hours 
2) students of the department of nursing, 2. semester, 24 hours 
At the end of this course the student should be able to performe 
examination of the cardiovascular system, to establish serious disor­
ders of the cardiovascular function, to know the epidemiology and risk 
factors of cardiovascular diseases, main principles of diagnostics and 
management of cardiac patients, and be able to give first aid to acute 
cardiac patient. 
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3. Nursing 
Subject supervisor: Assistant Tiit Pokk 
For: 
students of the department of medicine and stomatology, 1. semester, 
32 hours. 
At the end of this course students should know the main principles 
of the functioning of the medical establishment, be able to perform the 
physical examination of vital functions, to be familiar with the main 
principles of nursing, be able to perform certain medical procedures. 
Optional courses: 
1. Research work in a doctor's work. Professor Emeritus Elmut 
Laane 
2. The sauna and health. Professor Emeritus Elmut Laane 
3. Geriatric cardiology. Associate Professor Kai Saks 
4. Diagnostics, prevention and treatment of atherosclerosis. Epide-
miolgy of ischemic heart disease. Assistant Michail Zemtsovski 
Courses for physicians: 
1. Principles of physical rehabilitation for coronary heart disease pa­
tients and hypertonic patients. Professor Emeritus Elmut Laane 
2. Electrocardiography. Professor Emeritus Elmut Laane 
3. Age-dependant cardiology. Associate Professor Kai Saks 
The unit of nursing science 
Mare Lind 
The unit was opened in 1991. The study period is 3 years. The first 
20 students graduated in June 1994 and in September 1994 the ma-
gistry study was established in this discipline. The teaching staff of 
practically all clinics of the Medical Faculty and several other faculties 
is involved in the teaching process. The head of the department is 
associated professor M.Lind. Valuable help in organizing teaching 
process and practice has been delivered by the Estonian Nurses As­
sociation and Tartu Medical School. 
Why has the necessity for medical nurses with higher education 
come up? 
In 1977 the 30-th World Health Assembly adopted two important 
resolutions: "Health for all by the year 2000" and the resolution 
recognizing the importance of nursing and midwifery personnel in 
primary health care. Estonia belongs to the European Region of 
the WHO, that is why those resolutions serve as guidelines for our 
activities also. The global strategy of WHO pays special attention to 
the training of health personnel. In addition, the European Region has 
formulated its own four main areas of concearn: lifestyles and health, 
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risk factors affecting health and environment; the reorientation of 
the health care system; preventing disease; treatment and nursing. 
The member states share their experiences in professional training 
of nursing and midwifery personnel. Estonia has closest relations 
with the Scandinavian regional organizations. For example, we have 
very useful contacts with Ersta Diakonisallskaps Sjeksköterskehög 
Skola and Ersta Vardetiska Institut.. Nursing practice should focus 
on promoting and maintaining health as well as preventing diseases 
in whole population, especially in risk groups. The nursing and the 
nurses are part of the process of change today. These changes involve 
also our medical school. 
After graduating from the medical school and practising as a nurse 
for 2 years, nurses can start their higher education programme at the 
unit of nursing science. Candidates for nursing training should go 
through intelligence test and write an essay. 
Why is higher education of medical nurses reasonable within the 
University and not in a medical school? 
The subjects include preclinical and clinical disciplines, nursing, 
medical deontology, psychology, pedagogics, philosophy, languages, 
economy, book-keeping and basis for leadership. The teaching 
process is not limited with medical disciplines only but requires in­
volvement of the staff of other faculties. In practical training special 
attention is paid to intensive care, administrative work and pedago­
gics. The first graduates had the possibility to go through practice in 
Sweden and Finland. For this we are very thankful to the Estonian 
Nurses Association and similar national organizations in Sweden and 
Finland. We are looking forward to continue this kind of work. 
Final exams include pedagogics, intensive care and health care. 
The graduates get the qualification to act as a leader of nursing care 
team and help nurses and other staff to acquire new knowledge and 
skills. 
Division of cardiology 
Maido Uusküla, Enno Kõiv 
The division of cardiology with 80 beds began to work in April, 1976 
and is one of teaching units of Maarjamõisa Hospital. The personell 
is made up of 1 head of division and 10 cardiologists, working in the 
wards and giving emergency treatment as doctors in charge; 19 nurses, 
11 assistant-nurses and 8 technical workers. All of the physicians 
have high or first degree of qualification in cardiology. In 1993 ca 
7000 ambulatory patients were seen by cardiologists in our outpatient 
department. 
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Everyday clinical and teaching activities are connected with ot­
her units of clinic, as laboratory, sonography, X ray, cardiosurgery, 
radionuclear image etc. There is a good cooperation with CCU in 
the division of myocardial "infarction. Among cardiologists there are 
two who are specialized in echocardiography, two — in rhythmology. 
Regarding cardiac arrhythmias, all the major fields are covered both 
by research and everyday clinical work. The following procedures 
and operations are available: electrophysiologic studies, noninvasive 
and invasive; antiarrhythmic treatment testing; Holter and ambulatory 
blood pressure monitoring; cardiac pacing, temporary and permanent, 
single, dual chamber and rate responsive. Besides, radiofrequency 
catheter ablation is about to be started. 
There are supervisors-consultants from the teaching staff of the 
university who are responsible for everyday clinical and research work 
in the division: prof. K. Valgma, ass. prof. M. Uusküla. 
Main statistical data about the 5-year period are as follows: 
Mean data of last 5 years per year 
No of beds 80 
No of patients 2159 
No of bed-days 31542 
Turnover of bed per year 27,6 
Mean lenght of hospitalization 14,6 
No of deaths 24 
In-hospital mortality 1,1% 
The mean number of more frequent diseases, treated in the divi­
sion of cardiology were as follows: 
Diseases of myocardium 622 27% 
viral or infectious myocarditis, 
dilated or hypertrophic cardiomyopathy 
Coronary heart disease 481 21% 
Hypertension 268 12% 
Rhythm and conduction disorders 355 15% 
35% of patients treated in the division of cardiology were urgent: 
acute heart failure, uncontrolled hypertension, rhythm and conduc­
tion disturbances. 
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Division of myocardial infarction 
Üllar Soopõld 
The division of myocardial infarction, was founded in 1976. The 
Coronary Care Unit started working as an ingredient part of this 
department in 1980. The following seven physicians are working there 
at present: Üllar Soopõld Ph.D, head of department, Ago Kõrgvee 
deputy head, Külli Teesalu, Mare Õim, Mart Kalder, Sirje Tikk, Heli 
Pallo. Everyone has high-degree cardiological qualifications and has 
been specially trained for intensive care. Rein Teesalu is the consulting 
professor. 
The medical staff consists of 28 people (nurses, hospital atten­
dants, technical workers and students). We have 36 beds and 7 ones 
in CCU. About 800 patients are hospitalized per year. The majority of 
patients suffer from coronary heart disease. Approximately 250 pa­
tients are hospitalized with myocardial infarction. A large number 
of patients with angina pectoris, rhythm disturbances and heart failu­
re need stationary treatment. Frequently patients with hypertonia 
and arterialhypertension, infectious myocarditis are examined. On 
an average, a patient stays in our department for 13.5 days. Hospital 
mortality rate of myocardial infarction was 15.5% in 1993. Successful 
cardiopulmonary resuscitations were performed in 14 cases last year. 
CCU plays a great part in emergency cardiology. In 1993 53% of 
patients who needed examination and treatment in the department 
passed through the CCU. They are patients with acute myocardial in­
farction, lifethreatening rhythm distrubances, expressive heart failure, 
hypertonic crisis, pulmonary artery embolism and with other cardio­
logical emergencies. 
In CCU there are medicinal facilities for ECG and hemodynamic 
monitoring, noninvasive or transvenous cardiac stimulation. In 1993 
we used electric cardioversion in 56 cases to restore regular sinus 
rhythm. 
In the management of myocardial infarction we try to use throm­
bolytic therapy as early as possible. As a rule, we give intravenous 
infusion of 1,5 million units of streptokinase. In 1993 about 20% 
of patients with myocardial infarction were treated by thrombolysis. 
In post-thrombolytic period we continue prohylaxic treatment with 
aspirin and Fragmin to avoid reocclusion. 
The information about our clinical experiences is of interest for 
research workers of Tartu University and others. In 1992-1993 the 
personnel of the department participated in the international coope­
rative study ISIS-4. 
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Division of Cardiac Surgery 
Mati Ress 
The Division of Cardiac Surgery dates back to the sixties and has 
developed over a period of more than 30 years. The first closed mitral 
commissurotomy was performed in 1958. Open heart surgery started 
in 1966 when the first atrial septal defect was closed. Up to now 
1755 open heart and 1463 closed operations have been carried out. 
Over 2600 cardiac pacemaker operations have been performed. 
The division includes 40 beds and a 8-bed ICU. Preoperative diag­
nostics, surgery and postoperative care are performed in the division. 
This is the only center for congenital and heart valve surgery in Esto­
nia. About 600 patients are admitted and 250 of those are operated 
upon. 
Congenital heart defects are operated on from the very first days 
of life. These operations include arterial switch, palliative shunts, 
coarctation of aorta, closure of DAP in premature babies etc. Alto­
gether some 40-60 open heart and 40-50 closed operations are carried 
out for congenital heart defects annually. 
Over 120 patients with acquired heart valve disease are operated 
upon per year. Of those 70-80 are open heart operations. Pati­
ents with single or multiple valve disease, but without complications, 
present very low operative mortality. However, more complex cases 
(e.g. extensive valve calcinosis, intracavitary thrombosis, reopera­
tions, high grade CHF) account for 60-70% of our case load. Patients 
with infective endocarditis of native cardiac valves often present va­
rious complications, however the results of operative treatment are 
highly rewarding. Operative mortality of the consecutive 112 cases 
was 11.6%. Operative treatment of ascending aortic aneurysms or 
dissections has been introduced. The results so far are promising. 
Smaller amount of our patients include combined cases of heart valve 
and coronary artery disease and patients with heart tumors. 
The overall number of operations on cardiac pacemakers exceeds 
2600, including over 1600 primary implants. Total heart block and sick 
sinus syndrome are the main indications. Intermittent heart block and 
atrial fibrillation account for implants as well. Transvenous approach 
is used exclusively, both atrial and ventricular leads are being imp­
lanted. We perform single and dual chamber pacing as well as rate 
responsive pacing. 
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MAGNESIUM STATUS IN PATIENTS 
WITH ESSENTIAL HYPERTENSION: 
RELATIONSHIP WITH PLASMA RENIN ACTIVITY 
Kristina Allikmets, Ttiin Parik, Rein Teesalu 
Abstract 
Objectives. This study was designed to investigate the relationship 
between magnesium metabolism and renin-angiotensin system activity 
in patients with essential hypertension 
Subjects and design. Patients with uncomplicated essential hy­
pertension (n=32) with diastolic blood pressure 95-115 mmHg were 
studied. Assessment of plasma renin activity (PRA) related to uri­
nary sodium excretion was used to define subgroups with high (n=7), 
medium (n=16) and low renin profile (n=9). Serum magnesium and 
calcium concentration, also urinary magnesium and calcium excretion 
(in 24-h urine sample) were assessed photometrically. Normotensive 
age- and sex-matched persons (n=19) served as controls. 
Results. Serum magnesium concentration in the patient group 
(n=32) was significantly lower, than in the controls (p<0.01), so was 
the urinary excretion of magnesium (p<0.05). Serum total calcium 
concentration was similar in the patients and in the control group, 
so was the urinary excretion of calcium. Patients with high PRA had 
lower levels of serum magnesium and lower urinary magnesium excre­
tion, than the low PRA group (p<0.05). Serum calcium concentration 
was higher in patients with high PRA, when compared to the low PRA 
group (p<0.05). Urinary calcium excretion was also higher in the high 
PRA group, but this difference was statistically not significant. 
Conclusions. Our results indicate, that patients with essential 
hypertension display lower serum magnesium concentrations when 
compared with the normotensive controls, and that this magnesium 
deficiency is more pronounced in the high PRA group of patients. 
Introduction 
Hypertensive disease in known to be associated with abnormalities 
of magnesium metabolism (Altura 1990). Magnesium, in close coo­
peration with calcium, is an important regulator of vascular tone and 
peripheral vascular reactivity (Altura 1984). It has been suggested that 
magnesium can regulate calcium flux across the vascular smooth musc­
le cell membranes as well as its release from intracellular storage si­
tes, thus facilitating muscle contraction and relaxation (Sjogren 1989). 
Magnesium depletion could therefore induce vasoconstriction, resul­
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ting in elevated blood pressure (Zhang 1993). Several studies have 
demonstrated the presence of hypomagnesemia in serum and/or in 
tissues in arterial hypertension (Touyz 1987, McCarron 1983). 
While the deviations of calcium metabolism in essential hyper­
tension have been studied extensively and shown to be closely linked 
with the renin-angiotensin-aldosterone system activity (Resnick 1983), 
the relation between magnesium metabolism and blood pressure is 
still incompletely understood (Altura 1993). Despite the above men­
tioned hypomagnesaemia, not all hypertensive patients benefit from 
magnesium supplementation, suggesting an underlying heterogenity 
of magnesium metabolism in essential hypertension (Ferrara 1992, 
Cappuccio 1985). 
Therefore, this study was designed to investigate the relationship 
between magnesium metabolism and renin-angiotensin system activity 
in patients with essential hypertension. 
Materials and Methods 
Study subjects. Thirty two patients with mild to moderate essential 
hypertension were studied (diastolic blood pressure 95-115 mmHg; 
mean age 30.7 yr., range 20-44 yr.). Blood pressure was determi­
ned with mercury sphygmomanometer, with the subject seated for 
10 min before the pressure was measured. The diastolic blood pres­
sure (DBP) was recorded at the disappearance of Korotkoff sounds 
(phase 5). The mean of three measurements was used. None of the 
subjects had evidence of coronary heart disease according to history, 
ECG, exercise test and echocardiography. Secondary forms of arte­
rial hypertension were excluded on the basis of clinical and laboratory 
investigation (incl. renography). Body mass index (BMI) was calcula­
ted as weight (kg) divided by height squared (in meters). Subjects did 
not use any drugs for at least 4 weeks prior to the study. Normotensi­
ve, healthy, age and sex-matched persons (n=19) served as controls. 
Informed consent was obtained from all study subjects. 
Methods. Venous blood samples were drawn at 8-9 a.m. after an 
overnight fast. Blood for the determination of plasma renin activity 
(PRA) was collected into КЗ EDTA Vacutainers and centrifuged at 
2000 g for 10 min. Samples were not chilled during processing to 
avoid cryoactivation of prorenin, that could result in artificially high 
PRA values (Sealey 1991). Plasma was stored immediately at -20°С 
and analysed later by radioimmunoassay (kits by Medgenix, Belgium). 
Assessment of PRA related to concurrent 24-h sodium excretion was 
used to define patients with low, medium and high renin profiles 
according to the method of Laragh and co-workers (Brunner 1972). 
Magnesium concentrations in serum and in 24-h urine were deter­
mined photometrically (FB-901, Labsystems, Finland) by xylidyl-blue 
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methods ("Mercotest", by Merck, Germany). Serum total calcium 
concentration and urinary calcium excretion (in 24-h urine samp­
le) were assessed photometrically with cresolphtalein complexon (by 
"Biolabo", France). 
Statistical methods. Results were expressed as mean ± standard 
deviation. Statistical differences between groups were determined by 
Student's t-test, p<0.05 was considered as significant. 
The study protocol was approved by the Ethical Committee of the 
Medical Faculty, University of Tartu. 
Results 
Baseline characteristics of the study subjects according to their renin 
profile are presented in Table 1. The groups did not differ significantly 
with regard to age, gender or BMI. Blood pressure values were also 
similar in the three PRA groups. 
T a b l e  1  
Baseline characteristics of patients with essential hypertension, 
according to renin profile and of normotensive controls 
Characteristic High PRA Medium PRA Low PRA Controls 
(n=7) (n=16) (n=9) (n=19) 
Gender (M/F) 5/2 10/6 6/3 13/6 
Age (years) 27.2(20-38) 30.1(17-44) 30.4(19-41) 30.2(20-44) 
BMI (kg/m2) 27.9±5.7 29.1±4.8 28.5±5.2 25.2±3.4 
SBP (mmHg) 161±5 156±6 155±8 117±6* 
DBP (mmHg) 101±4 102±3 100±3 74±4* 
BMI, body mass index; DBP, diastolic blood pressure; SBP, 
systolic blood pressure; 
*p<0.05 vs. all the three PRA groups 
Serum magnesium concentration in the patient group (n=32) was 
significantly lower, than in the controls (pcO.Ol, Table 2). The same 
applies to the urinary excretion of magnesium (p<0.05, Table 2). Se­
rum total calcium concentration was similar in the patients and in the 
control group, so was the urinary excretion of calcium (Table 2). 
Magnesium and calcium concentrations (in serum and in 24-h 
urine) in patients according to their PRA group are presented in 
Tkble 3. Patients with high PRA had lower levels of serum magnesium 
and lower urinary magnesium excretion, than the low PRA group 
(p<0.05). Serum calcium concentration was higher in patients with 
high PRA, when compared to the low PRA group (p<9,05). Urinary 
calcium excretion was also higher in the high PRA group, but this 
difference was statistically not significant. In the medium PRA group, 
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T a b l e  2  
Serum levels and urinary excretion of magnesium and calcium 
in patients with essential hypertension and in normotensive controls 
Characteristic Patients (n=32) Controls (n=19) 
Serum magnesium (mmol/1) 
Serum calcium (mmol/1) 
Urinary magnesium (mmol/1) 
Urinary calcium (mmol/24 h) 
0.86±0.10* 
2.35±0.26 
3.29±0.25* 
4.85±1.84 
0.93±0.02 
2.41±0.16 
3.62±0.06 
4.69±3.04 
Mean values ± SD are given; 
* p<0.05 compared to the control group 
the serum and urinary concentrations of magnesium and calcium did 
not differ significantly neither from the high PRA group nor from the 
low PRA group (Table 3). 
T a b l e  3  
Serum levels and urinaiy excretion of magnesium and calcium 
in patients with essential hypetension, according to renin profile 
Characteristic High PRA Medium PRA Low PRA 
(n-12) (n=16) (n=8) 
Serum Mg (mmol/1) 0.84±0.08* 0.89±0.11* 0.92±0.08 
Serum Ca (mmol/) 2.43±0.08* 2.3±0.28 2.25±0.17 
Urinary Mg(mmol/l) 3.04±1.3* 3.38±1.63* 3.96±1.65 
Urinaiy Ca (mmol/24 h) 5.6±2.23* 4.87±1.65 4.31±2.08 
PRA (ng/ml h) 7.4±3.34* 1.75±0.96 0.64±0.33 
Urinary Na (mmol/24 h) 157.4±51.8* 149.0±32.5 123.8±22.6 
ALDO (ng/ml) 118.6±43.1 158.8±39.9 181.8±54.9 
Means ±SD are given; Mg, magnesium; Ca, calcium; Na, sodium; 
ALDO, serum aldosterone; 
* p<0.05 vs. the low renin group 
Urinary sodium excretion was significantly higher in the high PRA 
group, than in the low PRA group (p<0.05). This is in concordance 
with the lower serum aldosterone levels detected in the high PRA 
group. In the medium PRA group, the values for urinary sodium 
excretion were in between the values the high and low PRA groups, 
but these differences were not statistically significant. 
Discussion 
Our results indicate, that patients with essential hypertension dis­
play lower serum magnesium concentrations when compared with the 
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normotensive controls, and that this magnesium deficiency is more 
pronounced in the high PRA group of patients. 
Contradictory data have been presented concearning the serum 
magnesium level of the hypertensive patients. Early studies reported 
that hypertension was associated with elevations of serum magnesium 
levels (Walker 1936). However, others found lower levels of serum 
magnesium in hypertensive patients (McCarron 1983; Touyz 1987; 
Tillmann 1988), and some detected no difference in this respect in 
comparison to normotensive controls (Fisher 1993; Kjeldsen 1990; 
Resnick 1983). 
Our results are in concordance with the hypothesis that essential 
hypertension is associated with hypomagnesaemia. Up to the present 
there are at least 28 independent studies to confirm this (see Altu­
ra 1990, for references). In addition, one recent study demonstrates 
clearly that subjects with a positive family history of hypertension ha­
ve concommitant lower levels of serum magnesium (Shibutani 1990). 
Magnesium deficiency has been implicated in the pathogenesis of hy­
pertension, because at the cellular level magnesium acts as a gate for 
entry and exit of calcium at the vascular smooth muscle cell membra­
ne (Altura 1993). Therefore, magnesium deficiency promotes excess 
calcium uptake and induces elevation of the peripheral resistance 
(Altura 1986). Also, it has been shown that magnesium depletion 
inhibits the release of endothelial-derived relaxant factors (Ku 1987), 
and potentiates the action of a variety of neurohumoral constriction 
agents, including angiotensins, serotonin and adrenergic amines (Tiir-
lapaty 1982; Goldstein 1978). Overall, these findings suggest that 
magnesium deficiency is, at least partially, responsible for a rise in 
blood pressure and that a genetic predisposition to hypertension is 
probably closely related to magnesium metabolism. 
We analysed the measurements of magnesium concentrations with 
respect to the concurrent plasma renin activity. It appeared, that the 
magnesium deficiency was most pronounced in the high PRA group. 
Admittedly, serum magnesium level is an insensitive measure of total 
body magnesium stores, but 24-hour urinary magnesium excretion 
is considered to be a reliable index of magnesium status, provided 
that fluid balance and renal function are normal (Altura 1986). We 
detected significant differences (p<0.05) in the urinary magnesium 
excretion between the PRA groups, thus confirming, that each renin 
group had a distinctive magnesium profile. 
Considering the close association between magnesium and calcium 
at the cellular level, we evaluated the indices of calcium metabolism 
in hypertensive patients and detected differences between the PRA 
groups, that were opposite to those observed in magnesium concent­
ration. Thus, high-renin hypertension is a condition characterized by 
lower levels of serum magnesium and higher levels of serum calcium. 
30 
Conversely, hypertensives with low plasma renin activity have higher 
levels of serum magnesium and lower serum calcium levels. When 
all the hypertensives were analysed together, no deviations in calcium 
metabolism were observed in comparison to normotensive controls. 
Conclusions 
In conclusion, magnesium deficiency is a characteristic feature for 
essential hypertension, especially for the high PRA group. These fin­
dings raise the possibility that the pathophysiologic mechanism that 
causes either suppression or stimulation of renin secretion is also in­
volved in the deviations of magnesium metabolism in patients with 
essential hypertension. However, the precise mechanism of this as­
sociation needs to be futher defined. 
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Kokkuvõte 
Essentsiaalne hüpertensioon on seotud heterogeensete muutustega 
magneesiumi metabolismis. Käesoleva töö eesmärgiks oli uurida mag­
neesiumi metabolismi ning reniin-angiotensiin-aldosterooni süsteemi 
aktiivsuse vahelisi seoseid essentsiaalse hüpertoonia korral. Uuri­
tud 32 patsienti tüsistumata essentsialse hüpertensiooni diagnoosi­
ga (diastoolne vererõhk 95-115 mm Hg). Uuritavad jagatud kolme 
reniini aktiivsuse gruppi vastavalt plasma reniini aktiivsuse (PRA) ja 
24-tunni uriinis erituva naatriumi hulga suhtele nomogrammi alusel. 
Kontrollgruppi kuulus 19 tervet, normaalse vererõhuga isikut. Fo­
tomeetriliselt määratud magneesiumi ja kaltsiumi sisaldus seerumis 
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ning 24-tunni uriinis. Tulemustest selgus, et haigetel oli seerumi mag­
neesiumi sisaldus märgatavalt madalam, kui kontrollgrupis (pcO.OOl), 
seerumi kaltsiumi sisalduse osas erinevust ei olnud. Kõrge PRA-ga 
haigete grupis (n=7) oli seerumi magneesiumi sisaldus madalam ning, 
vastupidi, seerumi kaltsiumi sisaldus kõrgem (p<0.05), kui madala 
PRA grupis (n=9). Ööpäevas erituva magneesiumi hulk oli väiksem 
kõrge PIIA grupis, võrreldes madala PRA grupiga (p<0.05), erituva 
kaltsiumi hulga osas oluline erinevus puudus. Kokkuvõttes selgus, 
et essentsiaalse hüpertensiooni korral esineb magneesiumi defitsiit 
seerumis normotensiivse kontrollgrupiga võrreldes ning et see defit­
siit on enim väljendunud kõrge PRA-ga haigete grupis. 
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DYNAMIC INVESTIGATION 
OF POSTINFARCTION PERIOD 
BY STATISTICAL DATA PROCESSING METHODS 
Külliki Karu, Liina Mai Tooding 
Abstract 
The authors present a possibility for the complex evaluation of the 
functional status of the cardiovascular system by the hemodynamic 
response to low-level exercise 2-3 weeks after acute myocardial in­
farction and in the posthospital phase by modelling the dynamics of 
the postinfarction period. The multidimensional analysis in combi­
nation with the development of integrated parameters was employed. 
For eveiy observation moment factor analysis was used. 
Introduction 
The choice of management strategies and the optimal level of physical 
activity for patients with recent myocardial infarction (MI), as well as 
solving the problems of return to work, assume evaluation the degree 
of rehabilitation. The time needed for the improvement of functional 
status of the cardiovascular system greatly differs in individual pati­
ents. In this connection, predicting of the course of the postinfarction 
period becomes particularly important. 
The authors present a possibility for the complex evaluation of the 
functional status of the cardiovascular system by the hemodynamic 
response to low-level exercise before hospital discharge (2-3 weeks 
after acute MI) and in the posthospital phase by modelling the dyna­
mics of the postinfarction period. 
Material and Methods 
Initial data for processing constituted about 1500 variables: clinical 
characteristics, data of selective coronarography and left ventriculog­
raphy, as well as parameters measured during exercise in 62 patients 
with acute transmural MI without clinical evidence of congestive heart 
failure aged from 31 to 60 years (mean 49,6 ± 0,9 years). At rest (in 
the supine and sitting position), during and after moderate upright 
exercise on bicycle ergometer (maximal load up to 1 W.kg"1 in most 
patients) in about 8-10 moments of time the ECG, FCG, central pul­
se tracings and impedance cardiograms by W. C. Kubicek (1966) were 
recorded. The patients were studied three times in the course of a 
6-month follow-up period. 
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Although the number of parameters was reduced to 270 by means 
of exploratory analysis, the essential complexity of data set makes 
the traditional statistical approach inefficient. To overcome metho­
dical difficulties the multidimensional analysis in combination with 
the development of integrated parameters was employed. For every 
observation moment factor analysis was used to get complex indicators 
which were added to the initial data. 
Results and Discussion 
30 most informative parameters forming the basis for the factor mo­
dels included the age, arrhythmias, previous MI, previous arterial 
hypertension, the duration of the coronary artery disease, the type of 
asynergy and the number of impaired segments, the ejection fraction, 
maximal work load, "double product", PEP/LVET at rest and at the 
maximal work load, changes in stroke index, systolic ejection rate and 
total peripheral vascular resistance, as well as in heart rate-corrected 
systolic and diastolic time intervals during exercise. 
This initial information was expressed by 6 synthetic factors 
(VI,... ,V6), describing 65% of the total dispersion of the initial data. 
The content of the factors was interpretated as follows: VI — factor 
of age and central hemodynamics; V2 — orthostatic factor; V3 — 
factor of asynergy; V4 — factor of anamnesis and physical working 
capacity; V5 — factor of time interval changes; V6 — preejection 
period factor. 
Individual factoral coefficients for every patient were calculated 
while the direction of the favourable effect was connected with the 
positive area and the adverse effect with the negative area of the 
scale. General estimates of the functional status of the cardiovascular 
system of the patients were derived by summarizing the values of 
individual factoral coefficients. On the basis of general estimates, 
using the expert method, patients were grouped as belonging to the 
good, satisfactory and poor functional condition level, respectively 12, 
38 and 12 patients. Moreover, it was possible to judge which of these 
factors was the most important in determining the functional status of 
a concrete patient. 
On the basis of these data regression models were found to prog­
nosticate the functional state F( of patient in moment t by F$ while set. 
Physical working capacity, stroke volume index (SVI), cardiac index, 
duration of systolic time intervals and other central indicators have 
obtained statistical significant prognosis by hospital leave state for F3 
(3 months later) and F6. The corresponding regression equation for 
predicting individual values for SVI at rest (in the sitting position) 
3 months later was: 
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Yi = 26,6 + 5,8V1 - 2,9V2 - 1,4V3 + 3,2V4 - 0,3V5 - 0,9V6 , 
where Yi — prognosis for SVI at rest, V1-V6 — factor coefficients. 
The coefficient of multiple correlation R = 0,62 (p<0,001) was obtai­
ned. 
SVI at exercise 3 months later might be expressed as: 
Y2 = 33,6 + 5,9V1 - 3,6V2 - 1,0V3 + 1,0V4 + 0,9V5 + 0,2V6, 
where Y2 — prognosis for SVI at exercise (R = 0,56; p<0,01). 
Conclusions 
Predicted values of central indicators were compared with really me­
asured values of these parameters to evaluate treatment and physical 
rehabilitation efficiency. Such analysis allowed to distinguish the pati­
ents whose functional status in the posthos pital phase strongly differed 
from the predicted one. 
At the present time we are continuing our studies to find out 
the prognostical significance of echocardiographically gained data for 
predicting development of heart failure after acute MI. 
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Kokkuvõte 
Autorid on uurinud ägeda müokardi infarkti kulu prognoosimise või­
malusi haiglajärgses perioodis, lähtudes hemodünaamika muutustest 
varajasel veloergomeetrilisel koormustestil. Mitmemõõtmelise fak-
toranalüüsi meetodil on välja töötatud regressioonivõrrandid hemod­
ünaamika parameetrite (löögiindeks, südameindeks, väljutusfrakt-
sioon) prognoosimiseks ning võrreldud haigetel 3 ja 6 kuud peale 
ägeda infarkti põdemist reaalselt mõõdetud näitajaid prognoositute-
ga. Leiti, et tetrapolaarne reograafia kombinatsioonis varajase veloer-
gomeetrilise testiga võimaldab usaldusväärselt prognoosida müokardi 
kontraktiilse funktsiooni dünaamikat infarktijärgses perioodis. 
36 
ATRIAL VERSUS VENTRICULAR PACING 
IN PATIENTS WITH SICK SINUS SYNDROME 
Rein Kolk, Jüri Samarütel, Indrek Roose, Jüri Väli 
Abstract 
The present study was undertaken (a) to evaluate comparative acute 
hemodynamic effects of atrial pacing (AP) versus ventricular pacing 
(VP), and VP in the presence versus absence of retrograde ventricu­
loatrial (VA) conduction in symptomatic sick sinus syndrome (SSS) 
patients, and (b) to study their long-term survival, development of 
permanent atrial fibrillation (AF), systemic embolism and atrioven­
tricular (AV) conduction defects. Cardiac index (CI) was assessed by 
thermodilution technique in 22 patients undergoing pacemaker (PM) 
implantation. Altogether 30 atrial and 58 ventricular paced patients 
were followed up for an average of 3.6 and 7.2 years, respectively. 
Noninvasive electrophysiologic study was performed preoperatively 
and at follow-up. 
Conclusions: AP produced an average of 19% higher CI than 
VP. VA conduction was the crucial hemodynamic determinant dur­
ing VP: CI was higher in patients without VA conduction than in 
those with intact VA conduction, and could decrease below prepacing 
values in the latter subgroup. Atrial paced patients exhibited better 
long-term survival than ventricular paced ones and no incidence of 
permanent AF or systemic embolism. AP reduced the incidence of 
paroxysmal AF. Development of high degree AV block during AP 
was uncommon. Moderately impaired AV conduction ("Wenckebach 
point" 100-120 pulses per minute (ppm)) does not exclude the use of 
AP. 
Key words: arrhythmia; cardiac pacing, artificial; cardiac output; 
follow-up studies; hemodynamics; pacemaker, artificial; sick sinus 
syndrome. 
Introduction 
Permanent cardiac pacing has become the treatment of choice for 
SSS. Its main aim is symptom relief. Long-term follow-up studies sug­
gest that cardiac dysfunction and the rate of systemic complications 
can be reduced by physiologic rather than VP (Sasaki et al. 1991). 
Although this concept is widely accepted, supporting evidence is not 
fully conclusive. On the other hand, SSS is reported to have com­
paratively benign natural course (Rasmussen 1981) and the overall 
survival rate is not much different from that of normal population 
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(Shaw et al 1980). So far there is no evidence of better survival in 
paced patients compared to those not paced. 
A variety of single and dual chamber (DDD) PMs is available for 
clinical use. It has been postulated that AP is the most physiological 
mode for patients with SSS as it provides both AV synchrony and a 
normal ventricular activation pattern (Rosenqvist 1990). DDD pac­
ing can be chosen if the risk for developing high-degree AV block is 
considered significant. However, it is an expensive and sophisticat­
ed method of treatment with a greater potential for complications 
(Hayes, Furman 1983). Therefore, it should be reserved for only a 
well-defined subgroup of PM recipients. 
Ventricular inhibited (WI) pacing was the first pacing mode used 
to treat patients with symptomatic SSS. Unfortunately, in contrast 
to AP, it does not offer the above-mentioned hemodynamic advan­
tages. Furthermore, preserved VA conduction is supposed to be an 
additional contributor to the impaired hemodynamics during VP. In 
the most pronounced cases these factors may lead to pacemaker syn­
drome, referred to by Ausubel and Furman as "a complex of clinical 
signs and symptoms related to the adverse hemodynamic and elec­
trophysiologic consequences of VP in the absence of other causes" 
(Ausubel, Furman 1985). Unfortunately, it does not coincide with 
everyday practice: according to the last published World Survey of 
Cardiac Pacing in most cases of SSS conventional WI pacing was still 
employed (Feruglio et al 1987). It seems that the hemodynamic supe­
riority of AP is sacrified to the convenience of handling the ventricular 
lead. 
This study was performed to: 1. To evaluate the comparative acute 
hemodynamic effects of (a) AP versus VP (b) VP in the presence 
versus absence of VA conduction in symptomatic patients with SSS. 
2. To study their long-term survival, development of permanent AF, 
systemic embolism and AV conduction defects. 3. To define these 
subgroups of PM recipients with SSS who are to benefit from AP and 
those who will do satisfactory with VP. 
Material and methods 
Hemodynamic study. TWenty-two consecutive patients (8 males and 
16 females) with symptomatic SSS undergoing permanent atrial in­
hibited (AAI) pacing were studied. Clinical details of the patients are 
listed in Table 1. The mean age was 64±9 years (M±SD). The average 
New York Heart Association (NYHA) functional class was 2.5±0.7. 
The patient population was divided into two groups according to the 
presence (Group 1; 12 patients) or absence (Group 2; 10 patients) of 
VA conduction. The two groups did not differ statistically significantly 
from each another by the variables listed in Table 1. 
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Patient data 
T a b l e  1  
No Age and Underlying ECG NYHA Prepacing 
sex heart disease findings class symptoms 
Group 1 
1 70 M None AV escape rhythm II Dizziness 
2 80 F CAD Sinus bradycardia IV Syncope 
3 61F CAD Sinus arrest III Syncope 
4 59 M None SA Block II II Dizziness 
5 63 F None AV escape rhythm II Syncope 
6 62 F CAD+SH BTS II Syncope 
7 58 M HC Sinus bradycardia II Syncope 
8 78 F CAD Sinus bradycardia III Syncope 
9 77 M CAD Sinus bradycardia III Dizziness 
10 64 F CAD BTS IV Syncope 
11 76 F CAD Sinus bradycardia III Syncope 
12 54 F None Sinus bradycardia II Syncope 
Group 2 
13 66 F None Sinus bradycardia III Syncope 
14 64 F None BTS III Dizziness 
15 55 M CAD BTS II Dizziness 
16 57 F CAD Sinus bradycardia II Syncope 
17 5 1 F  None Sinus bradycardia II Syncope 
18 75 F SH AV escape rhythm II Syncope 
19 58 F CAD+SH AV escape rhythm II Syncope 
20 70 M CAD Sinus bradycardia III Dizziness 
21 63 F None Sinus bradycardia III Dizziness 
22 48 F None Sinus bradycardia II Syncope 
CAD = coronary artery disease; 
HC = hypertrophic cardiomyopathy; 
SA = sinoatrial; 
SH = systemic hypertension. 
Studies were carried out in the angiocardiographic laboratory. In 
all cases antiarrhythmic treatment had been stopped 2-4 weeks earlier. 
Transesophageal electrophysiologic testing was performed to assess 
sinus node automaticity and AV conduction defects. Corrected sinus 
node recovery time and AV conduction "Wenckebach point" were 
determined. Quantitative assessment of hemodynamic changes was 
carried out by standard thermodilution technique (Ganz, Swan 1972). 
Transesophageal ECG lead was used to determine the presence of VA 
conduction during VP. 
Through left external jugular or left cephalic vein monopolar 
screw-in PM lead was positioned in right ventricle. Asynchronous 
VP was performed at two rates: 70 and 90 ppm. Thereafter the PM 
lead was removed from the ventricle and positioned in right atrium 
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from where asynchronous pacing at the same rates was carried out. 
Cardiac output measurements were performed in triplicate after sta­
ble hemodynamics were obtained, but not earlier than 5 minutes after 
each adjustment of PM settings. Later the mean was calculated and 
cardiac hemodynamics were expressed as CI. 
Follow-up study. Thirty out of 41 consecutive AAI paced symp­
tomatic SSS patients (7 males and 23 females) aged 64±9 years were 
followed up for an average of 38±10 months (ranging 20 to 80 months). 
Four patients operated during the study period were interviewed only 
and the remaining 7 were lost for follow-up. In 16 cases (53%) the 
underlying heart disease was coronary artery disease, in 3 cases (10%) 
systemic hypertension, in 2 cases (7%) their combination, in 2 cases 
(7%) rheumatic heart disease and in 1 case (3%) hypertrophic car­
diomyopathy. Six subjects (20%) were without morphologic heart dis­
ease. Among ECG findings sinus bradycardia was prevailing (17 cas­
es). Sinoatrial block was diagnosed in 7 cases and sinus arrest in 1 case. 
Bradycardia-tachycardia syndrome (BTS) was present in 5 cases. The 
average preoperative NYHA functional class was 2.6±0.7. The lead­
ing indications for PM implantation were syncopal attacks, dizziness, 
fatigue and cardiac failure. 
Transesophageal electrophysiologic investigation was carried out 
both preoperatively and at follow-up. The same protocol was em­
ployed as in previous hemodynamic study. Besides, basic heart rhythm 
and rate were recorded when reprogramming the pacing rate of the 
implanted PM below the spontaneous heart rate. 
Fifty-eight ventricular paced patients, 38 females (66%) and 
20 males aged 60±11 years were followed up for a mean of 
75±40 months (6.2 years). In the majority of cases an underlying 
heart disease such as coronary artery disease, systemic hypertension 
or cardiomyopathy was diagnosed. The remaining 25% of cases 
were classified as idiopathic. The leading indication for PM inser­
tion were syncopal attacks in 81% of patients. In 39 patients trans­
esophageal electrophysiologic study was carried out according to the 
above-mentioned protocol. Besides, the presence of VA conduction 
was tested. 
All data are presented as the group mean (M) and standard devia­
tion (SD). Comparisons of means for continuous variables were made 
by Student's paired and unpaired t-test. Probability levels with p value 
of <0.05 were regarded as significant. 
Results 
Hemodynamic study. Prolonged (>525 ms) corrected sinus node 
recovery time was demonstrated in 13 patients (68%). First degree 
AV block with prolonged P-R interval was present in 2 cases. Another 
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6 patients developed "Wenckebach point" during incremental left 
AP at rates below 120 ppm. So, in 8 cases (42%) some kind of 
AV conduction defect was revealed. No His bundle branch block or 
intraventricular conduction defect was present. 
In all cases basic rhythm was either sinus or AV escape rhythm 
with the mean rate of 49±7 beats per minute (bpm) and no significant 
difference between the groups at baseline (50±5 bpm in Group 1 
and 49±8 bpm in Group 2). CI was roughly on the same level with 
baseline during VP in the overall patient population. In Group 1 at 
pacing rate of 70 ppm it was even 11% lower than during basic rhythm 
(p<0.05). AP resulted in 16-20% higher CI from baseline in both 
groups. Figure 1 compares CI during AP and VP. In Group 1 the 
former pacing mode offered higher CI than the latter (pcO.Ol). In 
Group 2 the corresponding difference was nonsignificant. 
As the prepacing values of CI varied noticeably from one patient 
to another the change from baseline at each PM setting was calculated 
(Table 2). Figure 2 compares these variables from the point of view 
of presence or absence of VA conduction. There was a significant 
difference in the change in CI from baseline between the two groups 
during VP: in Group 1 towards increase and in Group 2 towards 
decrease (p<0.05). Nonsignificant increase in CI was gained from 
raising the pacing rate from 70 to 90 ppm at either pacing modes. 
T a b l e  2  
The change in cardiac index from baseline (1/min/m2) during pacing 
Overall 
n=22 
Group 1 
n=12 
Group 2 
n=10 
VP 70 ppm 
VP 90 ppm 
AP 70 ppm 
AP 90 ppm 
-0.10±0.33 
-0.01±0.41 
+0.43±0.40** 
+0.53±0.39** 
-0.31 ±0.23 
-0.19±0.20 
+0.37±0.43* 
+0.48±0.42** 
+0.17±0.24 
+0.23±0.50 
+0.51±0.36** 
+0.58±0.37** 
*p < 0.05; **p < 0.01; vs baseline 
Follow-up study. Ninety-seven per cent of AAI paced SSS patients 
were alive after an average follow-up period of 3.2 years. One patient 
died of congestive heart failure at the age of 84 sixty months after 
PM insertion. During follow-up no sudden deaths occurred. AP of­
fered excellent symptom relief in all cases. Dizziness and syncopal 
attacks were abolished completely. In all 5 patients with systemic hy­
pertension the tendency towards lowering both systolic and diastolic 
blood pressure was noticed, and only one of them remained on an­
tihypertensive medication at follow-up. In 3 out of 5 subjects with 
BTS the episodes of atrial tachycardia were prevented by AP alone. 
In the remaining the incidence of paroxysmal AF was markedly di­
minished by combining AP and antiarrhythmic medication. No onset 
70 PPM 90 PPM 
Group 2 
0 
70 PPM 90 PPM 
Group 1 
K\N Ventricular pacing 
Atrial pacing 
Figure 1. 
+1,0 л 
о—о Group 1 
Group 2 
'S +0,5-
-0,5-
<0.001 <0.05 NS NS 
-1,0 
1 2 3 4 5 
1 — baseline 
2 — vp 70 ppm 
3 — vp 90 ppm 
4 — ap 70 ppm 
5 — ap 90 ppm 
P: Group 1 vs Group 2 
Figure 2. 
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of permanent AF was documented, neither were thromboembolic 
events present. The average NYHA functional class changed from 
the prepacing value of 2.6±0.7 to 1.4±0.4 at follow-up (pcO.Ol). 
At follow-up the underlying heart rhythm was sinus bradycardia 
in 24 cases and AV escape rhythm in 6 cases. The average preoper­
ative basic heart rate was 51 ±7 bpm and decreased nonsignificantly 
to 50±9 bpm at follow-up. The corresponding figures for "Wencke­
bach point" were 138±22ppm and 136±18 ppm (p=NS), respectively. 
Hvo patients having first degree AV block showed the same degree 
of AV conduction defect at follow-up. No development of second or 
third degree AV block was present. All 12 patients (40%) with im­
paired AV conduction ("Wenckebach point" <130 ppm) showed 1:1 
AV conduction at pacing rate of 100 ppm at follow-up. 
Eighty-one per cent of ventricular paced patients survived more 
than 3.6 years and 78% were alive by the end of an average of 6.2-year 
follow-up period. Thirteen patients aged 68±9 years had died. Fatal 
stroke was present at least in 3 cases. However, the cause of death 
was not known for all patients. No patient had had syncopal attacks 
after PM insertion in either subgroup. Not surprisingly, a few among 
ventricular paced ones, particularly those having intact retrograde VA 
conduction, complained on mild dizziness and hypotension, that may 
be attributed to pacemaker syndrome. 
All ventricular paced patients were either in sinus rhythm or AV 
escape rhythm at implantation. Sinus rhythm persisted only in 49% 
and AV escape rhythm was present in another 10% of ventricular 
paced patients at follow-up. In 36% and 5% of ventricular paced 
patients permanent AF or high-grade AV block had developed, re­
spectively. Basic heart rate and AV conduction "Wenckebach point" 
were 58±16 bpm and 124±21 ppm, respectively, in ventricular paced 
subjects at follow-up. In this subgroup 46% of patients showed 1:1 
VA conduction during VP at 70 ppm. Among these 7 patients had 
normal AV conduction and a suggestion was made to change their 
pacing mode to AAL 
Discussion 
The average 19% increase in CI in the overall patient population 
from VP to AP in our study is similar to other studies using invasive 
techniques (Samet et al 1966, Mukharji et al 1990). Substantial 
differences in cardiac hemodynamics were revealed when the overall 
patient population was divided into two groups according to the pres­
ence of VA conduction. So, in group 1 the average increase in CI from 
VP to AP was 27% opposed to 10% in group 2 patients who showed no 
evidence of VA conduction. AP offered equal improvement in cardiac 
output from basic rhythm in both groups. The average augmentation 
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was 16-20% and is comparable to studies of Samet et al. 1966 and 
Wirtzfeld et al. 1987. 
There was no significant change in CI from baseline in the over­
all population during VP. Nevertheless, changes of different direction 
and magnitude were demonstrated in patients of the two groups dur­
ing that particular pacing mode. Our study shows clearly, that VA 
conduction* is the critical determinant of cardiac performance during 
VP. In case there is no VA conduction, VP develops AV dissociation 
and atrial systole is of very little benefit to left ventricular perfor­
mance. In case retrograde conduction is intact, excitation from the 
paced ventricles reaches atria during ventricular ejection period when 
AV valves are closed. The atria will empty in the retrograde direction 
into the pulmonary and systemic veins, causing a marked increase in 
the mean right atrial and pulmonary wedge pressures (Ausubel, Fur­
man 1985). This might be called a "negative atrial kick" resulting in 
further deterioration of cardiac output. However, this can happen 
intermittently in exceptional cases in the absence of VA conduction 
during bad timing of atrial and ventricular contraction. 
DiCarlo et al 1987 measured cardiac hemodynamics at AV in­
tervals of 130, 0 and -130 ms during VP in patients with normal and 
diminished left ventricular ejection fraction. Significant decrease in 
CI appeared in both groups when AV interval was changed from 130 
to 0 ms. No further decrease in cardiac hemodynamics occurred in 
either group when AV interval was changed from 0 to -130 ms. With 
some limitations the latter condition can be extrapolated as VA con­
duction during VP. This finding is in contrast with our study and may 
partly be due to considerable variance in the magnitude of hemody­
namic changes in DiCarlo's study, so that the average changes didn't 
reach statistical significance. 
Special considerations when pacing patients with SSS include im­
proving the overall prognosis, prevention of atrial tachyarrhythmias, 
overcoming an increased risk for systemic embolism, the state of AV 
and VA conduction. There are few data on overall mortality in this 
disorder and these available have described a survival rate similar to 
a matched control population (Shaw et al. 1980). Whether cardiac 
pacing per se affects longevity in patients with SSS deserves further 
investigation. Although no prospective randomized studies exist com­
paring AP with VP, a considerable amount of data has accumulated 
over the last decade indicating the beneficial long-term effects of AP. 
It has to be pointed out that in none of these studies a bias in favour 
of preoperative selecting the sickest patients with the worst prognosis 
for WI pacing cannot be excluded. 
In larger patient series Hesselson et al 1992, Santini et al 1990 and 
Rosenqvist et al 1988 have reported on better survival in AAI paced 
compared to WI paced subgroups. In our series, too, patients with an 
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atrial PM showed better overall survival than those with a ventricular 
PM. However, the average follow-up time of VP was significantly 
longer than of AP (7.2 years versus 3.6 years). AP became available at 
the University Hospital of Tartu in 1987. The majority of ventricular 
PM implants were performed prior to 1987 that excludes the bias 
favoring one or another pacing mode in these patients. 
There is no doubt about that cardiac pacing offers significant symp­
tom relief in most of SSS patients. Syncopal attacks are usually pre­
vented by either pacing mode. Randomized double-blind studies 
have proven that all other symptoms are better controlled and gener­
al well-being provided by physiologic pacing compared to WI pacing 
(Rediker et al 1988). An interesting study was performed by Sui­
ke et al 1992, who upgraded symptom free patients with a ventricular 
PM to a dual chamber device. Seventy-five per cent of patients pre­
ferred DDD pacing and it was concluded that this is the incidence of 
"subclinical" pacemaker syndrome. The prevalence of "clinical" pace­
maker syndrome is supposed to be 7-20% of WI patients (Travill, 
Sutton 1992). 
A number of follow-up studies comparing the incidence of atri­
al tachyarrhythmias, the onset of permanent AF, in particular, have 
proven AP to be more favorable in SSS patients. The development 
of chronic AF will render atrial PM ineffective, but many patients 
will have an adequate ventricular response rate, and the need for the 
change in pacing mode to WI is rather limited. Lamas et al 1992 
have reviewed published data concerning the likelihood of permanent 
AF in paced SSS patients and reported on an average reduction of the 
incidence of AF from 34% in VVI to 9% in AAI or DDD pacing over 
an average 51-month follow-up. The 36% incidence of permanent AF 
in ventricular paced patients in our series is in line with these data, but 
still impressive. We agree that AP has somewhat protective effect on 
the onset of atrial tachyarrhythmias. This is of clinical relevance for 
patients with BTS. As shown, in some cases AP alone may be sufficient 
to avoid paroxysmal AF. 
The risk of systemic embolism is closely linked with the develop­
ment of AF. Thus, it is not surprising that the incidence of stroke is 
lower when a PM with an incorporated atrial lead is chosen. Camm 
and Katritsis (Camm, Katritsis 1990) have pooled the data of pub­
lished studies and calculated the thromboembolic incidence for the 
first year of VP of 12%. 
We found only one study comparing AP and VP where the ven­
tricular paced group was further subdivided according to the presence 
of VA conduction. Ebagosti et al 1988 in a 3-year follow-up of 
45 WI patients, noted atrial arrhythmias and deaths only in cases 
with demonstrated VA conduction and they proposed it as an inde­
pendent prognostic factor in patients treated with VP. 
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The main reason why AP is not widely used is probably the fear 
of impending high-degree AV block. This is based on the observation 
that associated conduction disturbances in the AV node and the His-
Purkinje system frequently coexist (Vallin, Edhag 1981). In addition, 
some of the patients with normal conduction at the time of implant 
may develop impairment of AV conduction in time. Thus far it may be 
concluded that the risk of development of clinically important AV con­
duction disturbances in atrial paced subjects is low. Rosenqvist and 
Obel (1989) surveyed published reports and found 28 studies. The 
median prevalence of development of significant AV block was 2.1% 
during the median follow-up period of 3 years, the annual incidence 
was 0.6%. This is contradictory to the survey of Sutton and Kenny 
(1986) who reported on an estimated annual incidence of significant 
AV conduction dysfunction of 3%. Such high incidence might reflect 
the fact that their definition of significant AV dysfunction included 
first degree AV block, complete bundle branch block, HV prolonga­
tion in His bundle electrogram and "Wenckebach point" at left atrial 
incremental pacing below 120 ppm. Rosenqvist and Obel restricted 
their definition to second and third degree AV block. 
Patient selection criteria for AP have direct influence on the out­
come. The key question to be answered is to what extent AV conduc­
tion may be defective to provide still safe AP. One method to establish 
eligibility for AP has been to assess "Wenckebach point". An unfor­
tunate finding of the survey of Rosenqvist and Obel was that there 
was no correlation between the "Wenckebach point" used and the 
prevalence of AV block. In our series no significant change in AV 
conduction "Wenckebach point" was observed during an average of 
3.2 years of AP. Even in these cases when it was as low as 100-120 ppm 
the outcome was satisfactory. No second or third degree AV block de­
veloped and no changing of pacing mode to WI or DDD was needed. 
Therefore, we agree with van Mechelin et al. 1984, who suggest that 
the deterioration of antegrade AV conduction is possibly more often 
related to the use of antiarrhythmic drugs rather than degeneration 
of the AV conduction system itself. 
In several published guidelines for PM prescription in symptomatic 
bradycardia AP is considered an appropriate pacing mode for SSS 
(Dreifus et al. 1991, The British... 1991), and one has to agree with it. 
In our opinion there is a limited but defined subgroup of SSS patients 
without VA conduction, who do not necessarily require a DDD unit 
when concomitant AV conduction defect is present, but will do with 
VP. These are most likely elderly people with limited physical activity 
suffering from clinical symptoms associated with episodes of severe 
bradycardia or temporary cardiac arrest. Although VP offers only a 
little increase in cardiac output, the attacks of syncope and dizziness 
are prevented this way. Besides, rate hysteresis function has proven 
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to be helpful for these patients: it enables to keep the PM inhibited 
most of the time and pacing is performed only as the attack of severe 
bradycardia develops (Stangl et al 1988). 
Conclusions 
1. AP produced higher cardiac output than VP and, therefore, 
should be preferred in symptomatic SSS patients with normal AV 
conduction. 
2. VA conduction was the crucial hemodynamic determinant dur­
ing VP: CI was higher in patients without VA conduction than in those 
with intact VA conduction, and could decrease below prepacing values 
in the latter subgroup. 
3. Atrial paced SSS patients exhibited better long-term survival 
than ventricular paced ones and no incidence of permanent AF or 
systemic embolism. 
4. AP reduced the incidence of paroxysmal atrial tachycardias in 
patients with BTS. 
5. Development of clinically significant AV conduction defects 
during AP was uncommon. Moderately impaired AV conduction 
("Wenckebach point" 100-120 ppm) does not exclude the use of AP, 
however, more frequent pacemaker follow-up (once in 3 months) is 
mandatory to check the status of AV conduction. 
6. As suggested both by hemodynamic and follow-up studies AP 
should be chosen for SSS unless contraindicated. WI can be con­
sidered for controlling symptoms associated with attacks of severe 
bradycardia or temporary cardiac arrest in selected patients without 
VA conduction, when clinically significant AV conduction defect co­
exists. 
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T-CELLULAR IMMUNITY IN PATIENTS \VITH 
ACUTE MYOCARDIAL INFARCTION AFTER 
THROMBOLYTIC TREATMENT 
Kristin Lamp, Maido Uusküla 
Abstract 
Cellular immunity (the number of T- and functionally active 
T-lymphocytes, the level of sensibilization of T-cells to myocardial 
antigen) was investigated in 150 patients with acute myocardial in­
farction (AMI). 35 of them received intravenous thrombolytic thera­
py (TT) with 1,5 million units of Streptokinase. TT caused a short-
term decrease of the number of lymphocytes in peripheral blood that 
was accompanied by decreased numbers of T- and functionally acti­
ve T-lymphocytes. In patients with TT sensibilization to myocardial 
antigen appeared later and was on lower level as compared with pa­
tients without TT. This lower level of sensibilization is favourable to 
the course and prognosis of AMI. 
Introduction 
There is a general agreement, that coronary thrombosis is the precise 
pathological event in the majority of transmural myocardial infarc­
tions. Although this view was postulated in 1912 already it remained 
a contraversial issue until the end of the 1970-s when substantial pat­
hological, anatomic and angiographic data had been accumulated. It 
was the time when thrombolytic therapy became an important part of 
complex treatment of patients with acute myocardial infarction (AMI) 
and many of the trials showed a significant reduction of mortality in 
patients treated with thrombolytics when compared with untreated 
controls (Stampfer M. J. et al 1982, Heikkilä J. et al 1988). 
The effect of several drugs used in treatment of patients with isc-
haemic heart disease (verapamil, nifedipine, dipyridamol, pindolol, 
propranolol, heparin) on the function of lymphocytes has been de­
termined (Molinoff P. В., Aarons R. D. 1984, Derenne F. et al 1987, 
Bruserud Q. 1987) . The influence of thrombolytic therapy on the 
function of macrophages and phagocytes has been investigated quite 
thoroughly but the results of different investigators have been contra­
dictory. It is found that essential activation of phagocytes takes place 
after thrombolysis and these activated cells are recognized as media­
tors of reperfusion injury (Engler R. L. 1989, Ranjadayalan K. et al 
1991). Danish researchers (Obel N. et al 1993) have shown that 
streptokinase treatment did not modulate neutrophil function. The 
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opinion of T. W.Stief (1991) is that activated phagocytes participate 
in physiologic fibrinolysis. There is very few data about the effect of 
thrombolysis on lymphocytes, the other part of immune system. The 
aim of our study was to investigate cellular immunity, that plays cer­
tain role in healing processes, in patients with AMI in connection with 
administration of thrombolytic therapy. 
Subjects and methods 
150 patients with AMI in age of 31-70 years (mean age 53±0,8 years) 
were investigated. In 35 of them intravenous thrombolytic therapy 
with 1,5 million units of streptokinase was carried out. Thrombolysis 
was started 1-8 hours (3 h 25 mini 18 min) after onset of anginal pain, 
in case of firm electrocardiographical signs of AMI. All 35 patients 
received prednisolone (90 mg) as premedication. Streptokinase was 
infused intravenously for 30-60 min: 250.000 units in 20 ml saline given 
rapidly in 5-10 min, followed by 1,25 million units in 150 ml saline at 
a slower infusion rate. Thrombolytic treatment was combined with 
anticoagulant-therapy with heparin for 3-5 days (20.000 units per day 
s/c —> 10.000 units per day). All patients received oral or intravenous 
nitrates and acetylsalicylic acid (125 mg dayly); antiarrhythmic drugs 
or other supportive treatment were given, if necessary. 
Early coronary reperfusion was clinically indicated in 72% of strep­
tokinase treated patients (rapid relief of chest pain, resolution of ST-T 
wave changes, ventricular arrhythmias, early enzyme peak). These in­
direct data were supported by data of coronary angiography, carried 
out 2-5 weeks after the onset of AMI. 
Electrocardiographically 80% of streptokinase-treated patients 
developed transmural infarctions. In 6 cases subendocardial and in 
1 case microinfarction was diagnosed. 
Lymphocytes were separated from whole blood by density gradient 
centrifugation over Ficoll-Verographin (Boyum A. 1974). After was­
hing lymphocytes were resuspended in Eagle medium to final concent­
ration of 1,5x10 cells/ml. The number of T- and functionally active 
T-lymphocytes was determined by E-rosette formation methods. The 
level of sensibilization of T-cells to myocardial antigen (MA) was de­
termined by a method, worked out by us, the method of inhibition of 
active E-rosette formation under the influence of myocardial antigen 
(Reisenbuk V. et al 1985). Briefly: 1,0 ml of lymphocyte-suspension 
was incubated for 2 hours in 37° С with 30 ß\ of MA (concentration 
of protein 0,25 mg/ml, i.e. 5 ng per 1,0 million cells). After that the 
number of active T-cells was determined in lymphocyte-suspension, 
incubated with MA and in control suspension. The inhibition % of 
active E-rosette formation showing the quantity of sensibilizated cells, 
that have receptors to MA was calculated as follows: 
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Inhibitio„%(I%) = %AE-RF^-J'f-RFC^ 
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' %AE-RFCC 
%AE-RFCç — % of active E-rosette forming cells (active 
T-lymphocytes) in control suspension 
%AE-RFCma — % of active E-rosette forming cells in lymphocy­
te suspension incubated with MA 
The absolute number of sensibilizated T-lymphocytes per mm3 was 
also figured out. 
Results 
In patients with AMI next day after thrombolytic therapy the num­
ber of lymphocytes in peripherial blood was considerably lower than 
in patients, who were not treated with streptokinase. The normal 
quantity of lymphocytes was restored by the end of the first week of 
illness (Table 1), in some patients even on the second or the third day 
after thrombolysis. The number of T-lymphocytes (Table 2) as well as 
functionally active T-lymphocytes (Table 3) was decreased during the 
first week after thrombolysis and also normalized on the second week 
after the onset of AMI. 
T a b l e  1  
The effect of thrombolytic therapy on the number of lymphocytes 
Days Pts with thrombolysis Pts without thrombolysis P 
n=35 cells/mm3 n=115 cells/mm3 
1. 1214±111 2030±96 <0.02 
7. 1928±121 2156±106 ns 
14. 2192±123 2164±104 ns 
21. 2236±104 2307±98 ns 
28. 2164±108 2172±98 ns 
T a b l e  2  
The effect of thrombolytic therapy on the number of T-lymphocytes 
Days Pts with thrombolysis Pts without thrombolysis P 
n=35 cells/mm3 n=115 cells/mm3 
1. 569±54 1115±46 <0.001 
7. 838±58 1133±51 <0.05 
14. 989±63 1165±43 ns 
21. 1147±73 1225±49 ns 
28. 1196±101 1241±54 ns 
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T a b l e  3  
The effect of thrombolytic therapy on the number of active T-lymphocytes 
Days Pts with thrombolysis Pts without thrombolysis P 
n=35 cells/mm3 n=115 cells/mm3 
1. 320±41 617±34 <0.001 
7. 509±39 722±42 <0.05 
14. 645±66 753±39 ns 
21. 725±70 849dt39 ns 
28. 802±81 823±39 ns 
Sensibilization to myocardial antigen in patients with primary in­
farction appeared by the end of the second week of illness. In case of 
reinfarction sensibilizated cells were present on the first day already. 
After thrombolytic treatment sensibilization in patients with primary 
infarction developed by the end of the third week and the number 
of sensibilizated cells was considerably lower than in patients, not 
receiving thrombolytic therapy, so was the level of sensibilization in 
patients with reinfarction (Figure 1). 
0 7 14 21 28 
' ' " , Primary infarction without thrombolysis 
•h" _ Reinfarction without thrombolysis 
-Ж- Primary infarction after thrombolysis 
-•- Reinfarction after thrombolysis 
Figure 1. Sensibilization to myocardial antigen in patients with myocardial 
infarction. 
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In our previous works we have shown that in patients with constant­
ly decreased activity of cellular immunity myocardial infarction often 
(in 70-80%) is accompanied by inflammatory processis. From 35 
thrombolized patients 4 had pneumonias and in one patient exacer­
bation of chronic pancreatitis was diagnosed (14%). Patients with 
long-lasting immunodepression often have healing disturbances, that 
may lead to forming of left ventricular aneurysm and progression of 
heart failure. In thrombolized patients no left ventricular aneurysm 
was diagnosed and chronic cardiac failure progressed considerably 
more rarely as compared with patients not receiving thrombolysis and 
having constantly low number of active T-lymphocytes. 
Thrombolized patients, as compared with patients with high level 
of sensibilization, had considerably better left ventricular function 
(Figure 2), although most of them had transmural infarction. They 
had seldom anginal pain and rhythm disorders in subacute phase of 
infarction. No Dressler's syndrome, nor exitus letalis was met among 
them (Table 4). 
T a b l e  4  
Some clinical data of patients with myocardial infarction 
with different level of sensibilization to myocardial antigen 
Low sensibilization High sensibilization p 
I%<40 n=43 I%>40 n=35 
Stenocardia 
acute phase 82% 84% ns 
subacute phase 16% 80% <0.001 
Rhythm disorders 
acute phase 42% 56% ns 
subacute phase 13% 44% <0.01 
Congestive heart failure 15% 76% <0.001 
Aneurysm 9% 32% <0.05 
Dressler's syndroma 0% 20% <0.001 
Mortality 0% 24% <0.001 
Discussion and conclusions 
Thrombolytic therapy causes a short-term decrease of the number of 
lymphocytes in peripheral blood. It can most likely be explained by 
displacement of these cells from circulation into depot organs. In 
some patients we can even notice enlargement of peripheral lymph 
nodes. As organism tries to keep its homeostase, the constant rela­
tionship between various populations of blood cells, a decrease of one 
population (thrombocytes) may bring about the leaving of another 
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Stenosis >75% (number of arteries) Number of a- and dyskinetic segments 
Ejection fraction (%) End diastolic pressure (mmHg) 
| Low sensibilization 
High sensibilization 
After thrombolysis 
Figure 2. Angiographic and ventriculography data of patients with myocar­
dial infarction with different level of sensibilization to myocardial antigen. 
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population (lymphocytes) from circulation. As a rule younger and 
more active cells depart from circulation. 
Decrease of the number of lymphocytes is accompanied by a 
temporary diminishing of the quantity of T- and functionally active 
T-lymphocytes, that lasts for a certain extent longer. Although, usual­
ly this kind of diminishing of the number of immunocompetent cells 
in peripheral blood of thrombolized patients is not long lasting, we 
should take into consideration the possible complications (inflamma­
tory processes, healing disturbances) that may occur in case of long 
duration of immunosupression, particularly in patients, who have had 
trouble with their immune system before. 
Releasing from the area of necrosis myocardial antigen calls forth 
the answer of the immune system: formation of sensibilizated to MA 
T-lymphocytes and production of antimyocardial antibodies. This 
reaction is a physiological one. But in some cases the answer of immu­
ne system is inadequate, an increased sensibilization to MA develops. 
It has been shown in experiments (Terechova-Uvarova N. A. 1982 Gut­
hrie M. et al. 1984), that sensibilizated to MA lymphocytes are able to 
damage the function and structure of myocytes. Histamine, releasing 
from these damaged cells can irritate receptors of the nervous system 
and induce pain. Mediators, produced by activated T-lymphocytes are 
able to modify the inotropic and chronotropic answer of the tissue of 
myocardium and cause rhythm disorders (De Bracco M. M. E. et al. 
1985). 
After thrombolytic therapy sensibilization to myocardial antigen 
develops later and is on a moderate level. Reasons for that may be: 
1) lack of lymphocytes in circulation during the period of releasing 
of antigen from necrotic myocardium, 2) immunosupressive effect of 
streptokinase, 3) immunosupressive quality of heparin, thrombolysis 
was combined with. As it was shown by Q. Bruserud and K. Lu-
din (1987) heparin inhibited antigen, but not mitogen induced DNA 
synthesis. 
However, the lower level of sensibilization to MA noticed in pa­
tients after thrombolysis is in every respect favourable to the course 
and prognosis of acute myocardial infarction. 
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Kokkuvõte 
150-1 südamelihase infarkti põdenud haigel uuriti rakulist immuun­
sust. Määrati T-lümfotsüütide ja funktsionaalselt aktiivsete T-lümfo-
tsüütide hulk ning T-rakkude sensibilisatsiooni tase müokardi antigee­
nile. 35-1 haigel 150-st viidi läbi intravenoosne trombolüüs 1,5 miljoni 
ühiku streptokinaasiga. Trombolüüsi järgselt esines haigetel lühiaeg­
ne (kuni 1 nädal) statistiliselt tõepärane nii lümfotsüütide koguhulga 
kui T-ja funktsionaalselt aktiivsete T-rakkude hulga langus perifeerses 
veres. Sensibilisatsioon müokardi antigeenile kujunes neil välja hiljem 
ning oli oluliselt madalam kui ilma trombolüütilise ravita haigeil. Tko-
line madal sensibilisatsiooni tase mõjub soodsalt haiguse kliinilisele 
kulule ja prognoosile. 
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EFFECT OF ADAPTATION ON THE MODERATE 
VELOERGOMETRY STRESS IN YOUNG 
SUBJECTS WITH EARLY MILD HYPERTENSION 
Eevi Maiste 
Abstract 
Adaptationprocessions of cardiorespiratory system on the bicycle 
stress test (of 1 W/kg body weight) were studied in young subjects 
(in 19... 30 years) with early mild hypertension, and in normotensive 
vegetolabile and unvegetolabile healthy persons. Hemodynamic para­
meters were recorded by impedance cardiography. Significant diffe­
rence of adaptional process of hemodynamic were evaluated between 
subjects with hypertensive heart disease in early stage and normoten­
sive persons. Special attention should be paid the parameters, which 
characterize the systolic dysfunction (initial velocity of elevation of 
left ventricular pressure and mean velocity of stroke volume ejection 
velocity) as marker of hypertensive heart disease in nonhypertrophic 
left ventricle. 
Introduction 
Hypertension plays an important role in the factors for heart disease 
and heart mortality (Levy et al. 1990, Koren et al. 1991). In young 
people the progression of hypertension in early stage is often asympto­
matic and difficult to discover by ordinary screening methods (Iriarte 
et al. 1993). Quite recently diastolic dysfunction accompanied by an 
increase in left ventricular wall thickness has been recognized as an 
early marker of hypertensive heart disease (Cohn et al. 1986, Dianzum-
baetal. 1986, Fröhlicher«/. 1992). Systolic function in the early stages 
is often preserved (Hartford et al. 1985). But animal models of pressu­
re overload (Dubeus et al. 1993) have shown that modification of the 
shortening velocity of hypertensive heart can be detected very early. 
Subjects and Methods 
One hundred and thirthy eight persons in 19... 30 (mean 25.6+1.16) 
years were included in study (73 females and 65 men). Mild essential 
hypertension was diagnosed in 47 subjects, of them borderline hyper­
tension (0) in 16, the first stage (I) in 17, the second stage (II) in 
14 persons. The history of hypertension was not more than 3 years. 
For the comparision 50 normotensive vegetolabile and 41 normo­
tensive unvegetolabile healthy persons were studied. The vegetolabile 
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were deleted into 2 subgroups — without complaints (A) and with 
complaints (B). All subjects had normal weight. In all groups the 
relative quantity of adipose tissue was equal. Nobody of them didn't 
have got a high degree physicaltrainingstage. 
All patients underwent echocardiographic examination following 
the recommendations of the American Society of Echocardiography 
(Sahn et al 1978). A physical exercise capacity was established by 
bicycle exercise testing. For examination of adaptationprocession of 
cardiorespiratory system was used the load of 1 W/kg body weight 
until 5 minutes. That intensity of exercise is used as the basisload for 
the value of the adaptationprocesses (Schwalb et al 1981). Hemody­
namic parameters were recorded by impedance cardiography in rest, 
during the exercise and in the 8 minutes recovery time. We continu­
ously monitored the oxygen consumption during the some time and 
recorded the dynamics of the blood gases by Micro-Adstrup in the 
capillare blood before and after the test. 
Results and Discussion 
By echocardiography only in hypertensive II stage in part of the pati­
ents hypertrophy of left ventricle was found. In the other groups the 
wall thickness of the left ventricle didn't exceed the wellknown stan 
dards. The left ventricle wall thickness in vegetolabile subjects was 
significantly thinner (p<0.05) then in the other groups. The parame­
ters of hemodynamics and oxygen consumption didn't differ between 
the groups in the rest (Table 1). The exercise tolerance was significa-
vithy less (p<0.05) compared with hypertensive subject. The cause to 
stop the exercise test in the majority of cases was complain of dyspnea. 
As shown in Table 2 by exercise with load of 1 W/kg body weight 
dynamics of storke volume index, heart index and increasing of the 
oxygen consumption didn't differ between the groups. We found sig­
nificant decrease of the adaption velocity of oxygen consumption in 
early stage of arterial hypertension. In patients with the first sta­
ge arterial hypertension the disturbances were also registered in the 
initial stage of recovery period. In approximately one half of the sub­
jects with vegetolabile disturbances there was no onset of steady state 
plateau. 
Initial velocity (Table 3) of elevation of left ventricular pressure 
on onset of exercise increased by 23.6±1.65%, during the exercise 
did not change and increases by approximately 30% during the first 
minute of recovery time and reaches preexercise values to the end of 
3 minutes recovery period in all cases. In 50% of vegetolabile patients, 
who had complaints Vi velocity decreases during exercise in relation 
to lengthening of isovolumetric contraction stage. 
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in hypertensive subjects the Vi velocity is significantly higher 
(p<0.05) than in normotensive subjects. In the borderline hyper­
tension during exercise the excessive increase of Vi velocity at first is 
diminished and absolute values in most of cases do not differ from 
those of healthy subjects. In I stage hypertension no decrease of Vi 
velocity does occur and in II stage hypertension the Vi velocity shows 
tendency to increase exceeding significantly (p<0.05) the normal va­
lues. 
Mean velocity of stroke volume ejection velocity (VQS) in normal 
subjects increases during exercise by 48... 60% as compared to rest 
values and during the exercise has tendency to accelerate. In subjects 
with borderline and stage I hypertension VQS is shortening during 
exercise (p<0.05). The values of VQS and Vi at rest and during 
exercise are in correlation with the left ventricular mass and volume 
(r=0.495). 
The increase of the heart rate during exercise in vegetolabile sub­
jects were both in absolute values and as calculated per 1 W intensity 
of the exercise, significantly higher (p<0.05) than in other groups (Fi­
gure 1). The increase of the heart rate during exercise with intensity 
of 1 W/kg is in correlation with mass of skeletal muscles (r=0.560), 
proportional index (r=0.528) and left ventricular mass (r=0.368). 
Absolute values of systolic blood pressure (SBP) were in hyper­
tensive subjects regardless of the stage during exercise significantly 
higher (p<0.05) than in normotensive subjects. The increase of SBP 
per 1 W/kg (Figure 2) was in correlation with skeletal muscle mass 
(r=0.501) and with relation of the interventricular septum and left 
ventricular volume (r=0.340). SBP increment per 1 W/kg did not 
differ between the groups. 
The values of diastolic blood pressure (DBP) were in hyperten­
sive subjects significantly higher than in other groups. In stage II 
hypertension we found continuos increase of DBP during exercise. 
Characteristic of hypertensive subjects is a short time decrease of 
DBP during the first minute of recovery time after the DBP rises and 
by the 8 minute of recovery exceeds preexercise values in a number of 
cases. 
Conclusion 
In young hypertensive subjects the disease of adaptational process 
on the stress test can be evaluated already in the early stage of mild 
hypertension. 
Special attention should be paid to the parameters, which charac­
terize the systolic dysfunction (Vi and VQS dynamics) as marker of 
hypertensive heart disease in nonhypertrophic left ventricle. 
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Kokkuvõte 
Uuriti hemodünaamika ja respiratoorse süsteemi adaptatsioonireak-
tsioone veloergomeetrilisele koormusele 1 W/kg hüpertooniatõve 
varases staadiumis ning tervetel vegetolabiilsetel ja mittevegetolabi-
ilsetel isikutel. 
Juba hüpertooniatõve labiilses ja I staadiumis ilmnesid kar-
diorespiratoorse süsteemi olulised adaptatsioonihäired koormusele. 
Vasaku vatsakese süstoolset funktsiooni peegeldavaid parameetreid 
(rõhutõusu algkiirus vasakus vatsakeses ja löögimahu keskmine välju-
tuskiirus) võib pidada üheks olulisemaks varaseks differentsiaaldiag-
nostiliseks markeriks hüpertrofeerumata vasaku vatsakesega isikutel. 
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REACTION OF MACROPHAGAL PHAGOCYTIC 
SYSTEM ON THROMBOLYTIC THERAPY IN 
PATIENTS WITH ACUTE MYOCARDIAL INFARCTION 
Silvia Noodla, Maido Uusküla 
Abstract 
The aim of this study was to investigate the influence of thrombolytic 
therapy on functional activity of macrophagal-phagocytic system in pts 
with acute myocardial infarction (AMI), to compare the connection 
of functional activity of phagocytes with the size of the necrotic zone 
and the left ventricle function in pts with myocardial infarction with 
and without thrombolytic therapy.Intravenous thrombolytic therapy 
with streptokinase in the first hours of AMI increases the spontaneous 
adherence of phagocytes and causes normalization of phagocytic reac­
tion to myocardial antigen. The increased spontaneous adherence of 
phagocytes is not connected with the size of necrotic zone, the functio­
nal state of the left ventricle and the occurrence of some complications. 
Normal phagocytic reaction to myocardial antigen accompanies the 
formation of smaller necrotic zone and the development of fewer left 
ventricular dyskinetic segments. 
Introduction 
Myocardial necrosis induces the activation of phagocytes and their 
migration to the zone of necrosis, where they participate in the for­
mation of necrotic zone and in healing processes (Chatelain et al, 
1987). Achievement of reperfusion with thrombolytic agents reduces 
myocardial infarction size, improves infarct healing and reduces its 
complications (Ritchie et al., 1988). 
Reperfusion after thrombolysis may cause several metabolic and 
functional changes in ischaemic myocardium, such as the production 
of a large amount of oxygen-derived free radicals, which can induce an 
irreversible oxidative damage in the myocardium and thus decrease 
the benefit from reperfusion (Giardino et al., 1993). One source 
for oxidative metabolites in the damaged myocardium is activated 
leucocytes. It has been established that reperfusion increases the 
amount and the functional activity of leucocytes in the necrotic zone 
and that antiinflammatory pretreatment before ischaemia and after 
reperfusion reduces infarct size and leucocyte infiltration. (Klein et al., 
1988). 
The aim of this study was to investigate the influence of throm­
bolytic therapy on functional activity of macrophagal-phagocytic sys-
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tem (FAP) in patients (pts) with acute myocardial infarction (AMI) 
and to compare the connection of FAP with the size of the necrotic 
zone and the left ventricle function in pts with AMI with and without 
thrombolytic therapy. 
Material and Methods 
We examined 51 pts with AMI (mean age 55 years), who received int­
ravenous thrombolytic therapy with streptokinase (Celiase) in the first 
hours of AMI (group I) and 52 pts with AMI (mean age 51 years), who 
received conventional therapy without thrombolysis (control group). 
Spontaneous adherence of phagocytes and the adherence with 
myocardial antigen (MA) were measured by the modified K. Donald­
son macrophage adherence and spreading assay on the first to second 
and fifth to seventh days of AMI. The infarct size was assessed on the 
basis of maximum numbers of ECG leads with Q/QS. The left ventric­
le ejection fraction (EF) and the number of dyskinetic segments were 
assessed on the basis of ventriculography and echocardiography. 
Results and Discussion 
Spontaneous adherence of phagocytes (SAP) on the first days of AMI 
was normal in 14% of pts in group I (7 from 51 pts).It increased 
above 80% in all pts by the end of the first week of disease. In 
the control group SAP was normal in 48% of pts (16f from 33 pts, 
p<0.05) on the first days of AMI. By the end of the first week of AMI 
SAP was increased in group I in 86% of pts (44 from 51 pts), which 
was significantly higher than in the control group (in 10 pts from 60, 
p<0.01) 
By the end of the first week a more extensive necrotic zone was 
found in pts without thrombolytic treatment with increased SAP than 
in pts with normal SAP, despite the lack of differences in degree of 
coronary stenosis. But in pts with thrombolytic therapy regardless of 
the increased adherence of phagocytes statistically fewer ECG leads 
with Q/QS (2.3±1.5) was found and the EF was higher (51.6±13.9) 
than in pts with increased SAP in the control group (ECG leads with 
Q/QS were 4.8±3.1, p<0.05 and EF was 32.9±16.6, pcO.Ol). 
The occurrence of some complications in pts with thrombolysis 
with increased SAP was smaller than in respective pts in the control 
group, for example, in group I there were no pts with acute heart 
insufficiency, whereas in the control group there were 2 cases from 
10 pts (p<0.05); in group I chronic heart insufficiency was noted in 
9 pts from 43, but in the control group in 8 pts from 10 (p<0.05). The 
occurrence of rhythm disturbances in the two groups did not differ. 
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The adherence with MA (FFA-MA) on the first to second days 
of AMI treatment with thrombolysis was increased in 6 from 51 pts 
(12%), was normal in 35 from 51 pts (69%) and decreased in 10 from 
51 pts (19%). In the control group the appropriate data were 15 from 
52 pts (29%), 29 from 52 pts (56%) and 8 from 52 pts (15%). 
In the control group in pts with normal FFA-MA on the first days 
of AMI significantly fewer dyskinetic segments, higher EF and fewer 
occluded coronary arteries were found than in pts with increased 
FFA-MA. But in pts with thrombolysis and with normal FFA-MA 
significantly fewer leads with Q/QS and fewer dyskinetic segments 
were established as compared with the respective pts in the control 
group; no differences in EF and the number of occluded coronary 
arteries were found (Table 1). The occurrence of complications on 
the first and second weeks of AMI did not differ in the 2 groups. 
These data indicate that in case of thrombolytic therapy there were 
significantly more pts with normal FFA-MA, the necrotic zone and the 
number of dyskinetic segments were smaller than in pts with conven­
tional therapy, which indicates the opportune effect of thrombolysis 
on the formation of necrotic zone and healing processes. 
T a b l e  1  
Data of necrotic zone size and left ventricle function 
in pts with AMI with and without thrombolytic therapy and 
with normal FFA-MA on the first days of AMI (M±SD) 
FFA-MA -8.5 -r 51.5 
control group pts with thrombolytic p 
n = 29 therapy 
No of ECG leads with Q/QS 3.7 ± 2.3 2.5 ± 1.5, n = 33 <0.05 
No of dyskinetic segments 0.4 ± 0.8 0.04 ± 0.2, n = = 23 <0.05 
EF% 53.3 ± 13.4 50.9 ± 13.5, n = 23 >0.05 
No of occluded coronary 
arteries 0.4 ± 0.5 0.9 ± 0.9, n = 14 >0.05 
The increased spontaneous adherence in pts with thrombolytic 
therapy is not connected with the size of the necrotic zone, but evi­
dently it is due to immediate activating effect of thrombolytic drug 
on phagocytes, because streptokinase is foreign protein with antigenic 
properties (Bremm et al., 1987). The frequent occurrence of rhythm 
disturbances in pts with thrombolytic therapy indicates microcircula-
tory disturbances in the ischaemic zone. Reperfusion increases the 
accumulation of leucocytes in the necrotic zone, which can induce 
plugging of white blood cells in capillaries, and thus increase mic-
rocirculatory disturbances. 
69 
Conclusions 
1. Intravenous thrombolytic therapy with streptokinase (Celiase) 
in the first hours of AMI increases the spontaneous adherence of 
phagocytes. The increased spontaneous adherence of phagocytes is 
not connected with the size of the necrotic zone, the functional state 
of the left ventricle and the occurrence of some complications of AMI. 
2. Intravenous thrombolytic therapy causes normalization of pha­
gocytic reaction to MA, which accompanies the formation of the smal­
ler necrotic zone and the development of fewer left ventricular dyski­
netic segments. 
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Kokkuvõte 
Müokardiinfarkti puhul fagotsüiidid võtavad osa infarktitsooni 
formeerimisest ja paranemisprotsessist. Töö eesmärgiks oli uurida 
trombolüüsi mõju makrofagaal-fagotsütaarsüsteemi funktsionaalsele 
aktiivsusele akuutse müokardiinfarktiga (AMI) haigetel ja võrrelda 
trombolüüsitud haigete ja ilma trombolüüsita ravitud haigete fagot-
sütaarsüsteemi aktiivsust ja selle seost nekroosikolde suurusega ja 
vasema vatsakese funktsionaalse seisundiga. Uuriti 51 AMI haiget, 
kes said intravenoosset streptokinaas-ravi AMI esimestel tundidel ja 
52 AMI haiget, kes ei saanud trombolüütilist ravi. 
Trombolüütiline ravi AMI haigetel provotseeris kõrgenenud 
spontaanse fagotsüütide kleepuvuse 86%-l haigetest (kontroll­
grupis — 17%-1). Trombolüüsitud haigetel kõrgenenud fagotsüütide 
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spontaanse kleepuvusega ei kaasnenud ulatuslikum nekroosikolle, 
madalamad vasema vatsakese funktsiooni näitajad ja sagedasem tü­
sistuste esinemine, nagu seda leiti kontrollgrupi vastavatel haige­
tel. Seega võib arvata, et kõrgenenud fagotsüütide spontaanne 
kleepuvus on tingitud trombolüütikumi otsesest aktiveerivast mõjust 
fagotsüütidele. Fagotsüütide kleepuvus müokardi antigeeni (MA) 
toimel trombolüüsitud haigetel näitas normaliseerumise tendentsi: 
trombolüüsitud haigete grupis oli fagotsüütide kleepuvus MA toimel 
kõrgenenud 12%-1 ja normaalne 69%-l haigetest, kontrollgrupis ol­
id vastavad näitajad 29% ja 56%. Trombolüüsitud haigetel, kellel 
oli normaalne fagotsüütide kleepuvus MA toimel, esines väiksem 
nekroosikolle ja vasemal vatsakesel täheldati vähem düskineetilisi seg­
mente kui kontrollgrupi vastavatel haigetel, mis näitab trombolüüsi 
soodsat mõju infarktikolde formeerumisele ja paranemisele. 
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LUNG PERFUSION SCANNING AS 
A SCREENING METHOD IN DIAGNOSTICS 
OF PULMONARY EMBOLISM 
IN CARDIOLOGY DEPARTMENT 
M. Ojamaa, К. Uist, M. Viigimaa 
Abstract 
Diagnosis of the patient with pulmonary embolism remains avexing 
clinical problem. Radionucleide methods offers the only non-invasive 
technique with an accetable sensitivity. We studied 40 patients with 
suspicion of pulmonary emboli. 16 of them had a pulmonary emboli, 
witch was seen also in the perfusion-ventilation studies. We suggest 
that radionucleide perfusion-ventilation study is always needed when 
there is a suspicion of pulmonary emboli and pulmonary angiography 
is needed only occasionally. 
Introduction 
Pulmonary embolism (PE) is the third most common cardiovascular 
disease, after acute ischaemic syndroms and stroke. PE continues 
to be a major contributing factor for in-hospital mortality in patients 
and is responsible for approximately 10% of deaths in hospital (Sand­
ler 1989). The mortality in patients with PE is 31%, but if patients are 
treated the mortality is only 8%. 11% of patients will die within the 
first hours from the onset of PE, in 29% of patients the PE is diag­
nosed and the treatment is started, the rate of underdiagnose is 64% 
(Benotti 1983). PE is known clinically as the "great masquerader", 
the most common features that suggest this diagnosis are chest pain, 
profound dyspnea, tachypnea, hemoptysis, cyanosis with distended 
neck veins. ТЪе EKG tends to show characteristic abnormalitis, tra­
ditional manifestation of acute cor pulmonale, only in patients with 
massive PE. The chest X-ray may demonstrate an oligaemic segment 
of the lung if the embolus is large or a small basal effusion with a 
linear atelectasis with smaller emboli. It is generally accepted that 
pulmonary angiography, as the "gold standard" (Alderson 1987) is 
the definitive examination for excluding or confirming the presence 
of PE. But in patients with pulmonary hypertension and/or elevated 
right ventricular and diastolic pressure risk of mortality in this exa­
mination is very high (Perlmutt 1987). Therefore the non-invasive 
ventilation/perfusion lung scanning with its acceptable sensitivity is 
the screening test for the PE (Gray 1990, Kohn 1990, Cooper 1991, 
Juni 1991, Berg 1993, Gottschalk 1993). In the perfusion scan the 
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radiotracer is distributing in the lungs proportionally with blood flow, 
and an area of reduced perfusion will visualise as an area of decreased 
activity. In the case of PE the ventilation in the reduced perfusion 
area remains Unchanged and combining these two scans together will 
increase the accuracy of the diagnose. 
The aim of this study was to evaluate the lung perfusion scanning 
as a screening method in diagnostics of PE. 
Matherial and Methods 
During the period from January 1993 to October 1994, 40 patients 
with suspected PE from the Department of Cardiology of Tartu Uni­
versity Hospital were submitted to lung perfusion scanning to Nuclear 
Medicine Department of TUH. The patients were 22-82 years old 
(mean age 51 years); 17 of them were men and 23 were women. Prior 
to the perfusion study the chest X-ray was performed to exclude the 
other possible causes of the perfusion defects in lung scans. Two 
patients with perfusion defects underwent lung ventilation scanning. 
Perfusion lung scans were performed after an intravenous injection 
of 100-140 MBq (3-5 mCi) of Tc-labelled human albumin macroagg-
regates. Four views (anterior, posterior, left lateral and right lateral) 
were done with the use of the planar gamma camera PHO GAM­
MA IV equipped with the low energy and high resolution, diverging 
collimator. Each view was acquired for 400 000 counts. Ventila­
tion lung scan was performed using a nebulizer filled with 100 MBq 
(3 mCi) 99mTc-DTPA in 4 ml, and inhalation was performed through 
the mouth using the nasal clip for 8 min of forced ventilation with 
8-10 1/min oxygen flowing trough the nebulizer. Scan images were 
obtained in the same way as the perfusion images. 
To evaluate the lung scan images we used modified Biello criteria 
(Biello 1987): 
1. Normal: 
— no perfusion defects present 
2. Low probability of PE: 
— subsegmental perfusion defect without ventilation study 
— segmental or larger perfusion defect with ventilation matching 
— any perfusion defect with a substantially larger chest X-ray abnor­
mality 
3. Intermediate probability of PE: 
— subsegmental perfusion defect with mismatching ventilation study 
— segmental or larger perfusion defect without ventilation study 
4. High probability for PE: 
— segmental or larger perfusion defects mismatching ventilation 
study. 
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Results and Discussion 
Using the above described criteria our patients divided into groups: 
I group: 22 patients 
II group: 2 patients 
III group: 7 patients 
IV group: 9 patients 
PE diagnose was excluded in 24 cases: 22 patients from group I 
with normal lung perfusion scan and 2 patients from group Л whose 
perfusion defects size and location was matching with the chest X-ray 
film lesions. The remained 16 patients demonstrated variable size 
and location perfusion defects on lung perfusion scan. In all those 
patients the lung perfusion scan was performed 2 to 7 days after the 
onset of clinical symptoms, and 9 of them had already been submit­
ted to anticoagulation and/or thrombolytic therapy. However in lung 
scan there were still visible some perfusion defects in variable sizes. 
Perfusion defect size was quite well correlated with clinical symptoms 
and PE was diagnosed in all of 16 patients. 9 patients had large 
multiple segmental perfusion defects, 5 patients had over two subseg­
mental perfusion defects, 2 patients had lobar defects. In 2 patients 
we performed the lung ventilation scan and the mismatching defects 
confirmed the PE diagnose. 5 patients underwent the pulmoangiog-
raphy and there was no significant differense between the size and 
localisation with defects found in perfusion scan. 
In conclusion the present study showed that radionucleide imaging 
of lung is a valuable test for the diagnosis of PE. It is easy to perform, 
noninvasive and safe for the patient. The test has also sufficient 
sensitivity. Low probability lung scan makes PE unlikely and high 
probability lung scan usually indicates the presence of PE. By using 
the radionucleide scanning as the first choice diagnostic modality, we 
could in most cases avoid performing an invasive and relatively high 
risk pulmonary angiography. 
We suggest that radionucleide lung scanning is always needed when 
there is a suspicion of PE and pulmonary angiography is needed only 
in some cases, mostly in patients from the group of intermediate PE 
probability. 
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Kokkuvõte 
Kopsuarteri trombemboolia diagnoosimine ja õigeaegne ravi alus­
tamine on haiguse prognoosi seisukohalt väga oluline. Tänapäe­
val kasutatakse kopsuarteri trombemboolia diagnoosimiseks kogu 
maailmas üha enam kopsude perfusiooni-ventilatsiooni uuringut ra-
dionukleiididega. Uuring on piisava tundlikkusega, mitteinvasiivne ja 
haigele kergesti talutav. Tartu Maarjamõisa Haigla isotoopdiagnos-
tika osakonnas on tehtud 40 kopsude perfusiooni uuringut kopsuar­
teri trombemboolia kahtlusel. Perfusioonidefektid esinesid 16-1 pat­
siendil ja neil diagnoositi ka kopsuarteri trombembooliat. Kopsude 
ventilatsiooniuuringuid on osakonnas võimalik teha alates 1994 a. 
jaanuarist ning seda on tehtud patsientidel, kellel perfusiooniuuringul 
esinesid defektid. Need on rutiinuuringud kopsuarteri trombemboo­
lia diagnostikas ja nende uuringutega on võimalik välja selekteerida 
ka need patsiendid, kes vajavad diagnoosi täpsustamiseks kopsude 
angiograafiat. 
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METABOLIC DISTURBANCES 
AS CHARACTERISTIC FEATURES 
OF ESSENTIAL HYPERTENSION 
TViin Parik, Kristina Allikmets, Rein Teesalu 
Abstract 
Objective: To evaluate metabolic cardiovascular risk factors in young 
(<40 yr) untreated patients with uncomplicated essential hypertension 
(EH) compared to normotensive controls. 
Metods: Plasma glucose and insulin responses during oral gluco­
se (75 g) tolerance test (GTT) were measured along with plasma 
lipid profile in 32 patients with mild-to-moderate EH and in 26 matc­
hed normotensive controls. Insulin sensitivity index (ISI) and fasting 
glucose-insulin ratio were calculated. Metabolic parameters were 
compared in normo- and hyperinsulinaemic (fasting plasma insulin 
>1 SD than the mean of all subjects) patient subgroups. 
Results: Plasma insulin response during GTT was significantly 
(pcO.Ol) greater and fasting glucose-insulin ratio lower in EH pati­
ents, despite normal glucose tolerance. ISI was decreased (pcO.Ol) 
in EH patients. The hyperinsulinaemic patients (25%) had elevated 
plasma levels of triglycerides, total and LDL-cholesterol compared to 
normoinsulinaemic subgroup.This pattern of dyslipidaemia was also 
found in the entire EH group, when compared to controls. 
Conclusions: The results show that young untreated patients 
with uncomplicated EH are characterized by multiple disturbances 
in glucose and lipid metabolism. Therefore, appropriate therapeutic 
approaches should be considered already in the early phases of the 
disease. 
Introduction 
The impact of antihypertensive treatment on coronary artery disease 
(CAD) endpoints has been disappointing (Hansson 1992), indica­
ting that factors beyond high blood pressure (BP) contribute to the 
development of atherosclerosis in hypertensive patients. Recently, 
increased attention has been focused on the association of essential 
hypertension with metabolic abnormalities, particularly hyperinsuli-
naemia and/or insulin resistance (Laws 1993). These disturbances, in 
addition to the widely accepted risk factors like hypercholesterolaemia 
and dyslipidaemia have been implicated in the development of athe­
rosclerosis (Standley 1993). Plasma glucose concentration has also 
been related to the incidence of atherosclerotic lesions, and this rela­
tion extends into the nondiabetic range of glycaemia (Drexel 1994). 
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Novel therapeutic strategies highlighten the need to consider in­
terventions already in the developing phases of hypertensive vascular 
disease. Therefore, the present study was performed to evaluate 
metabolic risk factors in young (<40 years) untreated patients with 
uncomplicated essential hypertension. 
Subjects and methods 
Study subjects. Thirty-two untreated patients with mild-to-moderate 
essential hypertension (diastolic BP 95-114 mmHg), aged 20-40 years 
(mean 32.4) were studied. The diagnosis of hypertension based upon 
measurements of diastolic BP (Korotkoff phase V, mercury sphyg­
momanometer) of 95 mmHg or above and systolic BP of 140 mmHg 
or above in the seated position on three separate occasions at least 
1 week apart. The average known duration of hypertension was 6.8 ye­
ars (range 0.5-12). None of the patients had any evidence suggestive 
of CAD, based on a negative history, ECG, exercise test and echocar­
diography. Other systemic diseases and secondary hypertension were 
excluded on the basis of clinical and laboratory investigations. 
The control group consisted of 26 healthy age-, sex- and body 
mass index-matched volunteers, in whom physical and biochemical 
examinations did not reveal any abnormalities and systolic BP and 
diastolic BP were lower than 140 and 85 mmHg, respectively. 
No dietary restrictions were imposed, and none of the participants 
used any drugs, including antihypertensives at least 4 weeks prior to 
the study. Informed consent was obtained from all subjects and the 
study protocol was approved by the Ethical Committee of the Medical 
Faculty, University of Tartu. 
Measurements. After an 12 h overnight fast an oral glucose (75 g) 
tolerance test (GTT) was performed. Blood samples were drawn at 
fast, after 60 and 120 minutes to determine plasma glucose levels (by 
the glucose oxidase method) and plasma insulin levels by radioim­
munoassay kits (Medgenix, Belgium). In the fasting samples total 
cholesterol, triglycerides, high-density lipoprotein (HDL) choleste­
rol and low-density lipoprotein (LDL) cholesterol were measured by 
standard enzymatic methods. Body mass index (BMI) was calculated 
by weight (kg) divided by height (m) squared. 
Data analyses. Hyperinsulinaemia was defined as fasting plasma 
insulin level >1 standard deviation (SD) higher than the mean of 
all study subjects.Insulin sensitivity index (ISI) was calculated accor­
ding to Cederholm et al. (Cederholm 1990), expressed as the relation 
between the glucose uptake rate and the mean plasma insulin concent­
ration at 0 and 120 minutes during GTT.Fasting glucose-insulin ratio 
was calculated according to Caro et al. (Саго 1991), after expressing 
plasma glucose levels in mg/dl. 
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Results are presented as mean ± standard deviation. Statistical 
differences between the groups were tested by Student's t-test. Linear 
regression analysis was used to show correlations between variables. 
P<0.05 was considered statistically significant. 
Results 
Fasting plasma glucose concentrations were similar in hypertensives 
and in controls, but significantly (p<0.05) higher fasting insulin le­
vel was found in the patient group (Table 1). Also, insulin response 
during oral GTT was significantly (p<0.01) greater in EH patients, 
despite similar plasma glucose responses in both groups. In addition, 
hypertensives were characterized by significantly (pcO.Ol) lower fas­
ting glucose-insulin ratio and lower insulin sensitivity index compared 
to controls. Despite the significant overall differences, a considerable 
overlap of plasma insulin values was observed between the two groups. 
T a b l e  1  
Characteristics of glucose metabolism according to responses 
during oral glucose tolerance test in patients with essential 
hypertension and in the control group 
Essential hypertension Control P (n-32) (n=26) 
13.3±7.1 6.7±1.9 CO.OI 
68.0±33.7 31.3±18.2 CO.OI 
27.5±11.5 13.3±9.2 CO.OI 
4.9±0.7 4.5±0.6 NS 
6.5±1.7 6.2±1.7 NS 
4.4±0.9 4.2±0.8 NS 
1.7±0.5 3.6±2.2 CO.OI 
51.9±17.8 72.3±14.2 co.oi 
F-insulin (mU/1) 
Insulin lh (mW) 
Insulin 2h (mU/1) 
F-glucose (mmol/1) 
Glucose lh (mmol/1) 
Glucose 2h (mmol/1) 
F-glucose/insulin 
ISI 
F-insulin, plasma insulin level at fast; 
F-glucose, plasma glucose level at fast; 
F-glucose/insulin, fasting glucose (mg/dl) insulin (mU/1) ratio; 
ISI, insulin sensitivity index. 
Values are expressed as mean ± SD. 
NS, not significant. 
Eight patients had abnormally high fasting insulin values (>1 SD 
than the mean of all subjects), leading to a 25% prevalence of hyperin-
sulinaemia in the hypertensive group. A similar prevalence was found 
while using postglucose-load insulin values. Metabolic characteris­
tics of hyper- and normoinsulinaemic hypertensives are presented in 
Table 2. 
Hyper- and normoinsulinaemic patients did not differ significant­
ly in respect of age, BMI, and blood pressure values Plasma gluco-
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T a b l e  2  
Metabolic characteristics of hyper- and 
normoinsuli- naemic hypertensive patients 
Hyperinsulinaemic 
patients 
Normoinsulinaemic 
patients 
P 
F-insulin (mU/1) 22.6±5.7 10.3±4.3 <0.01 
F-glucose (mmol/1) 5.0±1.1 4.8±0.6 NS 
Cholesterol (mmol/1) 6.4±1.5 5.9±1.5 NS 
Triglycerides(mmol/l) 1.9±1.2 1.6±1.0 NS 
LDL (mmol/1) 4.4±1.2 3.9±1.3 NS 
HDL (mmol/1) 1.2±0.1 1.2±0.2 NS 
Values are expressed as mean ± SD. NS, not significant. 
se concentrations were similar in both subgroups of hypertensi­
ve patients. Plasma levels of total cholesterol, triglyceride and 
LDL-cholesterol were higher in the hyperinsulinaemic subgroup, but 
this difference was not statistically significant. 
The comparison of plasma lipid profile between hypertensive pa­
tients and controls is shown in Table 3. Total cholesterol, triglyceride 
and LDL-cholesterol levels were significantly (p<0.05) elevated in the 
patient group. Plasma HDL-cholesterol concentration was lower in 
EH patients, but this change was not statistically significant. 
T a b l e  3  
Plasma lipid profile in patients with essential 
hypertension and in the control group 
Essential Control P 
hypertension (n=32) (n=26) 
Cholesterol (mmol/1) 5.99±1.02 4.98±0.8 <0.05 
TG (mmol/1) 1.66±0.97 1.08±0.35 <0.05 
LDL (mmol/1) 4.06±1.30 3.28±0.97 <0.05 
HDL (mmol/1) 1.17±0.20 1.21±0.19 NS 
TG, triglycerides; 
LDL, low-density lipoprotein cholesterol; 
HDL, high density lipoprotein cholesterol. 
Values are shown as mean±SD. 
NS, not significant. 
Discussion 
The results demonstrate that young untreated patients with essential 
hypertension are characterized by multiple metabolic disturbances 
compared to matched normotensive controls. Plasma insulin levels 
79 
were significantly elevated both at fast and after glucose load in hy­
pertensives compared to controls, despite normal fasting glucose le­
vels and normal glucose tolerance in both groups. The lower fas­
ting glucose-insulin ratio detected in the patient group indicates that 
higher plasma insulin concentrations are needed to maintain nor-
moglycaemia in young hypertensive patients. This finding is clinically 
meaningful, since hyperinsulinaemia generally precedes and provokes 
insulin resistance as a result of downregulation of insulin receptors 
(Rizza 1985). Besides, raised plasma glucose levels are recognized as 
independent risk factors for CAD and even in the nondiabetic range 
of glycaemia (Drexel 1994). 
There are several ways of assessing insulin sensitivity, the hyperin­
sulinaemic euglycaemic clamp technique being the "gold" standard 
(Berger 1994). However, some simple and noninvasive methods, inc­
luding the calculated insulin sensitivity index (ISI) have shown a high 
correlation to the insulin sensitivity measured by the clamp technique 
(Cederholm 1990). In our patients, ISI was significantly lower com­
pared to controls. Evidently, ISI cannot differentiate between various 
reasons for insulin resistance, but a low peripheral glucose disposal in 
skeletal muscle is the most probable cause (Lindhal 1993). To define 
the optimal cutoff point for hyperinsulinaemia with respect to plasma 
insulin levels, we used a value above the 75th percentile of the mean 
of all study subjects. Using this approach, eight patients out of 32 
were hyperinsulinaemic, leaoing to the 25% prevalence of hyperinsu­
linaemia in the hypertensiv e group. This result is in accordance with 
other studies (Pollare 199U, Pool 1993), although even higher (up to 
50%) prevalence has been reported previously (Zavaroni 1992). Such 
data have recently been challenged due to inadequately defined crite­
ria of hyperinsulinaemia (Berger 1994). Our results support the view 
that hyperinsulinaemia, although a characteristic feature of hyperten­
sive patients, is nol an invariable finding in essential hypertension. 
Hyperinsulinaemia may directly promote atherosclerosis by en­
hancing LDL-cholesterol accumulation, vascular smooth muscle mig­
ration and proliferation, and by augmenting connective tissue synthe­
sis in the vessel wall (Sowers 1993). The adverse impact of insulin resis­
tance on the activity of the fibrinolytic system has likewise been emp­
hasized (Swan 1994). In the hyperinsulinaemic patients the traditional 
lipid risk factors were all changed in an "atherogenic" direction com­
pared to the normoinsulinaemic patients, except for HDL-cholesterol. 
However, these differences did not reach the level of statistical sig­
nificance. This finding is consistent with previous observations that 
abnormalities in lipid profile tend to cluster together with disturbances 
in carbohydrate metabolism (Laws 1993, Pool 1993). Positive corre­
lations between plasma insulin and triglycerides and inverse correl 
tions with HDL-cholesterol have been shown in hypertensive patient? 
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(Laws 1992). In this context, insulin is assumed to enhance the activity 
of lipoprotein lipase, which stimulates triglyceride synthesis in the liver 
(Jackson 1990). Besides, high plasma insulin levels may downregulate 
both HDL-cholesterol binding and LDL-cholesterol efflux from the 
vasculature (Pool 1993). More recently, it has become apparent that 
small, dense LDL particles, which are thought to be highly atheroge­
nic (Sowers 1993), are also related to hyperinsulinaemia (Laws 1992). 
A decrease in HDL-cholesterol and increase in LDL-cholesterol are 
well-established risk factors for CAD. Although less commonly app­
reciated, hypertriglyceridaemia, particularly at lower plasma choleste­
rol levels, was reported to be an independent risk factor according to a 
metaanalysis of 15 prospective studies (Criqui 1994). Collectively, the 
pattern of dyslipidaemia observed in the hyperinsulinaemic patients 
may be considered highly atherogenic. 
The "atherogenic" pattern of plasma lipids was characteristic also 
for the entire group of hypertensive patients, suggesting that hyper­
tension is only one part of a complex risk factor syndrome. While the 
search for the basis of metabolic risk factor clustering with essential 
hypertension continues, the patological significance of this relation is 
evident (Williams 1992). 
In conclusion, the detected association between hypertension, hy­
perinsulinaemia and dyslipidaemia emphasizes that many young hy­
pertensive patients have an important metabolic component to their 
disease. Therefore, the presence of metabolic risk factors should be 
seeked for actively, and appropriate nonpharmacological and treat­
ment approaches considered already in the early phases of hyperten­
sive disease. One further aspect to take into account is the metabolic 
profile of the antihypertensive drug itself (Pool 1993, Williams 1994). 
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Kokkuvõte 
Antihüpertensiivse raviga pole saavutatud hüpertensiooni peamise tü-
sistuse—südame isheemiatõve riski oodatud vähenemist, mille üheks 
põhjuseks võib olla essentsiaalse hüpertoonia (EH) kombineerumine 
metaboolsete häiretega. Seetõttu uurisime metaboolseid riskifaktor­
eid noortel (<40 a) tüsistumata EH haigetel ja kontrollgrupil. 
Teostatud glükoosi (75 g) tolerantsustest! (GTT) alusel selgus, 
et plasma insuliini väärtused, samuti veresuhkru-insuliini suhe enne 
GTT-d olid EH haigetel oluliselt (p<0.01) kõrgenenud, vaatamata 
normaalsele glükoosi tolerantsusele. Haigetel oli insuliintundlikkuse 
indeks vähenenud. Hüperinsulineemiaga haigetel (25%) olid plasma 
triglütseriidide, samuti üld-ja LDL-kolesterooli sisaldus oluliselt kõr­
genenud võrreldes normoinsulineemiliste haigetega. Düslipideemia 
oli iseloomulik ka kogu haigete grupile võrreldes kontrollrühmaga. 
Antud tulemused näitavad, et noortel kliiniliselt tüsistumata es­
sentsiaalse hüpertooniaga haigetel esinevad väljendunud häired sü­
sivesikute ja lipiidide metabolismis, mida tuleks ka antihüpertensiivses 
ravis arvestada. 
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CARDIAC OUTPUT AND FOREARM BLOOD 
FLOW CHANGES DURING UPRIGHT 
EXERCISE IN PATIENTS WITH 
CORONARY ARTERY DISEASE 
Tiit Pokk 
Reflex adjustements of the cardiovascular system to the initiation and 
continuation of muscular exercise include a redistribution of of cardiac 
output (CO) by limiting blood flow to the skin, kidneys, splanchnic 
vessels and nonexercising muscles and at the same time delivering 
more blood to working skeletal muscle. 
We have previously reported using impedance cardiography for 
measurements of stroke volume (SV) and CO as well as forearm stroke 
volume (FSV) and forearm blood flow (FBF) changes during leg 
exercise in healthy subjects (1989). We have also described abnormal 
FBF recordings during exercise test (ET) in patients with various types 
of heart disease. 
The aim of our present study was to evaluate to what extent abnor­
malities in FBF changes correlate with altered parameters of central 
hemodynamics during ET in patients with coronary artery disease 
(CAD). 
Methods 
19 male patients with CAD (NYHA I—II, age 31-61 years) and 18 
healthy men (age 29-60 years performed upright ET on a cycle ergo-
meter. The initial load was set at 0.5 W/kg and the load was increased 
by 0.5 W/kg increments. Each load lasted for 3 minutes. Cardiac 
output was measured by impedance cardiography. The technique de­
pends upon the conversion of changes in thoracic impedance during 
each cardiac cycle into information about blood flow. 
Pairs of voltage sensing electrodes are placed at the root of neck 
and at the level of the xiphisternum. Of the current injecting electro­
des one is placed around the forehead and the other 10 cm below the 
thoracic sensing electrode. 
Thus an alternating current of low amplitude and high frequency 
is introduced and simultaneously sensed. Stroke volume is calculated 
in ml according to an empirical formula described by Kubicek. 
FBF was also measured by rheography and calculated using the 
same equation. For this purpose two sets of electrodes are placed 
around the right forearm with a distance of 10 cm between the two 
inner electrodes. 
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All the recordings were done before the exercise test, at the end 
of each 3-minute stage, immediately after exercise, and at 3 minutes 
of recovery. The ECG was continously monitored during the test and 
recorded at the same time intervals. 
Results 
Absolute values of SV and CO were in the CAD patients statistically 
lower as before ET so at all workloads and at 3 minute recovery time. 
At the same time the values of FSV and FBF differed significantly 
from those of healthy men only at workloads 0.5 W/kg and 1.5 W/kg 
(p<0.05). 
In the CAD group a strong positive relationship could be de­
monstrated between rest values of SV and FSV (pcO.006) and be­
tween CO and FBF (p<0.05). In contrast, no such correlation existed 
in the control group between the same parameters. 
Pre-exercise values of FBF as % CO were in CAD patients app­
roximately same and even exceeded those of healthy men being sta­
tistically different at maximal workload and at the end of 3 minute 
recovery time (p<0.05). 
In CAD patients the reduction of FBF as % of CO occurred main­
ly in response to the initiation of ET, with little changes on greater 
workloads and the values returned to pre-exercise levels in 3 minute 
recovery time (p<0.05). In healthy subjects we registered a progressi­
ve reduction in FBF as % of CO with increasing intensity of exercise 
and the values failed to return to rest values in 3 minute recovery time 
(p<0.05). 
In CAD group we found a negative correlation between CO and 
FBF as % of CO (from the first workload onward) and between SV 
and FBF as % of CO (from the second workload onward) and those 
correlations were present in 3 minute recovery time. In control group 
we found analogous correlations only at maximal workloads. 
Conclusions 
The results of present study confirm assumptions that inadequate 
redistribution of blood flow away from nonactive regions to activate 
skeletal muscles in CAD patients may in part be responsible for their 
decreased work performance. 
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SEQUENTIAL CHANGES IN CARDIAC 
INDEX IN 35 MALE-PATIENTS 
WITH FIRST MYOCARDIAL INFRACTION 
T. Ristimae, M. Viigimaa, R. Teesalu 
Abstract 
In 35 men (mean age 54,9 years) with first myocardial infarction car­
diac index was serially assessed on the day 1, 2, 6, 14 and 21 during 
in-hospital stay by the method of integral rheography. 19 patients 
submitted the hospital with anterior infarction; a total of 12 patients 
presented complicated course of disease during hospitalization. For 
the whole study group, bi-directional curve of cardiac index during 
convalescence was observed, with significant decline in cardiac per­
formance by the day 14 (3,53±1,00 on the day 1 vs 2,72±0,461/min/m2), 
and subsequent moderate increase at the final measurement on the 
day 21 (2,80±0,671/min/m2). However, in the whole study-population 
as well as in either subgroups admission levels of cardiac index were 
not obtained at discharge-point. In terms of individual differences du­
ring hospitalization, dynamic and mostly unpredictable bi-directional 
changes were found for all patients. Altogether, in the current study, 
complicated patients, those who received digoxin at discharge, and 
those who submitted the hospital with anterior myocardial infarction, 
presented lower values of cardiac index when compared to the remai­
ning subjects. 
Introduction 
It is now recognized that among a number of factors determining both 
short-term and long-term survival after acute myocardial infarction 
(AMI) the most important is the state of left ventricular performance 
(Beller et al, 1986, Cannon et al, 1976, Thanavaro et al, 1980, Mad-
sen et al, 1984). As a consequence, left ventricular function during 
in-hospital stay as well as alterations several months or years later 
have been extensively studied (De Feyter et al, 1982, Gibson et al, 
1989, Sanz et al, 1982, Gimple et al,1989, Brown et al,1990). 
In earlier years, predominantly measurements of cardiac out­
put/cardiac index have been a widely used time-honoured method 
of assessing cardiac performance and therapeutic interventions in the 
patients with AMI (Gammiii et aL, 1955, Thomas et al, 1965, Broch et 
al, 1959, Hamosh et al,1911, Ramo et al, 1970, Forrester et al, 1976), 
whereas in past two decades investigators have highlighted evaluation 
of left ventricular ejection fraction as a powerful indicator of prognosis 
(Rigo et al, 1974, Schelbert et al, 1976, Shah et al, 1980, Pilate et al, 
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1989). Altogether, however, there have been few hemodynamic stu­
dies that examined the sequential changes in ventricular performance 
during in- hospital period (Schillingford et al, 1967, Rigo et al, 1974, 
Kupper et al, 1977, Nemerovski et al, 1982, Kan et al, 1984, Traina et 
al., 1993). More detailed analysis of the natural history of ventricular 
function following AMI might provide valuable information that may 
not be available from assessment of cardiac pumping ability during the 
first few days after admission or later on discharge alone. These se­
rial data can be important in understanding clinical presentations and 
determining reasonable therapy in patients with AMI. Furthermore, 
regarding cardiac output and cardiac index (CI), the range of values 
and overlap encountered in uncomplicated patients as well as those in 
heart failure and cardiogenic shock (Freis et al, 1959, Gunnar et al., 
1966, Ramo et al, 1970, Ratshin et al., 1971) restrict the interpretation 
of a single measurement of these variables. Considering the lack of 
comprehensive measurements of CI over the entire period of hospi­
talization, the current study was performed to define the sequential 
changes in CI that occur during the hospital course in patients with 
first AMI treated with conventional therapy. 
Methods 
Patient population. The study group comprised 35 patients admit­
ted to the Coronary Care Unit at Tartu University Hospital with the 
diagnosis of first AMI. The diagnosis was assigned to the patient if 
two of the following three criteria were present: 1) compatible cli­
nical history with characteristic pain in the precordium or associated 
areas; 2) raised serum creatine Phosphokinase, glutamic oxaloace­
tic transaminase (GOT), and lactic dehydrogenase (LDH) activity in 
samples from at least two different days; 3) development of patho­
logic Q waves (>40 msec duration) in at least two ECG leads, or 
of evidence of non-Q-wave myocardial infarction. The diagnosis of 
nontransmural AMI was established when serial electrocardiogram 
revealed ST-depression >1 mm, or T-wave inversion >3 mm in >2 
adjacent leads leads (lasting >7 days). No previous myocardial in­
farction (MI) according to vital history and preadmission ECG was 
required. The location of AMI was characterized according to estab­
lished ECG criteria (Prineas etal, 1982). For purposes of analysis, the 
location of infarction was categorized into either anterior or inferior 
groups. Anterior infarction was considered to include anteroseptal 
and anterolateral leads, and inferior infarction included inferolateral 
and inferoposterior locations. Patients with intermediate infarct loca­
tions (e.g., presence of left bundle branch block) were excluded from 
analysis. Main characteristics for the patient population are given in 
Thble 1. All patients were categorized as to their clinical status on 
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admission according to the criteria of Killip and Kimball (Killip & 
Kimball, 1967). 
Table 1 
Patients' characteristics 
Number of patients 35 
Men (n) 35 
Age (years: mean and range) 54,9 (29-69) 
Previous infarction None 
Q-wave AMI (n) 31 
Admission Killip class: 
class I 23 
' class II 11 
class П1 0 
class IV 1 
Anterior AMI (inferior AMI) 19 (16) 
Beta-blockers at discharge 11 
Digoxin at discharge 11 
Complicated course of AMI 12 
Mean hospital stay (days) 17+11 
AMI=acute myocardial infarction 
During the period of our study, the patients received the fol­
lowing cardioactive drugs: nitrates (29-S2,3%), aspirin 125 mg per 
day (33-94,3%), beta-blockers (11-31,4%), calcium channel blockers 
(9-25,7%), dopamine (3-8,6%), digoxin (11-31,4%), lidocaine (4-
11,4%), and diuretics (9-25,7%). Four patients were treated with 
streptokinase (1,5 millions IU). Any therapy was not standarized and 
was at the discretion of the attending physician. 
Reproducibility of the method of measuring CI was concurrently 
assessed in 10 patients with AMI who were studied twice on the sa­
me day (with a 30 minute interval) by two different observers. The 
mean absolute difference in CI between the paired observations was 
0,29+0,17 with a range of 0,10 to 0,33. Therefore, changes in CI of 
less than 0,7 were recognized as spontaneous variability, or the limited 
reproducibility of the method. 
Statistical methods 
Data are expressed as means ± standard deviation (SD). Analysis 
among groups was made by Pearson's chi square test, or Fisher's exact 
test, as appropriate. Correlation coefficients were obtained using 
standard linear regression equations. Probability (p value) of less than 
0,05 was considered significant. In measurements of CI the method 
of integral rheography was used (Tischenko, 1973, Tischenko et aL, 
1973). 
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Results 
CI values (l/min/sq m) for both the whole group and subsets of patients 
during hospitalization on the days 1, 2, 6,14 and 21 are summarized 
in Ihble 2. For the whole study group, bi-directional curve of CI 
during in- hospital stay was observed. Important decline in cardiac 
performance evaluated on the day 6 (2,76 + 0,73, p<0,05) resulted in 
peak reduction of CI on the day 14 (2,72 + 0,46, p<0,05). Subsequent 
increase of CI was less pronounced (2,80 + 0,66, NS), failing to attain 
admission- level (3,53 + 1,00). 
Table 2 
Serial changes of cardiac index during hospitalization 
Day 1 Day 2 Day 6 Day 14 Day 21 
Tbtal population 
(n=35) 3,53±1,00 us £
 
H- ©
 
2,76±0,73 2,72±0,46 2,80±0,67 
Anterior AMI 
(n=19) 3,47±1,00 3,34±0,75 2,53±0,62 2,69±0,33 2,74±0,75 
Inferior AMI 3,61±1,00 3,59±0,78 3,03±0,78 2,75±0,59 2,95±0,38 
(n=16) NS NS NS NS NS 
Complicated 3,59±0,93 3,29±0,70 2,89±0,82 2,68±0,30 2,35±0,53 
AMI (n=12) 
Uncomplicated 3,50±1,06 3,55±0,74 2,69±0,69 2,74±0,53 3,07±0,60 
AMI (n=23) NS NS NS NS * 
Beta-blockers 4,18±0,97 3,77±0,79 3,00±0,71 3,01 ±0,53 3,41±0,17 
(n=ll) 
Digoxin 3,19±0,11 3,29±0,74 2,64±0,75 2,52±0,40 2,36±0,42 
(n=ll) * NS NS * * 
Relation to AMI location. Mean age of the anterior group was 
insignificantly lower (52,5 + 8 years), compared with inferior subset 
(55,5 + 8,5 years). Mean hospital stay was significantly longer in pa­
tients with anterior wall damage (22 + 9 vs 16 + 7 days). Therefore, 
CI on the day 21 was assessed in 15 patients with anterior AMI and 
in 6 patients presented with inferior AMI. There were no significant 
differences in treatment and in- hospital course of AMI between pati­
ents. Figure 2. depicts the serial changes in the mean CI for anterior 
and inferior AMI subsets over the entire course of the study. In terms 
of differences between subsets, patients with anterior infarctions as a 
group had lower mean CI than those with inferior wall damage at all 
points of the study. However, these differences failed to obtain sta­
tistical power. With respect to peak reduction values of CI, occurred 
on the day 6 in the anterior subset (2,53 + 0,62, p<0,001) and on the 
day 14 in the patients with inferior AMI (2,75 + 0,59, p<0,002), there 
were not significant difference between groups. 
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Figure 1. Changes in the mean CI for the patients with anterior (A) and 
inferior AMI (B). 
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Figure 2. Sequential changes in CI for the patients with complications (A) 
and the patients presenting uncomplicated course of AMI (B) during hospi­
talization. 
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In-hospital course of AMI. A total of 12 patients presented a comp­
licated course of AMI during 10 days after onset of symptoms as fol­
lows: infarct extension (2), ventricular tachycardia (2), ventricular 
fibrillation (2), advanced atrioventricular block (2), paroxysmal atrial 
fibrillation (1), cardiogenic shock (1), heart failure NYHA III—IV (2). 
Infarct extension or reinfarction was diagnosed if a new period of 
ischemic pain accompanied by development of re-elevation of the 
ST-segment, occurred in conjunction with a new rise in CK activity. 
Recurrent episodes of chest pain (4) and non-cardiac complications 
after AMI (acute pneumonia — 4) were not referred as complicated 
course of AMI in the current study. There were no significant diffe­
rence in relevant demographic data (mean age, site of AMI) between 
two groups. Five patients with anterior AMI and seven patients with 
inferior infarction presented the complicated course of AMI during 
hospitalization. Only, the time for mean hospital stay was longer in 
complication-group (20+11 and 16 + 9 days, respectively). 
Concerning serial changes of CI, the permanent worsening of car­
diac performance in complication-group opposites the bi-directional 
curve of CI in uncomplicated patients (with the "break-point" on the 
day 6, Figure 3). However, no admission-values were obtained in 
either subset. Significantly lower CI in complicated patients was ex­
hibited on the day 21 only, when compared with the remaining study 
subjects (2,34 + 0,53 vs 3,08 + 0,60, p<0,05). 
Treatment regimen implications. Special attention in the current 
series was given to CI changes in patients' subsets receiving either 
beta-blockers (11 patients — 31,4%, group I), or digoxin (11 pati­
ents — 31,4%, group II). All patients taking any of these two drugs at 
discharge and at least 4 consecutive days before leaving the hospital, 
were included the analysis (Table 2.). Sequential changes of CI in 
hospital period are depicted for all subsets of patients in accordance 
to different treatment regimens (Figure 4). The remaining 13 pati­
ents (37,1%, group III, Figure 4.) constituted the group receiving 
neither digoxin nor beta-blocking agents on discharge, and admitting 
the hospital predominantly with anterior infarction (9 vs 4 patients, 
p<0,05). When compared to digoxin-group, the values of CI were 
observed during entire period in this subset. Nevertheless, no statis­
tical significance was shown for any point of the series. Contrawise, 
in comparison with patients taking beta- blockers, depressed values 
of CI were demonstrated throughout the hospitalization in group III. 
Differences between subsets were found to obtain statistical power on 
the day 1 (3,28 + 0,70 us 4,18 + 0,97) and on the day 21 (2,85 + 0,82 vs 
3,40 + 0,17), whereas others were insignificant. 
Individual changes of CI. In order to uncover any relationships 
or trends that might have been masked by analysis of mean data, 
CI database was additionally analyzed with respect to changes in CI 
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Figure 3. Dynamical changes of the mean CIs for the different treatment 
regimens: beta-blockers (A), dgoxin (B), the remaining patients (C). 
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Figure 4. Individual changes on admission and discharge in patients submitted 
the hospital with normal values of CI (left and medium boxes), and those with 
abnormally low values of CI on admission (right box). 
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between admission and discharge levels for each individual patient. 
In 14 patients (40%) leaving the hospital before the day 21, CI values 
from the ultimate existing study point were assigned to the discharge-
database. On the basis of CI values assessed on admission (day 1), 
the study population was splitted into two subdivisions: those with a 
normal CI (>2,5 1/min/sq m) and those with an abnormal CI (<2,5 
1/min/sq m). The profile of patients according to hemodynamical 
changes is given (Figure 5). 
Summarizing bidirectional changes of CI between admission and 
discharge assessments for individual patients, 17 of them demonstra­
ted decrease of CI (p<0,05) and 3 had a significant improvement of 
CI. The remaining 15 patients, presenting predominantly depressed 
values of CI on discharge (10 patients), exhibited increase/decrease 
trends what did not attain statistical power. For this reason, those 
patients might be related as patients with no change between index-
and final- points in the current study. 
For patients with uncomplicated course of AMI (Figure 5) as well 
as for those with cardiac complications during hospitalization indi­
vidual changes throughout the study are shown (Figure 6). CI fluc­
tuations were revealed in both groups at sequential meas- urements. 
18 patients (51,4%) demonstrated abnormally low values of CI during 
study period, and 13 of them showed it on discharge. Unexpected­
ly, 9 patients without complications presented abnormal variables for 
cardiac performance, and 6 of them (3 with anterior AMI) left the 
hospital with remarkably depressed CIs. One patient (with inferior 
non-Q AMI and acute bilateral pneumonia) in this setting demonstra­
ted abnormally low CI on admission as well as at discharge, whereas in 
others important depression developed during hospitalization. Thus, 
among 6 patients discharged the hospital with abnormal levels of CI, 
in 3 patients (one with anterior AMI and two with inferior AMI, all 
Q-wave infarction) recurrent chest pain was registered on the day 2-
5, without concomitant increase of serum levels of specific enzymes. 
Also, one patient in this subset had pneumonia dextra with pleuritis. 
In complication-group, 9 patients from 12 (75%) showed abnormal 
levels of CI during in-hospial stay. 7 of. them left the hospital with 
abnormally low CIs. 
However, 3 patients in this group revealed no abnormal CIs at 
any measurement. All of them admitted the hospital with transmural 
inferior AMI; one patient suffered ventricular fibrillation on the day 2, 
in one advanced atrioventricular block developed, and one presented 
heart failure NYHA III at measurements on the day 6. 
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Figure 5. Sequential individual changes of CI for patients presenting comp­
licated course of AMI. 
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Figure 6. Serial changes of CI in uncomplicated patients. 
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Discussion 
The current study was performed to evaluate sequential changes of 
CI during hospitalization in male-patients with first AMI. 
First of all, a wide degree of variability in ventricular performance 
at the time of hospitalization was demonstrated with CI range from 
1,30-5,15 1/min/m. This finding is in accordance with previous data 
(Forrester, 1976, Freis, 1952, Gilbert, 1954, Hamosh & Cohn, 1971, 
Thomas, 1965). 
Most patients in our study (31-88,6%) presented normal CIs (i.e. 
>2,5 1/min/sq m) on admission. Surprisingly, no signifficant diffe­
rences on admission were revealed between subset presented comp­
lications and those with more benign course of AMI. In previous 
studies, the level of cardiac performance at the time of hospitalization 
was shown to bear a direct relation to in-hospital mortality (Forres­
ter, 1976), and patients with severely depressed cardiac pump per­
formance have shown to demonstrate more malign course of AMI 
(Freis, 1952, Gilbert, 1954, Brock, 1959). 
However, besides an overall variability of CI, a range within cli­
nical subsets and overlap of hemodynamic profiles between patients 
with different clinical manifestations were exhibited also (Ramo, 1970, 
Forrester, 1976, Ratshin, 1972). Despite differences in mean baseline 
values for CIs in nonsurvivors and those who survived hospitalization 
measurements in two groups overlapped enough to preclude con­
siderations of CI as a prognostic indicator (Ratshin, 1972). Also, 
significant differences in mean values of CI in complicated patients 
with circulatory failure were revealed in studies. Thus, in 9 patients 
with AMI and shock studied by Cohn and co-workers (Cohn, 1967), 
the average CI was 3,21/min/m, while in other study (Weil, 1968) mean 
CI of 1,31/min/m was found in patients complicated with cardiogenic 
shock after AMI. 
In our study, among four patients presenting abnormally low CIs on 
admission (<2,51/min/m), one patient was hospitalized in cardiogenic 
shock, and three remaining patients belonged to Killip class II. In the 
subset of initially normal CI, the majority of patients demonstrated 
no clinical deterioration (Killip class I — 23) and 8 patients admitted 
in Killip class II by initial evaluation. 
The most interesting finding in our study was bi-directional curve 
of CI during convalescence, with its highest value on the day 1 and 
peak reduction on the day 14. 
Up to now, limited data concerning serial assessment of CI after 
AMI (Schillingford, 1967, Broder & Cohn, 1972) have shown so­
me augmentation of ventricular performance during in-hospital stay. 
Over the first several weeks following AMI, CI has been demonstrated 
to increase, particulary in patients who had only mild hemodynamic 
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impairment during the acute phase of infarction (Thomas, 1965, Küp­
per, 1977, Rahimtoola, 1972, Broder, 1972). However, in the first 
study (Thomas, 1965) the number of subjects seems to be too small to 
draw any substantial conclusions. Also, in other investigation (Rahim­
toola, 1972) it was indicated that clinical improvement after AMI is 
not usually associated with the normalization of the impaired left vent­
ricular curve relating left ventricular filling pressure to stroke volume, 
allowing the authors to interprete gained data as the sign for unchan­
ged ventricular function during covered period or consider them not 
to be a reliable index of ventricular performance in this setting. 
Altogether, in the current study, complicated patients, those who 
received digoxin at discharge, and those who submitted the hospital 
with anterior AMI, presented lower values of CI when compared to 
the remaining subjects. 
Small increases in CI and stroke volume, as well as reduction in 
left ventricular end-diastolic pressure (LVEDP), have been obser­
ved after digitalization in patients with left ventricular failure fol­
lowing AMI (Ratshin, 1972), the finding that seèms at first sight to 
be somewhat conflicting with our results. However, the preliminary 
observations have also suggested receipt of digoxin at the time of 
hospital discharge to be the number one multivariate predictor of 
1 year mortality (Bigger, 1985). Previous experience suggests that 
myocardial infarction is less well tolerated in older patients because 
of preexisting heart failure, a decline in myocardial reserve, a hig­
her incidence of multivariate disease, age-related hypertrophy of the 
left ventricle, reduced ventricular compliance and other causes (Ro­
binson, 1988, Wilcox, 1980). In the current study, patients receiving 
digoxin at discharge were elder (57 + 5,0 vs 51 + 9,4, p<0,05) and 
tended to have more complicated course of AMI when compared 
with the beta-subset (5 vs 2, respectively). So, we postulate that in our 
study patients receiving digoxin at discharge comprised the group with 
more advanced hemodynamic deterioration and obviously in higher 
postinfarction risk. 
Patients receiving nonselective beta-adrenergic blockers without 
intrinsic sympathomometic activity (propranolol, metoprolol) de­
monstrated higher mean values of CI throughout the study. In the cur­
rent study, patients receiving beta-blockers comprised the AMI-subset 
with apparent hyperkinetic status of ventricular function, tended to 
be younger and less complicated when compared to other population. 
Our finding indirectly supports previous data revealing secondary car­
dioprotective properties of beta-adrenoblocking drugs in patients with 
AMI (ISIS-1 Collaborative Group, 1986). Also, life-saving benefit has 
also been shown to be particulary noticable in postinfarction patients 
with coexisting heart failure (Chadda, 1986).The latter could be of 
importance in some our patients as well. Also, the positive effect 
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of beta-blockers on myocardial metabolism (Chierchia, 1993) might 
explain the overall hemodynamic recovery in AMI-patients receiving 
this mode of therapy. However, concerning the differences between 
patients receiving beta- blockers or digoxin, it must be pointed out 
that dynamic and apparently unpredicatable changes in left ventricu­
lar function during hospitalization could hinder the validity of valua-
ting the effects of therapeutic interventions by comparing posttherapy 
values of CI to mean data on previous study points. 
Hemodynamic differences in anterior and inferior wall AMI sub­
groups were in consistence with previous experience confirming the 
importance of the site of ischemic damage. In the current study, the 
greater functional impairment with anterior wall infarction was fol­
lowed during whole hospitalization, with significantly lower discharge 
value for CI on the day 21. 
Surprisingly, no initial mean value of CI for enrolled population 
was attained in our study by discharge point (Table 2). Transient 
sympathetic stimulation could possibly explain this finding, resulting 
in an improved performance during the earliest measurements on the 
day 1 (and on the day 2), predominantly through improved function in 
noninfarcted zones. Acute compensatory mechanisms including the 
Frank-Starling mechanism and increased levels of plasma catecho­
lamines account for this hyperkinesis (McAlpine, 1981, Rigo, 1974). 
An increased motion of the noninfarcted region has shown to subsi­
de within 2 weeks after AMI (Serruys, 1986). So, in our study , the 
significant fall for CIs was demonstrated by the day 14. Over time, as 
sympathetic stimulation decreases, left ventricular function also may 
decrease, resulting in apparent deterioration in performance. 
Also, there appears to be a limit to the adaptive nature of increasing 
ventricular volume as evidenced by studies that have shown that sur­
vival is inversely correlated with ventricular volumes after myocardial 
infarction (Nortis, 1984, White, 1987). Dépendance on Starling mec­
hanism has been shown to be even more evident in patients with signs 
of manifest left left ventricular dysfunction (Rigo, 1974). While the 
increase in left ventricular end-diastolic volume maintains CI in th­
ese patients, it also increases left ventricular wall tension, myocardial 
oxygen demand (Rigo, 1974) and therefore possibly infarct size and 
number of complications. Thus, the compensatory mechanisms that 
promote ventricular dilatation (McKay, 1986) and initially preserved 
stroke volume (and decreased left ventricular filling pressure) may 
later contribute to deterioration of ventricular function. So, in our 
study, unexpectedly for the authors at first sight, higher initial values 
of CI were demonstrated in patients who later presented more manign 
course of AMI with pronounced fall in cardiac performance. 
In the current study, analysis of individual changes revealed signi­
ficant decrease of CI in 17 patients, whereas the remaining 18 patients 
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demonstrated no change (15 patients) or increse (3 patients) in CIs. 
However, all enrolled patients survived the disease and left hospi­
tal with clinical improvement. Symptomatic improvement in patients 
with AMI that can occur without much change or augmentation in 
the cardiac output, or even despite a fall in CI has been demonstra­
ted formerly (Thomas, 1965); thus there may be factors quite apart 
from the circulatory disturbance that contribute to the patient's cli­
nical condition. Also, in evaluation CIs and clinical outcome, it it has 
to be pointed out that all subjects in our study had their first AMI, 
and presumably well-preserved left ventricular function and less mec­
hanical dysfunction than patients with previous myocardial infarction 
(Moss, 1990). 
During in-hospital stay, bidirectional fluctuations for all patients 
were found in our study, whereas the changes in values of CI were 
more pronounced between the days 2 and 6, i.e. by the end of the first 
postinfarction week. Formerly it has been demonstrated that in 56% 
of patients with AMI spontaneous changes in left ventricular ejection 
fraction took place during the 24 hours after onset of disease (Wac-
kers, 1982). Therefore, changes in CIs that could not be related to 
complications as well-recognized directly deteriorating factor of vent­
ricular performance might be regarded as spontaneous variability (for 
example, as a result of changes in loading conditions, in neurohhor-
monal activity, or due to the recovery of ischemic myocardium). 
However, using CI for assessing the pumping ability of the heart, 
one always has to keep in mind that the wide range of CI (between 
2,5 and 4,21/min/sq m) makes this variable relatively insensitive in the 
evaluation of cardiac function (Braunwald, 1992). CI is considered 
to be quite incomplite and an occasion misleading due to variations 
in left ventricular compliance (Rigo et al 1974). In previous studies, 
CI has been found to correlated poorly with the ejection fraction, 
and was often normal in the presence of the reduced ejection fraction 
(Schelbert, 1976). 
Also, CI is critically dependent on preload and afterload in addi­
tion to myocardial contractility (Braunwald, 1974). Changes in left 
ventricular preload and afterload would have gone undetected in the 
present study because left ventricular volumes were not assessed. No 
measurements of ventricular filling pressure were made in the current 
study. 
Because of the limited number of basic hemodynamic variables 
in our study, direct comparisons of patients based on CI values only 
might be avoided. As it is shown formerly, caution must be taken in 
interpretation of changes of CI alone as approach for cardiac function 
(Rigo et al., 1974, Forrester et al., 1976, Rahimtoola et al, 1972, 
Rackley & Russell, 1972,). 
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Conclusions 
As hemodynamics varies widely among patients with AMI with simi­
lar clinical presentations, measurements of pertinent hemodynamic 
variables may be of great value in this setting suffering circulatory dis­
turbances of different extent. Method of integral rheography is free 
of discomfort, and most important, it is suitable for repeated applica­
tion at intervals in the same patient. As it was demonstrated in the 
current study, although the most pronounced differences of CI be­
tween AMI-subsets were measured on the discharge point, individual 
changes during the hospitalization carry useful information about cur­
rent hemodynamic status and might effectively used as guidlines for 
interventional therapy. 
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Kokkuvõte 
Käesolevas uurimuses vaadeldi südameindeksi (l/min/m2) dü­
naamikat haiglaperioodil 35-1 meeshaigel esmase müokardi infark­
tiga. Mõõtmistel 1., 2., 6., 14. ja 21. infarktijärgsel päeval 
kasutati integraalse reograafia meetodit Tischenko järgi. Haigete 
keskmine vanus oli 54,9 aastat, eesseina infarktiga hospitaliseeriti 
19 patsienti; 12-1 haigel ilmnesid haiglaperioodil kardiaalsed kom­
plikatsioonid. Tulemuste töötlemisel eristati täiendavalt 3 ravimrüh-
ma: patsiendid, kes tarvitasid haiglast lahkumisel digoksiini (11) või 
beeta-adrenoblokaatorit (11), ning ülejäänud haiged, kes ei tarvitanud 
hospitaliseerimise lõpul kumbagi nimetatud ravimit (12). 
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Uuritud gruppi iseloomustas 2-suunaline südameindeksi kõver: 
vähenemisele 1.-14. päevani (3,53±1,00 kuni 2,72±0.46 l/min/m2) 
järgnes tõus 21. infarktijärgsel päeval (2,80±0,67 1/min/m2,). Ülla­
tuslikult ei saavutatud hospitaliseerimise lõpuks (21. päev) üheski 
vaadeldud alagrupis südameindeksi lähteväärtusi (1. päev). Vaadel­
dud populatsioonis mõõdeti madalamaid südameindeksi väärtusi 
eakamatel haigetel, neil, kes haiglast lahkumisel tarvitasid digoksi-
ini (vs beeta-blokaatorit) ning eesseina infarktiga alarühmas. Siis­
ki täheldati südameindeksi ulatuslikku individuaalset ja rühmasisest 
varieeruvust, mis polnud üheselt seostatav kardiaalset jõudlust de-
primeerivate lisafaktoritega ning mis eriti ilmekalt esines esimestel 
mõõtmispäevadel. Summeerides individuaalseid muutusi haiglaperi-
oodi 1. ja 21. päeva vahel leiti, et 17-1 haigel esines märkimisväärne sü­
dameindeksi langus, 3-1 patsiendil oluline paranemine ning 15-1 haigel 
esinenud muutused kvalifitseeriti ebaolulistena. 
Käesoleva uuringu põhjal võib infarktihaigetel kui ilmeka individ­
uaalse variaabelsusega ebastabiilse hemodünaamikaga populatsioo­
nis otstarbekaks pidada tsirkulatsioonihäirete ja ravi efektiivsuse hin­
damiseks südameindeksi korduvat registreerimist. 
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EFFECT OE RECOMBINANT HIRUDIN AND 
HEPARIN ON PLATELET AGGREGATION 
IN CORONARY ARTERY DISEASE PATIENTS 
Yelena Saareoja, Tiiu Jõudu, Margus Viigimaa 
Abstract 
Hirudin is the most potent and specific known inhibitor of thrombin. 
The present study was aimed to compare the effect of recombinant hi­
rudin and heparin on platelet aggregation in coronary artery disease 
(CAD) patients. Platelet aggregation measurements were made in 
16 patients (mean age 56.8 years) with chronic CAD. Control group 
consisted of 14 healthy volunteers (HV; mean age 34.2 years). Pla­
telet aggregation was determined according to method of Born and 
by a new method based on the statistical analysis of platelet rich plas­
ma light transmission fluctuations. Results of our study showed that 
spontaneous platelet aggregation, measured by both methods was sig­
nificantly higher in heparinized than in r-hirudinized blood both in 
CAD patients and HV groups. ADP-induced platelet aggregation, 
measured by method of Born was more pronounced in heparinized 
blood than in r-hirudinized in both groups studied. The differences 
between aggregation in r-hirudinized and heparinized blood were mo­
re pronounced when adrenaline was used to induce aggregation. In 
conclusion, no activation of platelets by r-hirudin was observed in 
CAD patients when compared to heparin. This finding supports the 
opinion that r-hirudin has clinically important advantages compared 
to heparin in the treatment of CAD patients. 
Introduction 
The formation of a thrombus in a stenosed coronary artery has a cau­
sative role in the pathogenesis of acute form of CAD. Many throm­
bolytic and anticoagulant drugs have been used in clinical practice, 
but to date, without complete or consistent benefit (Topol, 1989). 
Developments in contemporary scientific methods have contributed 
significantly to provide some such drugs. 
The first description of the anticoagulant action of a water-soluble, 
heat-resistant substance derived from the salivary glands of leeches 
(Hirudo médicinales) dates back to 1884. This substance was called 
hirudin in 1904, but scientific research regarding this compound was 
studied in 1960's. More recently, after production of hirudin or frac­
tions by recombinant techniques and by synthetic methods, there has 
been a fast growing interest in the clinical use of this most potent and 
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specific inhibitor of thrombin (Duller, 1993). Direct thrombin inhi­
bitors have several potential advantages compared to heparin: they 
can inhibit thrombin bound to clots or extracellular matrices, which 
are relatively resistant to heparin.Also, their effect does not depend 
on antithrombin III as a cofactor, which may lead to a more predic­
table dose response. Furthemore, they are not inhibited by activated 
platelets, which release platelet factor 4 and other molecules that 
neutralize heparin (Johnson, 1994). Moreover, heparin may increase 
platelet aggregation and thrombocytopenia has been reported in some 
patients. 
The aim of the present study was to compare the effect of recom­
binant hirudin and heparin on platelet aggregation in CAD patients. 
Material and Methods 
Platelet aggregation measurements were made in 16 patients (mean 
age 56.8 years) with chronic CAD. All patients did not use neither 
r-hirudin nor heparin. Control group consisted of 14 HV (mean age 
34.2 years). Blood was taken from the antecubital vein into 2 plastic 
test-tubes with either r-hirudin (Behring) or heparin (Rotexmedica 
GMBH) as an anticoagulant, and mixed immediately. Blood was 
centrifuged 10 min for at 160 g, room temperature. The upper layer 
of platelet-rich plasma (PRP) was separated. The remaining blood 
specimens were centrifuged for 20 min at 1400 g, room temperature 
to prepare platelet-poor plasma (PPP). Platelet aggregation was de­
termined according to method of Born and by a new method based 
on the statistical analysis of PRP light transmission fluctuations (LTF) 
on 2-channel aggregometer (Biola, Russia) by continuously stirring 
the plasma (1000 rpm) at 37°. Using this new method relative disper­
sion of such fluctuations is proportional to the mean aggregate size, 
and it is applicable if aggregates are small and the aggregation can 
not be detected by turbidometric method (Gabbazov, 1989). Plate­
let aggregation was induced by 1.0 /tM ADP (Reanal) solution and 
0.5 дМ adrenaline (Sigma) solution. All studies were carried out 
within 90-180 min after blood obtainment. 
Data are presented as mean ± SD. Statistical analysis was perfor­
med using STATISTIGA for Windows program. A P value <0.05 was 
considered significant. 
Results and Discussion 
Results of our study showed that spontaneous platelet aggregation, 
measured by Born or LTF methods was significantly higher in hepa­
rinized than in r-hirudinized blood both in CAD patients and HV 
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groups (Tàble 1). But no significant differences in platelet aggrega­
tion were detected between CAD patients and HV group either in 
r-hirudinized or heparinized blood. 
Table 1 
Spontaneous platelet aggregation in r-hirudinized and 
heparinized plasma in CAD patients and HV group 
CAD HV 
Platelet aggregation Hirudin 1.5±0.9*** 2.0±1.1*** 
(light transmission), % Heparin 4.6±2.0 7.1±7.2 
Platelet aggregation Hirudin 1.3±0.9* 1.1±0.1*** 
(aggregate size), relative unit Heparin 1.7±0.4 1.9±1.0 
*p<0.05 when compared corresponding results hirudin versus heparin 
***p<0.001 when compared corresponding results hirudin versus heparin 
ADP-induced platelet aggregation, measured turbidometrically 
was more pronounced in heparinized blood than in r-hirudinized in 
both groups studied. Data are presented in Table 2. However, th­
ese results are not consistent with results obtained by LTF method. 
Thus, in both CAD patients and HV group ADP-induced platelet agg­
regation in heparinized blood is more pronounced, but the average 
radius of aggregates is significantly lower than in r-hirudinized blood. 
CAD patients and HV group did not differ significantly in respect 
of platelet aggregation in r-hirudinized blood. ADP-induced platelet 
aggregation in heparinized blood was more pronounced in HV group 
when compared with CAD patients. 
Table 2 
1.0 /tM ADP- induced platelet aggregation in 
r-hirudinized and heparinized plasma in CAD patients and HV 
CAD HV 
Platelet aggregation Hirudin 19.61ill.44*** 19.9±16.15*** 
(light transmission), % Heparin 33.77±15.15 56.25±25.33 
Platelet aggregation Hirudin 12.80±4.38*** 13.90±5.93*** 
(aggregate size), relative unit Heparin 4.58±1.57 5.40±1.26 
***p<0.001 when compared corresponding results hirudin versus heparin 
Extent of aggregation induced by adrenaline was significantly lower 
compared to ADP (Tàble 3). The differences between aggregation in 
r-hirudinized and heparinized blood were more pronounced when 
adrenaline was used to induce aggregation. Also, no significant diffe­
rences in platelet aggregation were found between CAD patients and 
HV group in r-hirudinized blood, but in heparinized blood adrenaline-
induced aggregation was significantly higher in HV group when com-
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»Table 3 
0.5 /хМ adrenaline-induced platelet aggregation in 
r-hirudinized and heparinized plasma in CAD patients and HV 
CAD HV 
Platelet aggregation Hirudin 4.1±3.4*** 2.2±1.6*~ 
(light transmission), % Heparin 18.2±11.2 35.3±28.5 
Platelet aggregation Hirudin 2.4±1.0* 2.1±0.8*** 
(aggregate size), relative unit Heparin 2.9±0.7 3.9±1.4 
*p<0.05 when compared corresponding results hirudin versus heparin 
***p<0.001 when compared corresponding results hirudin versus heparin 
pared to CAD patients. This finding demonstrates that heparin inc­
reases platelet aggregation in HV group more than in CAD patients. 
Our data concerning platelet aggregation in r-hirudinized and he­
parinized plasma are similar with some previous reports. The result of 
spontaneous platelet aggregation and aggregation induced by adrena­
line are in good agreement with results of Glusa (Glusa, 1990; 1991). 
However, in both of these studies ADP-induced platelet aggregation 
was reported to be similar in differently coagulated plasma samples. 
Basic-Micic and co-workers showed that spontaneous platelet agg­
regation was rarely observed in hirudinized PRP compared to citrate 
PRP. In addition, hirudin reduced the maximal response to adrenaline, 
but had no influence on the maximal response to ADP (Basic-Micic, 
1991). Also Chen et al (1991) showed that hirudin did not stimulate 
platelet aggregation in contrast to heparin and low molecular weight 
heparin. 
Conclusion 
No activation of platelets by r-hirudin was observed in CAD patients 
when compared to heparin. This finding supports the opinion that 
r-hirudin has clinically important advantages compared to heparin in 
the treatment of CAD patients. 
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Kokkuvõte 
Hirudiin on spetsiifiline ja' tugevaim teadaolev trombiini inhibiitor. 
Käesoleva töö eesmärgiks oli võrrelda rekombinantse hirudiini (r-
hirudiini) ja hepariini toimet kroonilise südameisheemiatõve (KSIT) 
haigete trombotsüütide agregatsioonile. Uuriti 16 KSIT haiget 
(keskmine vanus 56,8 a.). Kontrollgrupis oli 14 tervet vabataht­
likku (TV) keskmise vanusega 34,2 a. Trombotsüütide aggregat-
sioon määrati Borni meetodil ja uuel meetodil, mis põhineb plasma 
valgusläbilaskvuse fluktuatsiooni analüüsil. Uurimistulemused näi­
tasid, et trombotsüütide spontaanne agregatsioon oli hepariniseeri-
tud veres kõrgem kui r-hirudiniseeritud veres nii KSIT haigetel kui 
ka kontrollgrupis. ADP-ga indutseeritud trombotsüütide agregat­
sioon (määratud Borni meetodil) oli hepariniseeritud veres enam 
väljendunud kui r-hirudiniseeritud veres mõlemas grupis. Suuremad 
erinevused trombotsüütide agregatsioonis r-hirudiniseeritud ja hep­
ariniseeritud veres olid siis kui agregatsioon kutsuti esile adrenaliiniga. 
KSIT haigetel ei täheldatud trombotsüütide aktivatsiooni r-hirudiini 
toimel. Need tulemused näitavad, et hepariiniga võrreldes omab r-
hirudiin eelist KSIT haigete ravis. 
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THE DYNAMICS OF STROKE VOLUME 
DURING EXERCISE: HOW TO INTERPRET? 
Kai Saks, Elmut Laane, Ruth Kullus, Tiit Pokk 
Abstract 
100 healthy persons (40 women and 60 men) and 136 cardiac patients 
were examined to determine the dynamics of the stroke volume index 
(SVI) during an upright bicycle ergometя stress test. SVI was me­
asured by means of impedance cardiography before exercise and after 
each minute of load (the initial workload of 0.5 W/kg was increased 
by the same amount after each minute). SVI did increase in all the 
healthy persons during the exercise but did not increase in 17 (12.5%) 
cardiac patients. The maximal SVI was 167% ±45% (mean±SD) in 
healthy individuals when compared to rest value and it was achieved 
at the load of 1.7±0.7 W/kg. Criteria for assessing normal dynamics 
of SVI for young and middle-aged men and women were determined. 
Lack of increase of SVI during upright stress test might be considered 
as failure of myocardial reserve. 
Introduction 
It is generally recognized that during upright physical exercise the 
stroke volume (SV) increases in healthy individuals. Different studies 
report various mean SV increases during load, from 12 to 100 percent 
(Wyns W. et al., Higginbotham M. В. et al., Scruggs К. D. et al.). There 
are many factors that might account for these differences: age and sex 
of subjects, level of physical training, different exercise schemes and 
positions during exercise, differences in variance analysis (Blomqvist 
C. G. et al., Hindman M. С. et al., Ehsani A. A. et al., Mizutani Y. 
et al., Grandi A. M. et al, Ray C. A. et al.). A prospective study was 
undertaken to examine the dynamics of SV during the upright bicycle 
ergometer stress test in healthy men and women of different ages and 
in various groups of cardiac patients. 
Methods 
Subjects. Healthy population. A hundred healthy individuals (60 men 
and 40 women, 17... 64 years, mean age 42±9 years, mean±SD) 
volunteered to participate in the study; none had a history of heart 
disease, hypertension or diabetes mellitus, no cardiac abnormaliti­
es were found on physical examination or stress electrocardiogram. 
They all were physically moderately active (1... 3 hours a week) but 
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none was an active athlete. The line between young and middle-aged 
persons was drawn at 40 years of age. 
Patients population. Hventy-five male patients had angiograp-
hically documented significant coronary artery disease (CAD) and 
were on medical treatment (mean age 49±7 years, NYHA functional 
class 2.3±1.5); fifty male patients with CAD had had a coronary ar­
tery bypass operation 52±26 months before our investigation (mean 
age 54±7 years, NYHA functional class 1.4±0.7); twenty male pati­
ents with evidences of myocardial ischemia had no significant stenoses 
in coronary arteries and were considered having syndrome X (mean 
age 47±8 years, NYHA functional class 1.3±0.4); fourty one female 
patients (mean age 39±9 years) had light or moderate myocarditis. 
Exercise protocol. Exercise on the bicycle ergometer (Monark 
ergometer) was performed in the upright position at the constant 
pedalling rate of 60 rpm. After baseline measurements at rest were 
obtained in subjects sitting on the bicycle, exercise at the workload of 
0.5 W/kg was begun, each minute the workload was increased by the 
same amount. After each minute of load the exercise was stopped for 
10... 15 seconds to have a good quality impedance cardiogram. The 
exercise was continued until it had to be stopped because of fatigue, 
shortness of breath or anginal pain (at least 5 points on Borg's scale) 
or by changes in electrocardiogram. 
Electrical impedance data were obtained by means of an impe­
dance cardiograph (RPG 2-02, Russia) with four disposable strip elect­
rodes as described by Kubicek et al. ТЪе outer electrodes provided an 
electrical field from a constant current oscillator generating a cons­
tant sinusoidal current of 2 mA r.m.s. with a frequency of 40 KHz. 
The first derivative of the impedance change wave form was recorded 
on an 8 channel inkjet recorder (Nihon Kohden) simultaneously with 
ECG and phonocardiogram at the paper speed of 50 mm per second. 
SV was calculated after the equation of Kubicek et al. An impedance 
cardiogram was recorded by normal breathing during 10... 15 seconds 
after every step of the load, waveforms were manually determined. 
Data analysis. The SV standardized index i.e. the stroke volume 
index (SVI) was used to analyse absolute SV changes during the stress 
test. A relative SVI change (SVI%) during the exercise was expressed 
in per cent of the rest value (rest value±100%). The maximal value 
of SVI (SVImax) and SVI% (SVI%max) during the exercise were 
recorded for each individual, as well as the step of the work load at 
which SVImax was registered (SVImaxL); thus the mean maximal 
values for each index were calculated from the individual maximal 
values. The individual peak SVI was marked as SVIencj, a relative 
SVI change at the peak exercise as SVI%en(j. A SVI change was 
considered significant if it differed from the previous one by at least 
5 per cent. 
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The variables between the groups of subjects at rest and during 
exercise were compared with unpaired t-tests, the difference was con­
sidered significant at a p value of <0.05 
Results 
Healthy population. Load tolerance. The mean load tolerance of all 
healthy subjects was 2.9±0.5 W/kg (1.5.. .4.0 W/kg),peak heart rate 
161±16 bpm (111... 189 bpm). Load tolerance was higher and peak 
heart rate (HR) slower in men compared to women. Load tolerance 
was not influenced by age, while peak HR was higher in young subjects 
(Thble 1). 
Dynamics of the absolute values of the stroke volume index. 
The resting SVI of young female subjects was higher than that of ot­
her healthy persons (however the difference between young men and 
young women was not significant). SVI increased during exercise in 
all the healthy subjects. The maximal SVI during bicycle stress test did 
not differ in young men, young women and middle-aged women,but in 
middle-aged men it was significantly lower (Table 1). At peak exercise 
SVI was lower than the maximal SVI values in all the groups. The 
SVIend the middle-aged male subjects was significantly lower than 
in the other groups. 
Relative dynamics of the stroke volume index. 
The mean maximal SVI as compared to its rest value was 167±45% 
(106... 355%). The SVI%max did not differ in young women, middle-
aged women and middle-aged men (156... 168%) but in young men 
SVI%max was higher (191%). The mean decrease of SVI% from 
its maximal to the peak load value ranged from 15 to 30% but the 
differences were statistically not significant. The mean SVI%encj of 
all healthy persons was 142±46% (77... 310%). 
Exercise rate at the maximal SVI 
The maximal SVI was measured at the load of 1.7±0.7 W/kg in the 
whole group of healthy subjects. The load of the maximal SVI was 
bigger in men than in women but the age did not have any influence 
on SVImaxT (Table 1, Figure). 
We could not find any significant correlation between the work to­
lerance and the relative SVI increase or the load at which the maximal 
SVI was achieved. 
Patients population. The stroke volume index did not increase 
during exercise in 6 medical CAD patients, 2 surgical CAD patients, 
4 patients with syndrome X and 5 patients with myocarditis. That 
means that in 17 (12.5%) of 136 cardiac patients SVI failed to inc­
rease during upright physical exercise. In all the patient groups the 
mean SVI increase was smaller than in the age- and sex-matched 
healthy persons (Table 2) although the difference was statistically not 
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Figure. Dynamics of stroke volume index and its relative values during exe­
rcise in healthy men and women. 
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significant for the surgical CAD patients and patients with myocardi­
tis. The maximal SVI was achieved at lower loads in cardiac patients 
compared to healthy individuals. There were no correlations between 
the work tolerance and the relative SVI increase or the work load 
at which SVImax was registered in the cardiac patients. No correla­
tions could be established between the NYHA functional class and 
the dynamics of SVI. 
Discussion 
We used impedance cardiography to estimate the dynamics of the 
stroke volume index during exercise. The question is: how reliable 
is this method? Our aim was not a comparative study of the results 
of impedance cardiography and those of invasive measurements as 
there are many reports confirming a good correlation between the 
SV values of impedance cardiography and those of invasive methods 
(Aust P. E. et al., Eisenberg В. M. et al., Spinale F. G. et al. White 
S. W. et al.) Therefore, the absolute SVI values in our study should be 
treated with some caution. For instance the SVI was higher in women 
compared to men in our investigation. These results are opposite 
to the generally approved ones (Geigi... ) but in accordance with 
the results of another study where impedance cardiography was used 
(Gundarov I. A. et al.). Different conduction qualities of the skin in 
men and women might be responsible for the finding. However, the 
correlations have been good for both sexes in impedance cardiography 
SV measurements compared to invasive methods at rest and during 
exercise (Fujinami R. M. et al.) and therefore relative SV changes 
were not dependant on a systematic error of the method. 
Our results confirm that in healthy young and middle-aged males 
and females SVI increases during upright bicycle exercise. These data 
agree well with the results of other investigations (Wyns W. et al., 
Higginbotham M. В. et al., Scruggs К. D. et al., Hindman M. C. et al., 
Fujinami T. et al., Steingart R. M. et al., Miyamoto Y. et al., Ohlsson 
O. et al.). However the expected SV increase during exercise was not 
observed in 17 (12.5%) cardiac patients. 
We could not find correlations between SVI dynamics and work to­
lerance in healthy individuals and functional status in cardiac patients. 
Is this a conflicting result? We do not think so as our healthy group 
was rather homogeneous in their physical activity status and work to­
lerance capacity and most of our cardiac patients belonged to the first 
or second NYHA functional class. Many studies have pointed out that 
the NYHA classification based on the information gained through the 
patient's interview fails to reveal good correlations with the objective 
parameters of the left ventricular function (Dunselman P. H. M. J. et 
al., Remes J. et al., Dougherty A. H. et al., Davidoff R. et al.). Vent-
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ricular dysfunction may exist without evident heart failure; likewise 
heart failure is not always connected with persistent left ventricular 
dysfunction (Dougherty A. H. et al., Ross J. et al.). Lack of increase of 
stroke volume during upright exercise characterizes failure of myocar­
dial reserve that should be taken as a sign of myocardial damage but 
not necessarily of heart failure. D. W. Kitzman et al. have found that 
exercise intolerance in patients with heart failure and normal resting 
and peak ejection fraction correlated well with the depressed increase 
of left ventricular end diastolic volume and stroke volume during exe­
rcise. The findings of M. A. Konstam et al. indicate that symptoms 
of heart failure are linked to left ventricular responsiveness during 
diastole rather than during systole. 
The relative SVI increase varied much among the healthy persons 
(SVI%max 106... 355%). In medicine (as well as in biology) the 
question of normal and abnormal reaction is a very difficult problem. 
One of the possibilities often used in the evaluation of variable normal 
limits is the determination of the area as a mean value ±1.5 standard 
deviation of the mean. In this way about 80% of those investigated 
would be included. The consideration of everybody in the group of 
healthy persons (100%) will increase the sensitivity but diminish the 
specifity of the study. We could not apply the method (mean ±1.5 SD) 
because if we regard the SVI increase as an index of the myocardial 
systolic reserve then a SVI increase can never be considered excessive, 
i.e., myocardial systolic reserve does not have an upper limit. Our 
approach to evaluating a normal SVI increase during physical stress 
is based on the following assumption: 80% of healthy people can be 
expected to have a good myocardial reserve. The criteria for normal 
SVI increase were calculated with the help of distribution tables in 
different age and sex groups. An increase of SVI by at least 30% and 
up to the load of 1.0 W/kg or more were considered normal reaction 
in young and middle-aged women. The increase of SVI by 50% or 
more and up to the load of 1.5 W/kg or more was considered normal 
reaction in young men. In middle-aged men the dynamics of SVI was 
considered normal when the SVI increased by at least 30% and up to 
the load of 1.5 W/kg or more. 
The mean increase of SVI in healthy individuals was 67% in our 
study. The data presented by other investigators vary on a large scale. 
Fujinami et al. reported a 30% increase of SV during upright bicycle 
stress test in healthy young and middle-aged men measured by impe­
dance cardiography. Miamoto et al., using the same method, registe­
red a SV increase by 18% in four young healthy men. Higginbotham 
et al. reported a 20-30% increase of SV in normal men and women 
(31...68 years) without a significant difference between the sexes, 
measured by radionuclide ventriculography and expired-gas analysis. 
Steingart et al. used radionuclide ventriculography during graded 
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upright exercise and described a 73% increase of SV inmormal sub­
jects. Analysing these data it is evident that the results do not depend 
on the method used of SV estimation. Further analysis reveals that 
one of the reasons for the results being different may be the diffe­
rences in the exercise scheme. Fujinami et al. and Higginbotham et al. 
used the same exercise scheme (increase of load by 25 W, duration of 
each load 3 minutes) and got similar results. Steingart et al. used the 
same exercise scheme but the SV was measured after the first minute 
of exercise at a given work load. Miyamoto et al. tested the effect of 
two separate loads (50 W and 100 W) of 8 minutes each with a period 
of rest between them. The SV was monitored during loading and the 
data suggest a rapid SV increase immediately after the initiation of 
exercise and a possible decrease after some minutes of exercising at a 
constant load. 
Our exercise scheme differed from all the above-mentioned ones. 
It is more or less like the scheme used by Steingart et al. (Steingart 
R. M. et al). We measured SVI values after each minute of loading 
and then the load was increased. Our data do not differ from the 
results obtained by Steingart. 
In healthy persons the SVI values did not become stabilized after 
the initial rapid increase at low loads but, in most cases, they decreased 
slightly at high loads. The same SVI dynamics have been recorded 
by other investigators (Higginbotham M. B. et al., Fujinami T. et al., 
Miyamoto Y. et al.) but there are also data about a gradual SV increase 
up to the submaximal exercise (Steingart R. M. et al). These different 
findings are not easy to explain but one of the explanations may be in 
the differences of physical activity of the subjects. 
Clinical implications 
The dynamics of stroke volume during upright exercise might be an 
independent diagnostic index of myocardial reserve besides changes 
in the ejection fraction. In healthy young and middle-aged men and 
women the stroke volume should increase during upright exercise. 
Lack of increase of stroke volume indicates failure of myocardial 
reserve but it is not necessarily a sign of congestive heart failure. The 
increase of stroke volume is dependent on the exercise scheme. By 
the upright bicycle stress test with the starting load of 0.5 W/kg with 
the same amount added after each minute of exercise an increase of 
the stroke volume by 30% or more in young and middle-aged women 
and middle-aged men can be considered a normal reaction; in young 
men the expected increase of the stroke volume is 50% or more.The 
stroke volume should continue increasing up to the load of 1.0 W/kg 
or more in women and 1.5 W/kg or more in men. A smaller increase of 
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the stroke volume may indicate depression of the myocardial reserve 
or disturbance in the adaptability to physical loading. 
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BLOOD LIPIDS AND LIPOPROTEINS 
IN ACUTE MYOCARDIAL INFARCTION 
Mikhail Zemtsovsky, Galina Zemtsovskaya 
Abstract 
The lipids and lipoproteins spectrum was studied in 197 patients with 
acute myocardial infarction (AMI). AMI is accompanied by marked 
changes in plasma lipoproteins. Cholesterol content decreased by 
26.7 per cent by the 7th day of AMI. The concentration of alpha-
cholesterol decreased most — 30.7% of the initial value by the 14th 
day of AMI. By the third day of AMI the triglyceride content was 
decreased, 37% of the initial value, but the content started increasing 
more rapidly than cholesterol and alpha-cholesterol levels. By the 
fourth-sixth month the content of lipids and lipoproteins had reached 
the level measured by hospitalization. 
There are large changes in the lipoprotein content dynamics in the 
post-infarction period. The changes usually return to the initial levels 
by the 4th post-infarction month. 
Introduction 
The study was aimed at the lipoprotein spectrum analysis by coronary 
heart disease examined in post-infarction patients. The results show 
that by myocardial infarction there are distinct changes in the system 
of lipoproteins, and the type of dislipoproteinemia can be established 
four — six months after the infarction. 
Material and Methods 
The lipoprotein spectrum was studied in 197 patients, mean age 52.3 ± 
1.4 years, with large myocardial infarction.. Tbe diagnosis of infarction 
was based on the criteria approved by WHO. There were 161 cases 
of uncomplicated infarction and 36 cases of complicated infarction, 
i.e. with heart failure, cardiac rhythm disorders in the rehabilitation 
period, left ventricle aneuiysm, early recurrence of angina pectoris, 
post-infarction syndrome. Cardiospecific ferments returned to the 
norm in all patients by the seventh-tenth day. The control group was 
286 patients mean age 53.2 ±1.6 with chronic coronary heart disease 
and angiographically documented atherosclerosis. The lipoproteins 
were measured on the 1, 2, 3, 7, 14, and 28 days and in 3-6 month 
after hospitalization. 
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The apolipoprotein Apo A-l and apo-B content in blood plasma 
was measured with the help of a special device produced by "Orion", 
a Finnish firm. 
Results and Discussion 
Acute myocardial infarction is accompanied by marked changes in 
plasma lipoproteins (Table 1). Cholesterol content decreased by 
26.7 percent by the seventh day of the disease. The statistical content 
remained significantly lowered in the first post-infarction month. By 
the fourth-sixth post-infarction month, the content reached the level 
measured on the first post-infarction day. 
The alpha-cholesterol content reached its lowest level 30.7% of 
the initial value by the fourteenth post-infarction day and remained 
lowered all through the first post-infarction month. It remained lower 
than, even four-six month after the infarction onset. 
The largest changes in the plasma of acute infarction patients were 
noticed in plasma triglycerides. By the third post-infarction day, the 
triglyceride content was at its lowest, 37% of the initial value, but the 
content started increasing more rapidly than cholesterol and alpha-
cholesterol contents. The beta-cholesterol content was at its lowest 
on the seventh post-infarction day and remained lowered all through 
the month. By the fourth-sixth month the content had reached the 
level measured by hospitalization. 
In 18 patients with major infarction the content of apoproteins apo 
A-l and apo-B were measured (Table 2). The lowest apo A-l value was 
recorded on the seventh post-infarction day (20.1% of initial value). 
The lowered apo A-l values are in good correction with the lowered 
values of alpha-cholesterol, which shows how well alpha-cholesterol 
changes reflect changes in HDL by myocardial infarction, as apo A-l 
is the basic HDL protein. A month after infarction, the statistical 
level of apo A-l content was significantly lower than the initial value. 
The apo-B content was at its lowest on the third post-infarction day 
(26.7% of the initial value). The value began coming close to the initial 
value two weeks after the infarction and reached the initial value by 
the first post-infarction month. The changes in apo-B content are well 
correlated with the content changes of triglycerides and cholesterol in 
beta and prebeta lipoproteins. 
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Conclusions 
There are large changes in the lipoprotein content dynamics in the 
post-infarction period. The changes usually return to the norm by the 
fourth post-infarction month. 
The changes point to an excess of atherogenic lipoproteins in plas­
ma. 
As there are large changes in lipoprotein content, the important 
values are to be measured on the hospitalization day. The alpha-
cholesterol content changing most dramatically and recovering slowly 
recommends the index as the best one for atherosclerosis prevention. 
The lipoprotein content values are to be measured on the first post­
infarction day or in the fourth-sixth month, to administer adequate 
hypolipidemic and dietic treatment. 
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Kokkuvõte 
197 akuutse müokardi infarktiga (AMI) haigel määrati lipiidide ja 
lipoproteiidide spekter perifeerses veres. AMI korral esinesid olulised 
muutused plasma lipoproteiidide kontsentratsioonis. 7-ndaks AMI 
järgseks päevaks langes kolesterooli sisaldus 26,7%. Alfa-kolesterooli 
madalaim tase (30,7% algväärtuses väiksem) esines AMI 14-ndal päe­
val. Madalaim triglütseriidide kontsentratsioon (37% algväärtusest 
madalam) määrati 3-ndal infarkti järgsel päeval. Võrreldes koles­
terooli ning alfa-kolesterooliga hakkas triglütseriidide sisaldus taastu­
ma oluliselt kiiremini. 4-6 kuu möödudes saavutati sama lipiidide ja 
lipoproteiidide tase mis oli hospitaliseerimisel. 
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ECHOCARDIOGRAPHY TODAY AND 
TOMORROW 
Rein Teesalu 
(This overview is put together on the basis of the second Canterbury echo 
symposium "Echocardiography Today & Tomorrow", April 11-15,1994 at the 
University of Kent, Canterbury, UK). 
The first half of the symposium was "sate of the art" review of cur­
rent echo topics, including debates on the value of left ventricular 
function quantification. The second part of the symposium covered 
new advances, including intracardiac and intracoronary echo and a 
futuristic introduction into 3-dimensional imaging. Bellow an attemt 
to overview the ideas and views presented on the symposium has been 
made. 
Contrast echocardiography is an evolving technique. It may be 
used to get good left ventricular cavity contrast and border delinea­
tion, quantification of valvular regurgitation, evaluation of LV func­
tion, and detection of intraventricular flow patterns, especially when 
contrast agent is used during transesophageal echocardiography. Mo­
re recent development is myocardial contrast echocardiograpfy. This 
technique may, in the future, provide the means for quantitative as­
sessment of myocardial perfusion. Several contrast agents are used 
now and others should available in the next years. At the present time 
the most promising standardized contrast agent seems to be Albunex 
(R) (Nycomed) — sonicated human serum albumine. The mean size 
of Albunex bubbles is 4-5 qm. Being iso-osmolar and chemically inert, 
Alburex microbubbles have no adverse effects on coronary blood flow 
or LV and systemic hemodynamics. Their intravascular rheology is 
similar to that of red blood cells, making them ideal blood flow tracers. 
With the development of albumin microbubbles capable of transpul-
monary passage, it may be possible to screen patients for the presence 
of ischemic heart disease using only a single intravenous injection of 
ultrasonic contrast material. Contrast echocardiography, performed 
at the time of coronary angiography, can provide additional informa­
tion about the anatomical and physiological significance of coronary 
artery disease. The use of small, sonicated microbubbles to assess 
myocardial perfusion appears to be safe and efficacious. It is hoped, 
that myocardial contrast echo can be used to evaluate coronary flow 
reserve. Albunex microbubbles have the potential to serve as a cont­
rast agent for Doppler sonography in humans. Albunex can be used 
to enhance the Doppler signal from systemic arteries and the portal 
vein. Another possible use of Albunex is intraoperative detection of 
myocardial hypoperfusion to guide the order of graft placement and 
125 
to measure regional perfusion during cardioplegia delivery. Both uses 
might help lessen incidence of perioperative myocardial infarctions. 
Three-dimensional echocardiography refers to the technique of 
visualizing the heart, its structure and flow in three dimensions (eit­
her directly or after reconstruction, in static form or in real time) and 
drawing quantitative information from the three-dimensional data. 
Dynamic or real-time three- dimensional echocardiography refers to 
the ability to view the heart in three dimensions as it beats. Because 
the time factor is added, it is also called four-dimensional echocar­
diography. Five-dimensional or multidimensional echocardiography 
are terms occasionally used when viewing both the dynamic anatomy 
and flow jets. However, it is recommended to use the term three-
dimensional echocardiography as general name for all these functions 
rather than employing a host of confusing and unnecessary names. 
Every part of the heart and its pathology, every facet of its func­
tion, and every flow jet is three-dimensional in nature. An ability 
to directly view the heart and its structures in three dimensions rat­
her than attempting to perform mental reconstructions from two-
dimensional images could yield a better understanding of the dynamic 
anatomy, the spatial relationships, intricacies of cardiac pathology and 
flow disturbances. 3-D echocardiography portrays cardiac anatomy 
in unique projections not possible by 2-D echo. Recent efforts in 
three-dimensional echocardiography employing advanced ultrasound 
instrumentation and computer technology suggest that this approach 
is almost ready for clinical application. Volume and surface rendered, 
tissue-depiction three-dimensional reconstructions, performed from 
sequential tomographic images obtained with computer-controlled 
movement of the transducer at a predetermined mode and speed, 
show the best promise in contemporary clinical application. There 
are several sequential tomographic data acquisition methods using 
controlled transducer movement: parallel slicing or linear scanning, 
fan-like scanning in an arc, rotational scanning. Reconstruction of 
a 3-D image essentially involves realignment of 2-D images accor­
ding to their relations to each time point in the cardiac cycle and 
position in space. Interpolation is necessary to fill in gaps. For three-
dimensional image display a wire-frame mode and a tissue-depiction 
mode are used. Wire-frames ("a birdcage") are helpful in assessing 
geometry and mechanical properties of the left ventricle, chamber 
volume, and mass. The tissue-depiction mode portrays the cardiac 
structures better. Using x, y, z coordinates, the image can be rotated 
and tilted in various orientations and cut in the desired planes. Viewed 
in a dynamic mode, one could appreciate the motion of walls and the 
opening and closure of the valves. Images that portray intracardiac 
structures can be derived simulating intraoperative viewing of surgical 
anatomy. Basically, any structure can be visualized from any desired 
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vantage point. Guidelines are currently being formulated to define 
the clinically useful cut planes for various structures and pathology. 
Ongoing work in quantitative three-dimensional echocardiography is 
likely to provide newer indices that describe the cardiac pathology 
and function that have not been available before. Newer compu­
ter algorithms have shortened the image processing time from hours 
to minutes. Biologic color encoding is another technical advance in 
the evolution of 3-D echocardiography and is helpful in understanding 
and teaching 3-D echocardiographic depiction of the cardiac anatomy. 
Computer capabilities to perform electronic surgery in the reconst­
ructed images has also been demonstrated. A surgical procedure 
planned for a specific problem could be conceivably simulated in the 
ultrasound image and the effects and complications of the procedure 
predicted. This could allow the surgeon to modify the contemplated 
surgical approach. 
A unique truly 3-D display, developed from tomographic ultra­
sound information is holography. Holographic displays allow such 
presentations in which the image of the heart could have all the phy­
sical depth cues enabling the observer to appreciate the true spatial 
relations between various parts of the heart. 
Use of tomographic transesophageal probes has proven to be safe 
and easy to perform in patients. 3-D images obtained with this probe 
depict the valvular structures in a manner that has not been possib­
le before. However, if three-dimensional echocardiography is to be 
widely employed, one should be able to perform this technique transt-
horacically as well. Recent work has demonstrated that it is indeed 
possible to perform 3-D echocardiography with the transducer placed 
on the chest wall and subcostal regions. 
3-D reconstruction methods suffer from the fact that the derived 
data are collected at different times and are, therefore, not real time. 
Accordingly, it is difficult to evaluate complex beat to beat changes 
of the heart because the final data comprise a composite of multiple 
beats collected over time. 
A move towards real-time, three-dimensional appreciation of the 
heart has been the development of a phased array transducer which 
has the ability to scan, simultaneously, in two orthogonal planes. Pa­
rallel processing of the data corresponding to the two image planes 
allows, for example, a parasternal long-axis and short-axis view to be 
displayed simultaneously in real time. An attempt to obtain some 
perspective within the two-dimensional images can be employed so 
that, essentially, the two scan planes can be overlapped. However, 
this is still not true three- dimensional real-time imaging. The latest 
techniques utilize a matrix-style transducer array, which can collect 
ultrasound data in real time over a pyramidal volume. This system 
is still in the early stages of development (J. Kisslo and coworkers, 
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Duke University, USA). Another unresolved problèmes the issue of 
how best visualize a three-dimensional structure. Region-oriented 
and lesion-oriented display approaches are under investigation. 
Quantitative assessment of left ventricular size and function. 
Recent developments in digital image acquisition and display allow 
selection of cardiac cycles from different views followed by side-by-
side display of these cycles in a continuous cine loop. This techno­
logy enhances the endocardial definition during motion as well as in 
stand-still frames. Automatic boundary detection is based on quan­
titative assessment of tissue acoustic properties and permits on-line 
quantitation of ventricular cavity areas and indexes of function. New 
computer programs for quantitation of 2-D images are capable of 
providing measurements of LV volumes, EF, mass and centerline wall 
motion assessment from tracings of the end-diastolic and end-systolic 
endocardial contour in the apical views and the end-diastolic outer 
and endocardial border in the short axis. These programs are beco­
ming part of the newer echocardiographic instruments. Sonographers 
can therefore be trained to perform these measurements on-line with 
the physician acting as the experienced observer that integrates the 
quantitative results with the subjective evaluation. Two 2-D echocar-
diogrphic methods for determing LV mass have been developed: the 
area length model and the truncated ellipsoid model. 
Application of these methods have been greatly facilitated by the 
use of computers with digital image acquisition and cine- loop play 
back. However, the better reproducibility is still to be desired. Factors 
that will influence reproducibility are multiple and include variability 
within the patient, differences in image acquisition technique between 
the two studies and variability between observers in selection of car­
diac cycles and performance of the measurements. So, standardiza­
tion of image acquisition techniques and of measurement methods is 
as actual as before. 
Intravascular ultrasound (IVUS) imaging and intracardiac ec­
hocardiography (ICE). IVUS imaging is a newly evolving imaging 
method that employs miniaturized ultrasound transducers at the tip 
of catheters to visualize the cross-sectional and longitudinal morpho­
logy of small and large arteries. It supplies detailed information on 
the structure of an atherosclerotic lesion. IVUS imaging has great 
promise in comparison with angiography and fiberoptic angioscopy. 
Angiography can depict longitudinal silhouettes of the arterial lu­
men. It does not delineate the true anatomical severity of an arterial 
lesion and it does not show morphology of atheromatous lesions or 
abnormalities of the arterial wall. Fiberoptic angioscopy, another 
catheter-based technique that offers glimpses of the arterial lumen 
and inner surface of the wall, is limited by the cumbersome requi­
rement of replacing blood by clear fluid infusion and by its inability 
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to yield information on the composition of atheroma and the archi­
tecture of vessel wall. Intravascular ultrasound has been noted to 
be quite sensitive in the identification of various pathological com­
ponents, even in complex lesions. Abnormalities of the arterial wall 
and lumen are displayed by intravascular ultrasound in great detail, 
particularly in atherosclerosis. For examining the coronary and perip­
heral arteries, catheters varying from 3,5 to 9 French in size, carrying 
20 to 30 MHz frequency transducers, are used. Higher frequency 
catheters yield fine-resolution images up to distance of about 5 mm 
radius. Calibration in the display system allows measurement of the 
vessel diameter, luminal area, and wall thickness. Currently available 
intravascular instruments belong to either a mechanical or a phased 
array category. Repeated viewings of the recorded images are needed 
to ascertain the spatial relationship of two-dimensional images along 
the long axis of the vessel and to appreciate the effects of interven­
tions. These problems are overcome by 3-D reconstructions made 
by image-processing computers from a multitude of two-dimensional 
images recorded as the ultrasound catheter is pulled back at a constant 
speed from one location in the vessel to another. At the present time 
3-D reconstruction requires a separate off-line image-processing de­
vice. However, intravascular ultrasound instrumentation possessing 
three-dimensional imaging capability in itself is likely to be available 
in the near future. Intracardiac echocardiography (ICE) is a similar 
catheter-based ultrasound approach that displays cardiac chambers, 
valves, and other related structures. ICE catheters can be advanced 
into various cardiac chambers and the cardiac structures visualized 
from within the heart. The impetus behind the attempts to develop 
the modality of ICE is predominantly related to the need for bet­
ter guidance during various catheter-based therapeutic procedures 
for treating cardiovascular lesions. Currently 6 to 10 French catheters 
carrying 10,12.5,15, or 20 MHz transducers are used for ICE. For ICE 
to become a widely applicable clinical technique, the depth of field 
must be adequate to allow for visualization of the entire heart from the 
venous circulation. ICE performed with 10 French 10 MHz catheters 
permits an expanded field of view and represents a significant advance 
toward the goal of "whole heart imaging". Reduction in catheter size 
would be desirable to reduce the potential for vascular complications. 
There are attempts to construct catheters that combine intracardiac 
imaging and therapy (valvuloplasty, arrhythmia ablation, etc.). 
Transesophageal echocardiography (TEE). TEE provides en­
hanced appreciation of normal cardiac anatomy as well as of a variety 
of pathological entities in comparison with transthoracic echocardiog­
raphy. Panoramic transesophageal echocardiography (imaging field 
can be expanded to a width of 270') allows visualization of the atrium 
in its entirety, aids a better evaluation of pericardial and paracardiac 
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abnormalities, presents the aorta and the aortic arch more completely, 
and helps in recognizing mediastinal pathology. TEE has appeared 
to be an important diagnostic and monitoring technique after several 
types of open heart procedures and may reduce the need for re­
peat cardiac catheterization. TEE should be a complimentary test to 
transthoracic studies in patients with suspected prosthetic valve dys­
function. Patients suspected of having a prosthetic valve endocarditis 
should routinely undergo a TEE examination because of its superiority 
over transthoracic in detection of vegetations, valvular regurgitation 
and perivalvular abscesses. The role of TEE in detecting intracar­
diac thrombi, vegetations, and tumors has been well established. In 
particular, the left atrial appendage is readily apparent, and clots wit­
hin it can be detected with reliability. Transesophageal echo-Doppler 
echocardiography is a further refinement of Doppler technique and 
gives high quality signals of pulmonary venous inflow to help assess 
function of the left ventricle and left atrium. Transesophageal color 
Doppler echocardiography is useful in the detection of left-to-right 
shunts, being more sensitive than oximetry. TEE is very useful in 
the assessment of aortic dissection, left atrial thrombi and right atrial 
masses. TEE has emerged as an important adjunct to interventio­
nal cardiac catheterization providing crucial information which may 
not be obtainable by transthoracic echocardiography or angiography. 
TEE is also a safe and useful diagnostic technique with fairly broad 
applications in the critical care setting. Technological advances in the 
design and capability of TEE probes and transducers have been lar­
gely responsible for the emergence of TEE as an important clinical 
tool. Probes with multiplane capability in which an imaging plane is 
steered through a 180-degree arc have become commercially availab­
le. With further refinements in TEE and related technologies, the 
future of this modality will most likely include clinical application of 
3-D reconstruction and acoustic quantification. Eventually, the ul­
timate diagnostic imaging modality will provide an objective display 
of cardiac shape and size throughout the cardiac cycle. The availa­
bility of objective 3-D images of the heart would greatly improve the 
diagnostic accuracy in general. In addition to technological problems 
there is a lot of unresolved medical issues. While one is now better 
able to identify cardiac pathology by means of TEE, the significance of 
many of these lesions are not resolved. So, except in certain clearcut 
scenarios, many of the decisions regarding the use of TEE, and the 
implications of the TEE findings, will have to be made on an individual 
basis. 
For a long period developments in cardiac surgery and in cardiac 
catheterization and angiography have occurred to a large extent hand 
in hand. Rapid growth of noninvasive imaging techniques over the last 
10 to 15 years has dramatically changed the situation. These changes 
have taken place first of all thanks to diagnostic ultrasound methods, 
comprising of 2-D echocardiography, Doppler echocardiography, and 
color flow imaging. These methods have demonstrated the ability to 
provide detailed anatomic information, generally surpassing that ob­
tained by angiography and hemodynamic information. The methods 
are noninvasive, nonionizing, and far less costly. As a result, cardiac 
catheterization and angiography have become almost unnecessary in 
numerous cardiac conditions. Spectral and color Doppler echocar-
diographic techniques permit accurate measurement of transvalvular 
gradient, determination of functional orifice area, evaluation of as­
sociated valvular regurgitation, and assessment of pulmonary artery 
pressures. Doppler echocardiography has been used to assess physio­
logic changes with exercise in adults with asymptomatic aortic stenosis. 
Now exercise Doppler echocardiography offers a noninvasive tech­
nique to evaluate prosthetic valves. It is reproducible, safe, and less 
cumbersome than cardiac catheterization. A range of normal exercise 
hemodynamics has been established for aortic and mitral prostheses. 
Using these parameters, the diagnosis of early prosthetic dysfunction 
can be made. It is now possible to assess the severity of the lesion 
as well as its hemodynamic and functional consequences. The cross 
sectional imaging provides a far better assessment of the pathologic 
anatomy than angiographic methods. So, carefully done echocardiog-
raphic studies are definitive means of establishing the presence and 
significance of mitral stenosis and tricuspid stenosis, thereby obviating 
the need for invasive evaluation in many patients, reducing risk, and 
potentially decreasing the cost of diagnostic assessment. Doppler ec­
hocardiography has also been shown to be useful for documenting the 
intracardiac flow abnormalities related to constrictive pericarditis and 
cardiac tamponade. By means of Doppler echocardiography patients 
with constrictive pericarditis and restrictive cardiomyopathy can be 
differentiated by comparing respiratory changes in transvalvular flow 
velocities. It is currently feasible to obtain diagnostic quality echocar­
diograms in over 90% of the patients and the yield is even higher in 
a pediatric practice. Since management decisions can and will often 
made on the basis of echocardiographic findings, a high level of quality 
control in the administration of present-day echocardiography labo­
ratory is necessary. Echocardiography is highly operator-dependent 
technique. The more automated it could be in data acquisition and 
interpretation, the easier it will be to decrease the interoperator va­
riability. Ther are already data which point to the feasibility of this 
approach. 
Two-dimensional and Doppler echocardiography in acute myocar­
dial infarction and in patients with ischemic heart disease in general. 
Echocardiography, performed in the emergency room, can readily 
distinguish aortic dissection, pericarditis, pulmonary embolism and 
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hypertrophie cardiomyopathy from acute myocardial infarction. In 
the era of thrombolytic therapy it is particularly important to differen­
tiate aortic dissection and pericarditis from acute myocardial infarc­
tion. Echocardiography can identify extent of right ventricular invol­
vement. The basis for considering 2-D echocardiography as a tool to 
evaluate patients with suspected or known coronary artery disease is 
the clinician's ability to evaluate regional wall motion abnormalities 
with this examination. Because of the multiple tomographic views 
that can be obtained with this ultrasonic test, it is possible to evaluate 
virtually every segment of the heart. Wall motion score index and 
Doppler-derived ejection parameters serve to help determine the ra­
pidity with which individual patients can be progressed in CCU. Early 
determination of wall motion score index by 2-D echocardiography 
has been appeared to be useful for identifying patients for high risk 
for complications and is especially valuable in the subset of patients 
who initially seem to be in stable condition as judged from clinical va­
riables. Transthoracic and transesophageal echocardiography can be 
used to identify complications of acute myocardial infarction. Shor­
tened deceleration time is an independent predictor of heart failure 
with AMI. 2-D echocardiography is an ideal means for assessing re­
gional ventricular function in the setting of coronary artery disease. 
The examination is obtained in real-time with excellent spatial and 
temporal resolution. Ventricular function can be judged with regard 
to wall thickening as well as wall motion. The examination is pain­
less, avoids any ionizing radiation, and is truly non-invasive not even 
requiring an intravenous injection. The examination is also less cost­
ly than many other sophisticated imaging techniques. The utility of 
stress echocardiography in the detection of chronic stable coronary 
syndromes, measured in terms of sensitivity and specificity, is at le­
ast comparable to any other noninvasive imaging technique. The 
introduction of digital recording and display of two- dimensional ec­
hocardiograms has enhanced the value of exercise echocardiography 
for risk stratification following an acute myocardial infarction. The 
safety of pharmacologic stress echo, and transesophageal paced echo, 
in the early post-MI period has been established. These modalities 
(especially dobutamine stress echo) will be increasingly used to diag­
nose myocardial stunning. Dobutamine stress echocardiography is 
also used for assessment of cardiac risk before noncardiac surgery. 
Whereas dipyridamole produces ischemia by coronary steal, dobuta­
mine produces ischemia in a manner similar to exercise. Dobutamine 
echocardigraphy produces sensitivities and specificities comparable 
to exercise echocardiography. Pacing the heart is another alternative 
to exercise. An advantage of pacing is that with echocadiographic 
monitoring one could compare resting and immediate stress images 
at the same heart rate, as once the pacing is stopped the heart rate will 
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revert back to the original rate. Echocardiography can be added to re­
habilitation stress test, toward end of hospitalization, to improve both 
sensitivity and specificity for detecting post-infarct, exercise-induced 
ischemia. The ability to identify the regions supplied by individual 
arteries is also as good if not better than with a comparable nuclear 
approach. 
Doppler Tissue Imaging (DTI) is a new echocardiographic ima­
ging technique, which utilizes color Doppler maps designed to opti­
mally image slow-moving but highly echogenic tissue boundaries in 
preference to blood pool, enabling semi-quantitative assessment of 
myocardial contraction velocities. It is he ped, that DTI may provide 
a valuable new method of imaging ischemic myocardium, with greater 
sensitivity than В mode echocardiography and with the potential to 
differentiate ischemic but viable myocardium from fibrotic tissue. 
Tissue characterization by ultrasound, analyzing integrated back-
scatter is under investigation. The capability of clearly detecting the 
structure and composition of tissues (especially myocardial tissue) has 
come to have major implications in therapy. TTie clinical utility of this 
approach is yet to be proven. 
So, echocardiography today is what a stethoscope has been to phy­
sicians for over a century. It has become an integral part of contem­
porary cardiology. Though the pace of developments in echocardiog­
raphy in the last decade has been staggering, ultra- sound technology 
continues its rapid development. Dr. J. Tajik (The Mayo Clinic, USA) 
predicted in his Deryck Taylor Lecture during The Second Canterbury 
Echo Symposium, that by the end of this century invasive hemodyna­
mic techniques would be fully replaced by more informative ultra­
sound techniques. Clinicians scientists will soon be able to extract the 
heart from the body electronically for the purpose of anatomic, func­
tional, and histologic analysis without adverse effect on the patient. 
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